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ABSTRACT 
 
MOLECULAR LOGIC GATES IN THE ACTIVITY MODULATION 
OF POTENTIAL PDT AGENTS & RATIONAL DESIGN OF 
SELECTIVE CHLORIDE SENSORS 
 
Sündüs Erbaş-Çakmak 
PhD in Materials Science and Nanotechnology 
Supervisor: Prof. Dr. Engin U. Akkaya 
February, 2013 
Considering the time arrow of science, things are getting smaller and smarter as the 
information grows immensely. More is known about the molecular and genetic basis 
of diseases, and therapies become more personalized accordingly. In parallel, organic 
devices are becoming progressively intelligent. Molecular logic gates increase the 
flexibility in functionality of the Boolean logic operations, and allow the creation of 
demanding complex functionalities for different purposes. The missing link between 
the design of any kind of complex logic operation and assignment of a real function 
is addressed by our work. A dual-activatable photosensitizer acting as an AND logic 
gate enables a more selective photodynamic therapy with the use of biologically 
relavant concentrations of acid and glutathione. Additionally, with a combinatorial 
therapy and imaging approach, a proof of principle theranostic device with DEMUX 
logic behaviour is developed to select between singlet oxygen generation and 
emission in response to an address input (acid) in organic solvent. In another project, 
relay of information between two independent logic gates embedded into a 
physically constraining microenvironment was successfully demonstrated to report 
the activity of a pH-activatable photosensitizer as an enhanced emission. 
Independently, a series of highly selective fluorescent chloride anion sensors based 
on BODIPY-triazolophane conjugate are introduced with a surprisingly large 
dynamic response range.    
Keywords: Photodynamic therapy, logic gate, activatable photosensitizer, Cl− sensor 
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ÖZET 
POTANSİYEL FDT AJANLARININ MOLEKÜLER MANTIK 
KAPISIYLA AKTİVİTE KONTROLÜ & SEÇİCİ KLORÜR ANYONU 
ALGILAYICILARININ RASYONEL TASARIMI 
Sündüs Erbaş-Çakmak 
Doktora, Malzeme Bilimi ve Nanoteknoloji 
Tez Yöneticisi: Prof. Dr. Engin U. Akkaya 
Şubat, 2013 
Bilimsel gelişimin izlediği yola bakıldığında artan bilgi birikiminin, fonksiyonel 
aygıtların küçülmesiyle orantılı olduğu görülür. Bunun yanısıra, hastalıkların 
temelinde yatan moleküler ve genetik süreçler hakkında edinilen bilgi arttıkça 
uygulanan tedaviler daha vakaya özgü olma yolunda ilerlemektedir. Bu gelişmelere 
parallel olarak, organik malzemeler daha da akıllı hale gelmektedir. Moleküler 
mantık kapıları geleneksel Boole cebirine işlevsel esneklik kazandırmakta ve çeşitli 
amaçlar için ihtiyaç duyulan karmaşık işlemleri yapabilme olanağı sunmaktadır. 
Çalışmalarımızda, herhangi bir moleküler mantık kapısına atfedilen karmaşık 
işlemlerin uygulanabilir ve anlamlı bir yapıya sahip olacak şekilde iyileştirilmesi 
amaçlanmıştır.  Bu bağlamda, biyolojik olarak anlamlı asit ve glutatiyon 
derişimlerinde VE mantık kapısı olarak davranan aktifleştirilebilir bir fotodinamik 
terapi ajanı oluşturulmuştur. Bunun yanı sıra, tedavi ve görüntülemeyi birleştiren 
teranostik yaklaşımı kullanılarak, DEMUX mantık kapısı olarak davranan 
fotoduyarlaştırıcının, organik çözücüde singlet oksijen üretimi ve ışıması, asit adres 
girdisi ile kontrol edilmiştir. Bir diğer projede, sınırlı bir mikroalanda, birbirinden 
bağımsız mantık kapıları arasında bilgi iletişimi sağlanmış, pH ile aktifleşen 
fotodinamik ajanının aktivitesi, diğer bir mantık kapısı aracılığıyla emisyon artışı 
şeklinde takip edilebilmiştir. Bağımsız olarak, BODIPY ve triazolofen temelli, seçici 
bir seri floresan klorür anyonu algılayıcısı sentezlenmiş ve şaşırtıcı derecede geniş 
bir derişim aralığında bu anyonun algılandığı gözlenmiştir.   
Anahtar kelimeler: Fotodinamik terapi, mantık kapısı, aktifleşebilir 
fotoduyarlaştırıcı, Cl− algılayıcısı 
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CHAPTER 1 
1. INTRODUCTION 
 
This thesis presents four different projects related to use of chemical logic gates to 
allow mutually exclusive outcome of imaging and therapy in a unimolecular 
theranostic device (chapter 3), to develop dual-parameter activatable photodynamic 
therapy agent (chapter 4), to obtain functionally concatenated gate of bimolecular 
activatable photosensitizer embedded into a micelle with an activity reporting probe 
(chapter 6). In a separate context, this thesis also includes the synthesis and detailed 
photophysical analysis of BODIPY-based fluorescent sensors bearing triazolophane 
receptor for selective detection of chloride anion (chapter 5).  
Chemical logic gates, first introduced by de Silva et al.1 are primitive mimics of their 
silicon-based counterparts and can perform simple logic operations. The operation of 
these molecular devices is in response to a predetermined chemical or photonic input 
that enables a detectable output. Like digital electronics, thresholds are determined to 
structure the character of the output such as emission intensity. Since the device is 
molecular, the idea is promising considering the space limits of traditional Boolean 
computation. Indeed, certain semi-sophisticated processes have been conducted 
using chemical logic gates such as flip/flop memory devices2 which are the basic 
element of random-access memory (RAM) in modern technology, key-pad-lock3 
systems that produce an output only in the presence of certain order of inputs like in 
the case of a keypad of an ATM machine, and with the use of oligonucleotides, 
molecules are even designed to play games like Tic-Tac-Toe4. In this thesis, logic 
gates are used for different biomedical applications in different functional framework 
(chapters 3, 4, 6). 
Conventional diagnosis techniques for life threatening diseases such as cancer may 
require painful or uncomfortable operations such as biopsy, radio imaging, magnetic 
resonance imaging etc. Yet, the dose and effectiveness of the therapeutic agents 
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cannot be adjusted in accord with the stage and advance of the malignancy in 
different regions of the tissue. A number of different studies associated with selective 
accumulation or activation of the drugs in tissue of interest were reported. Most of 
them depend on the disease specific markers, such as over-expressed receptors,5,6 
symptomatic metabolites,7 enzymes,8,9 pH,10 reducing power11 and oligonucleotide 
hybridization.12 However, only a few have the imaging ability together with a 
remedy13 and none have reversible, interdependent, coupled therapeutic action with 
the diagnostic moieties.  
Here in this thesis, a smart theranostic system is proposed in which the disease state 
is monitored and corresponding information is used in situ for therapeutic action. To 
create a theranostic agent, DEMUX logic gate design is used and a pH-induced 
switch in the direction of excitation energy transfer between two chromophores is 
combined with the concept of theranostics. Photodynamic singlet oxygen generation 
and fluorescence emission was only mutually observed and the switch between the 
two modes of operation is reversibly controlled by pH, acidic pH being a well-known 
tumor symptom.14 The idea presented in chapter 3, is a proof of principle of 
molecular theranostics, unifying diagnosis with therapeutic activity.   
Logic gates are potential molecular devices for use as smart therapeutic agents. AND 
and OR gates with therapeutic acitivity is previously reported where the dual activity 
of both inputs are required for the therapy action in the former and activity of any of 
the two inputs are enough for the latter.15,16,17 To improve the biological relevancy of 
logic gate inputs, an extensive optimization process and pragmatical design is done 
to control the activity of the photosensitizer in second project presented in this thesis 
(chapter 4). Inputs are chosen as low pH and glutathione, two common parameters 
observed in most of the tumors. Compound is designed to show response to these 
parameters with the help of protonation induced spectral shift and reduction of the 
disulfide bond by glutathione to release energy acceptor moiety. Highly promising 
results are obtained such that compound displays a more singlet oxygen generation 
efficiency in the presence of both of these inputs.  
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The following step in molecular logic gate subject is to combine multiple simple 
logic gates to create a functional signal relay cascade. Attempts to integrate multiple 
gates are successfully performed in literature.18,19,20 However, functional assignment 
for such logic gates is still to be improved. In chapter 6, a research on the functional 
concatenation of simple logic gate is proposed where a pH-activatable 
photosensitizer acting as an AND gate is integrated, with the produced singlet 
oxygen, to a singlet oxygen reporter. The latter reporter act as either an AND gate 
with the use of light and singlet oxygen as inputs or INHIBIT gate with inputs singlet 
oxygen and glutathione. The controlled activity of the first photosensitizer is 
monitored with a concentenated manner by the second and a functional relay of the 
signal between two logic gates is successfully observed.  
The era of molecular sensor is highly rich in binding motifs selective for certain 
analyte and there are a number of different anion and cation sensors. Among them, 
triazolophanes21 are also promising receptor for halides showing a size-dependent 
selectivity for chloride. Since it is not usual for a receptor to differentiate between 
halides with such selectivity, a fluorescent sensor with this binding module seems 
encouraging. With this motivation, in the research introduced in chapter 5, a 
BODIPY-based fluorescent chloride sensor is developed. With the two modes of 
response, binding to the receptor and basicity/redox property of the halide provide 
surprisingly large dynamic range of response. With the aid of control compound 
lacking receptor module, the contribution of other pathways involved in sensing is 
analyzed.  
In summary, this thesis consists of functional improvement of molecular logic gates 
for biological applications such as development of a theranostic agent, dual-
activatable photosensitizers and self-activity reporting activatable photosensitizers. 
In addition, the first fluorescent sensor developed with triazolophane-BODIPY 
conjugate with a highly promising binding behaviour in organic solvent is 
introduced. 
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CHAPTER 2 
BACKGROUND INFORMATION 
 
2.1 Photophysics of Light Absorption by an Organic Molecule 
Excitation of an organic molecule by means of light involves transition of an electron 
from the orbital in the ground state to an unoccupied orbital with higher energy 
called excited state. Electronic transition within the molecule can take place between 
different molecular orbitals as far as the quantum selection rules are obeyed. The two 
major selection rules are the ones related to orbital symmetry and the spin 
multiplicity. Scheme 1 shows the possible transitions in an organic compound 
containing heteroatom in its structure. Transitions between the orbitals n-π* and π-π* 
require less energy. Transitions involving non-bonding orbitals usually result in a 
redistribution of electron density from heretoatom to the rest of the molecule and 
thus said to have a charge transfer character.22 The change in the dipole moment with 
respect to ground state as a result of charge transfer in certain molecules guides the 
design of chemosensors23, logic gates24 and some other smart organic materials.     
 
Scheme 1. Relative energy levels of molecular orbitals in an organic molecule containing 
heteroatom and possible electronic transitions  
The interaction of polarized light with the molecule during the absorption process is 
determined by the alignment of the transition moment of the molecule during the 
absorption process. Different transitions have different transition moment vectors on 
 
 
5 
 
an aromatic molecule and the parallel alignment of any of these moments with 
respect to polarization axis of the light increases the probability of the transition. 
Thus, any type of photon excitation would be expected to be related to the relative 
orientation of molecules and the polarization of light. Although this nature of 
transition is of great importance in confined molecular assemblies such as liquid 
crystals or membrane structures25, most of the spectroscopic applications are in 
solution with randomly oriented molecules excited with non-polarized light.   
Dependence of light absorption on the properties of absorbing species was first 
formulated by August Beer, Johann H. Lambert and Pierre Bouguer. Considering the 
intensity of incident light and the light that is transmitted, the law (Beer-Lambert 
law) states a coorelation between the concentration, light path length and the 
absorption as shown below:  
     log (Io/I) = Aλ = ε(λ) C l     Equation 1 
where Io and I represents the initial and transmitted light respectively, Aλ is the 
absorption of the molecule in a given wavelength (λ), ε is the molar absorption 
coefficient of the molecule in that wavelength, C is the concentration of the molecule 
and the l is the length of the absorbing medium through which light passes. Deviation 
from the ideal linear dependence appeared in higher concentrations either due to the 
aggregation of the absorbing molecules or emergence of new absorbing species such 
as excimers.22    
2.2 Providence of an Excited Molecule 
Upon excitation by a photon, a molecule can go through a number of diverse 
physical pathways depending on the nature of its electronic, vibrational or rotational 
characteristics or the properties of media it is in. All of the possible well-defined 
pathways are illustrated in a Jablonski diagram26 shown in Scheme 2. The initial 
essential process is the excitation and the transition would be to higher vibrational 
energy levels of the excited state (route 1). This process is exceedingly fast (10-15 s) 
and usually the reorientation of the nucleus during the process is not expected to 
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occur. Vibrational relaxation to the ground state vibrational level of excited 
electronic state (route 6) results in a subsequent lower energy emission profile which 
is called Stoke’s shift.22 The extent of this spectral shift is very important for some 
applications including luminescent solar concentrators in which larger Stoke’s shifts 
are demanded to decrease the self-absorption of the chromophore.27 The lifetime of 
singlet excited state differs a lot but most of the chromophores have lifetimes around 
0.1-100 ns.22 This lifetime depends on the relative fastness and the dominance of 
other deactivating pathways such as internal conversion (route 3) or intersystem 
crossing (route 4). Energy or electron/proton transfer routes to the molecules in close 
proximity, excimer or exciplex formation, interactions with the solvent or other 
molecules also change the excited state lifetime of a molecule.      
 
Scheme 2. Possible photophysical processes taking place after the excitation by photon and 
their time scales, the Jablonski diagram 
Amongst the deactivation pathways, perhaps the intersystem crossing is of great 
importance especially for some related applications such as photodynamic therapy. 
Selection rules forbits the transition between states of different multiplicity. 
However, presence of heavy atom creates a magnetic torque by the nucleus on the 
electron and mixes the spin states to some extent through spin-orbit coupling and 
allows such transitions.22 Molecules whose S0-S1 transition is n-π* type, have more 
efficient intersystem crossing. Apart from heavy atoms, some molecules such as 
fullerene are shown to have this effect.28 Identical molecules attached to oneanother 
in a perpendicular orientation and thus having close excited singlet states tend to 
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facilitate this transition as well.29 The fate of a triplet state in an aerated solution is 
usually the quenching by molecular oxygen. Phosphorence or delayed fluorescence is 
the emission from this state and usually can be observed at low temperatures in 
degassed solutions.Triplet-triplet annihilation is one important subsequent process of 
triplet state transition. In this phenomenon two molecules in triplet state collide and 
contribute their energy to the excitation of one of them or another molecule to singlet 
excited state. Since the energy given initially to excite the molecule is lower than the 
triplet-triplet annihilation induced excitation energy, this photophysical track is used 
as an energy upconverting method.30 The intersystem crossing phenomenon, 
succeeding interactions with ground state oxygen and their importance in 
photodynamic therapy will be explained in details in following sections.   
2.3 Energy and Electron Transfer Processes 
An excited molecule can transfer its energy to another molecule in close vicinity or 
the electron transfer between two different species can take place. While the former 
requires spectral overlap between the emission of the donor and absorbance of the 
acceptor moiety, redox potentials and relative alignment of energy levels of the two 
species are important for the latter.  
2.3.1 Electronic Energy Transfer 
 
Scheme 3. Types of energy transfer  
Energy transfer is the initial process in photosynthesis where perfectly arranged 
chromophores within a protein scaffold absorp and transfer energy through the 
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reaction center where series of redox reactions take place.31 Inspired by the beautiful 
example of nature, scientists develop energy transfer systems for a range of purposes 
such as for determining biochemical interactions32, for solar cell applications27, for 
regulation of activity of photosensitiser8. Förster and Dexter extensively explained 
the nature of the process and formute it.33,34 There are basically two different types 
of energy transfer mechanisms Förster type resonance energy transfer or electronic 
energy transfer (EET, FRET) and Dexter type energy or electron transfer as shown in 
Scheme 3.   
 
Figure 1. Distance dependency of FRET efficiency  
Förster type energy transfer is essentially a dipole interaction between one excited 
and one ground state chromophor. For the process to take place two moieties should 
be close enough (usually less than 10 nm, Figure 1) and the spectral overlap between 
the donor emission and acceptor absorbance is required for efficient process. The 
dependency of distance and overlap integral is given in equation 2 and 3 below:   
    EFRET = [1 + (R/Ro)6]-1  Equation 2 
   Ro6 = [9 Qo (ln10) κ2 J] / [128 π5 n4 NA] Equation 3 
where, Ro is Förster radius and defined as the distance between donor and acceptor 
moieties that enables 50% energy transfer efficiency. R is the separation between 
FRET modules, Qo is the fluorescence quantum yield of free FRET donor, κ is the 
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orientation factor of the dipole, J is the overlap integral, NA is Avagadro’s number, n 
is the refractive index of the medium.  As it is clearly seen from the formula, increase 
in spectral overlap enhances FRET efficiency and the efficiency decreases 
dramatically depending on the 6th power of distance between donor and acceptor 
modules. This reliance is also evidently revealed in Figure 1, in essence no FRET is 
observed beyond 10 nm.  
This property of EET is used widely to determine conformation of biological 
macromolecules such as proteins, DNA/RNA hybridization assays, to determine 
protein-protein, protein-DNA interactions, and as a biological metric system for 
differentially labeled regions or compartments, Figure 2.32 In order to determine the 
interaction partners of a protein in a downstream signaling pathway of a biochemical 
process or disease,35 protein of interest is labeled and screened against tagged protein 
pool. The same anology applies to DNA/DNA, DNA/RNA base pairing within or 
between molecular species to monitor the disease state, for diagnosis or gene 
Figure 2. Use of FRET for biological applications 
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expression analysis etc. Since the conformational status of most of the biological 
molecules is closely related to their functionality, the information on their folding 
state is highly important. Stimulus or ligand induced change in the conformation in a 
receptor can also be scrutinized using the FRET method.36  
Dexter energy transfer requires a shorter distance between donor and acceptor due to 
the fact that an orbital overlap is required for the route.34 Hence, the maximum 
distance required for the process is 1 nm which is 10 times less than FRET. In this 
process, electron exchange between the two modules is essential. This phenomenon 
is usually much faster and more efficient compared to FRET and usually occurs 
within conjugated systems. 
2.3.2 Quenchers, Quenching Mechanism and Applications 
 
Scheme 4. The dependency of quenching on distance, F represents FRET donor and Q 
represents quencher. 
For most applications, FRET is used between two fluorescent molecules and the 
change in the wavelength of emission is monitored as an output signal. However, 
sometimes, use of non-fluorescent molecules as an energy acceptor is required. In 
this case, fluorescence or activity of a molecule or sensitizer is controlled by a FRET 
to quencher in the vicinity which is usually called molecular beacon.8 A number of 
quenchers are present in literature and some are commercially available. The basic 
mechanism of quenching is described in Scheme 4, where the energy transfer to the 
beacon within the active sphere is followed by radiantionless dissipation of energy. 
Most of the molecular beacons shows dynamic quenching where the absorption of 
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the species does not change but the excitation energy is lost through non-
radiationless processes.22 In the other form of quenching called static quenching, 
physical interaction with the quencher is required to form a non-fluorescent comlex.  
Since the time scale of energy transfer is much shorter than both fluorescence and 
triplet intersystem crossing lifetimes, presence of a beacon as an energy acceptor 
competes well with the fluorescence outcome or singlet oxygen generation 
process.8,22 Ones the quencher diffuses out of the active sphere either followed by 
chemical dissociation or change in microenvironment, quenching efficiency 
disappears. The control of the dissociation or physical separation may depend on the 
activity of an enzyme that cleaves the linker between the two FRET modules or the 
change in the environment such as the polarity that physically partitions the modules 
apart.  
Molecular beacons or quencher-based systems with fluorescent compounds are 
widely used as chemosensors. Among them, control of photodynamic activity is 
intriguing in view of the fact that it enables the creation of activatable 
photosensitizers which will be examined in following sections in detail.  
 
2.3.3 Photoinduced Electron Transfer (PET) 
 
Scheme 5. Mechanism of photoinduced electron transfer and its use in chemosensor 
Photoinduced electron transfer (PET) is an excited state phenomenon where an 
electron from the highest occupied molecular orbital (HOMO) of the nearby moiety 
is transfered to the HOMO of the fluorophore followed by the excitation of the 
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fluorophore, Scheme 5. In the case of oxidative PET (or reverse PET) electron 
excited to lowest unoocupied molecular orbital (LUMO) of the molecule is 
transfered to a closely spaced moiety having relatively lower LUMO level. For the 
two processes to take place, energy levels should be compatible to allow this redox 
processes to take place. Since both of these electron transfer processes competes with 
fluorescence the compound is not emissive. Any interaction that change the levels of 
either fluorophore or electron donor/acceptor part in such a way that the process is no 
more favourable, fluorecence quantum yield tends to increase. With appropriate 
design of the receptor or fluorophore, analyte responsive fluorescence control can be 
achieved and chemosensors can be constructed accordingly.23  
 
2.3.4 Photoinduced Intramolecular Charge Transfer (ICT) 
 
Scheme 6. ICT process in cation sensing 
Molecules possensing electron donating and/or electron withdrawing groups in their 
structure tend to show an increased dipole moment upon excitation.22 The 
redistribution of the charge is established by the reorganization with respect to 
solvent to attain thermodynamic equilibrium. These type of compounds show solvent 
and polarity dependent fluorescent properties and when rationally designed, 
interaction with the analyte can be used to control the ICT character of the molecule. 
A spectral shift in absorbance/emission upon binding to analyte also enables 
ratiometric sensing (Scheme 6). Depending on the electronic character of the 
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receptor and analyte, ligand can induce a hypsochromic or bathochromic spectral 
shift in electronic absorption and/or fluorescence spectra.  
In Figure 3, two pH-responsive BODIPY fluorophores with a strong charge transfer 
property is shown. BODIPYs have electron-donating 4-(dimethylamino) phenyl and 
electron withdrawing pyridine groups in their structures. While protonation induces a 
hypsochromic shift in the first one, it results in a bathochromic shift in the second.37 
This distinct characteristic shifts in electronic absorptions of these two BODIPYs are 
used in the first project presented in this thesis to construct a molecular demultiplexer 
(DEMUX) logic operation. 
 
Figure 3. pH responsive BODIPY dyes with strong ICT character. 
2.4 Fluorescent Chemosensors 
In many cases, detection of concentrations of certain analyte is highly important. To 
detect the toxic inorganic compounds in the environment, drinking water is critical. 
Determining the concentration fluctuations of inorganic ions and biomolecules in 
certain biological processes gives highly valuable scientific information and helps to 
understand the molecular biology of the process. The recognition of analytes also 
used for diagnostic purposes. Roles of ion transport across membrane in neuron 
excitation and muscle contraction, calcium release in fertilization, chloride 
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channelopathies in cystic fibrosis, dependence of ATP synthesis on proton gradient 
are all understood with the aid of molecular sensors.  
When an appropriate binding pocket is attached to the structure of the fluorescent 
molecule reasonably, an interaction-induced observable change in fluorescence or 
electrochemical property can be obtained. The resultant response can be a change in 
intensity of emitted light (turn on/off sensor) or a shift in the emission wavelength 
(ratiometric). The mechanism of the first case is usually PET while it is ICT in the 
second. Agreat number of sensors have been developed and used for the detection of 
cations, anions, biomolecules.23 Some of them are examplified in following sections. 
 
2.4.1 Cation sensors 
Cations are important functional components of biology. They have important roles 
in neural activities, cell homeostasis, enzyme activity and a number of diseases are 
related to deficiencies in regulation of their concentration in the body. To detect 
these important analytes, a number of highly important chemosensors are developed. 
Some iportant examples with ICT, PET and FRET character are given in Scheme 7.  
BAPTA (1,2-bis (o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid) motif in the 
receptor part of compound A (Scheme 7) is widely used in literature as Ca2+ binding 
module.38 The BODIPY fluorophore is internalized into the cell in ester form, 
hydrolyzed within the cell and display increase in fluorescence intensity upon Ca2+ 
binding. Dipicolyl amine moiety is a Zn2+ chealator group and binding of this cation 
blocks the reductive photoinduced electron transfer from amine group to fluorescein 
in compound B.39 Whence the PET is no more effective, fluorescein’s green 
emission is observed. The coumarin attached through ester bond is hydrolyzed within 
the cell and this part is released consequenctly. The comparison of the blue emission 
of coumarin dye and green fluorescein emission enables real-time ratiometric sensing 
of the cation within the cell. This approach desreases the error associated with 
bleaching of the molecule or inhomogeneity in concentration of the fluorophore. 
Compound C is a K+ sensor developed to determine extracellular concentration of 
this cation.40 
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Scheme 7. Three of the Ca2+ (A), Zn2+ (B) and K+ (C) fluorescent chemosensors in literature 
2.4.2 Anion Receptors and Sensors 
Anions are essential components of biology as do cations. Phosphates are 
fundamental part of energy mothabolism, they are used to modify proteins hence 
control their function through modulating the interaction with other biomolecules. 
They also form the backbone of DNA and RNA polymers. Iodide is important for the 
synthesis of tyroid hormone. Citrate is an essential intermediate in Krebs cycle.  
Chloride regulates cell volume and pH, has roles in bone degradation and is 
associated with the disease cystic fibrosis.21 And for a number of anions, the 
biological roles are still to be determined. For that reason it is important to develop 
sensors to detect their level in biological media.  
Although selective detection of cation in aqeous media is improved a lot and most of 
them are in use, anion sensing is still challenging. The large radius of most anions 
requires tricky binding pockets. Most of the receptors developed in literature use 
either species with opposite charge to take advantage of electrostatic interaction, ion-
dipole interaction or strong hydrogen bond donors such as urea or pyrrole to enable 
stable coordination.41 There are very few examples of fluorescent chloride sensors in 
literature and most of them are turn-off type. Some of them are given in Scheme 8. 
The halide response of 6-methoxy-N-(3-sulfopropy1) quinolinium (SPQ) is first 
analyzed by Wolfbeis and Urbano in 1983 and derivatives of this compound are 
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commercially available now for chloride sensing.42 The turn off response of this and 
similar dyes are explained by collisonal quenching facilitated by reduction of the 
species.43 Although the response is turn-off, the detection range of these dyes for 
halides is quite high and spans beyond 100 mM.44    
When two pyrene units come close enough the excited state interaction between the 
molecules produce a new lower energy fluorecence called excimer (excited dimer) 
emission.45 This property of pyrene is used to detect fluoride, acetate, bisulfate and 
dihydrogen phosphate among others, (Scheme 8, compound B).46 Upon binding of 
these anions to the thiourea groups the molecule folds to bring pyrene units closer in 
dimethylsulfoxide solution. The excimer emission of pyrene increases as a result. 
Although the selectivity for a certain anion is poor, this molecule provides a 
ratiometric sensing.  
 
Scheme 8. Examples of fluorescent anion sensors 
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Compound C shown in Scheme 8, has chiral binding pocket and can discriminate 
between D-mandelate from the L-enantiomer. Quenching of the emission is more 
pronounced in the first one.47 Compound D is a BF2-bridged dipyrrolyldiketone and 
chloride anion interferes with the sol-gel transition temperature of this compound. 
Anion-induced decomposition of the gel structure at RT results in a bright orange 
fluorescence.48 Compound E exhibits excited state intramolecular proton transfer 
(ESIPT) phenomenon which is transfer of proton from one group to another at the 
excited state due to change in acidity upon excitation.49,50 Fluoride abstracts the 
proton and prevents tautomer emission. The resultant emission is at 495 nm. Lower 
basicity of other anions can not manage to deprotonate the urea NH thus tautomer 
emission survives. Finally, emission of compound F is highly quenched upon 
addition of fluoride which is attributed to PET from deprotonated urea to 
naphthalimide fluorophore.51  
In compound G in Scheme 8, authors take advantage of the ligand exchange of Cu 
(II) phenanthroline complex. Whence acetonitrile is coordinated to Cu (II), the 
emission is quenched. Change of the ligand with the chloride anion regenerates the 
emission at 402 nm.52    
2.4.2.1 Use of Co-ligand; Ion Pair Receptors 
 
4. Sometimes, presence of other ions may facilitate the recognition event or transport of 
ions across lipid membrane.53 The co-ligand is usually chosen to have opposite 
charge to benefit from electrostatic interactions. Scheme 9 depicts some important 
examples selected in literature. Since the strong Zn2+ binding of dipicolyl amines and 
tough phosphate - Zn2+ interaction are known, combination of both can be used to 
enable nucleoside polyphosphate54sensing. The fluorescence of xanthene is re-
established upon binding induced aromatization with the aid of Zn2+ bound water. 
Johnson and Haley et al. developed urea and ethynylpyridine binding motif to enable 
halide binding. The molecule B is non-emissive in neutral and slightly emissive in 
protonated form (TFA is used as organic acid).55 Chloride binding to protonated 
compound results in an enhanced emission in chloroform. Crystallograpic data 
supports the binding and protonation. 
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5. Compound C in Scheme 9 shows an enhanced binding of chloride in the presence of 
either sodium or potassium cation bound to crown ether moiety. Also the binding of 
these cations to a chloride-bound receptor is facilitated compared to free receptor.56 
This cooperative binding enables co-transportation of both ions across lipid 
membrane.57 Lastly, in compound D, pyridinium in the chloride receptor of one unit 
interacts with crown ether moiety in the second to construct a more confined binding 
cavity for the anion.58,59 A pseudorotaxane is formed between the two units with the 
aid of chloride and pyridinium ions.  
 
Scheme 9. Ion pair receptors 
In the fluorescent chloride sensor project presented in this thesis, proton is used as a 
co-ligand within the chloride binding pocket with the intension of measuring chloride 
anion level in acidic media.  
 
2.4.2.2 Triazolophanes as Chloride Receptor 
Triazolophanes and related foldamer-like structures, novel binding form for halides, 
selectively for chloride are discovered independently by three different research 
groups (Scheme 10).60,61,62 Highly preorganized cavity of the receptor use the 
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unconventional hydrogen bonding between carbon-bound hydrogen and halide. The 
dipole (4.7D) on the triazole moiety polarizes the CH groups making them good 
hydrogen-donors. Overall dipole orientation of the molecule decreases the electron 
density within the cavity hence increasing the anion binding further. 
 
Scheme 10. Structure of triazolophane 
The halide selectivity of triazolophane results from size of the cavity to which these 
anions perfectly fit. The size of the space is estimated to be 0.38 nm. The diameter of 
chloride and bromide anions are 0.36 and 0.39 nm respectively.21 Fluoride is too 
small and iodide is too large for this cavity. Among bromide and chloride, the 
stronger binding of chloride (107 M-1 in CH2Cl2) is attributed to its Lewis basicity.63 
In the fluorescent chloride sensor project documented in this thesis, triazolophane is 
used as chloride receptor to benefit from its size selectivity.  
 
2.4.3  pH Indicators 
Since this thesis includes a pH-activatable photosensitizer, pH responsive 
fluorophores are briefly reviewed in this section. In view of the fact that the pH 
inside and outside the cell, within organelles, in tissues is highly regulated and the 
change in pH during certain biochemical or physiological processes strictly 
determines the functionality, it is important to build up reliable sensors.The pH of the 
exterior of the cell is almost neutral (around 7.4) while within the intracellular 
organelles it drops down to 4.5 (lysosomes).64 Some of the pH sensors with different 
pH response in literature are given in Scheme 11. Fluorescein derivative (compound 
A) has a pKa value of 7.0 and suitable for cytosolic pH measurements which usually 
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varies between 6.8 and 7.4.65 Once the dye is internalized by the cell, leakage is 
fairly slow and the dye retains within the cytoplasm. However, the main drawback of 
this dye is its relatively fast photobleaching.66 Compound B is a cyanine-based near 
IR pH indicator with a pKa value suitable for cytoplasmic pH measurement. The dye 
absorbs and emits at 645 and 665 nm respectively.67  8-hydroxypyrene-1,3,6-
trisulphonic acid or pyranine (compound C) is a water soluble non-toxic dye with a 
unit fluorescence quantum yield with a pKa value of 7.3.68,69 The absorbance of the 
compound shifts from 405 to 465 nm upon deprotonation of the hydroxyl group. 
Cellular uptake of the compound is maintained by using sulfonic acid protection. 
With the aid of esterases, deprotection takes place within the cell and dye retains 
inside. For sensing acidic organelles, anthracene-based compound D is suitable with 
a pKa value of 5.1. In acidic organelles such as in lysosome, protonation of the 
amine group blocks the PET and an increase in emission intensity is observed.70  
 
Scheme 11. Fluorescent pH sensors 
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Versatility of BODIPY dyes allows different functionalization. This helps the 
development of different pH indicators with different pH response range. Among 
them, a few are given in Scheme 11. Compound E is non-emissive in neutral solution 
while PET is hindered upon protonation of amine and emission is reinstated. Imaging 
of the viable cancer cells are accompolished with this dye.71 For alkaline solutions 
compound F with pKa 9.3 is developed.72 Calixarene-BODIPY conjugate compound 
G is developed by Akkaya et al. with a pKa alue of 6.5 which is suitable for most of 
the biological applications.73 Among styryl BODIPY dyes, dimethylaminophenyl 
(pKa = 2.3 in acetonitrile, compound H)74, 4-hydroxy-3-chlorophenyl (pKa = 7.6, 
compound I),75 and imidazole (pKa = 6.0, compound J)76 derivatives are reported. 
Compound H shows a hypsochromic shift upon protonation and the absorbance and 
emission is solvent dependent due to strong ICT character of the dye. Compound I 
display a bathochromic shift upon deprotonation and quantum yield decreases a lot, 
protonation results in a small hypsochromic shift in emission of compound J.     
 
2.5 Logic Gates 
Physical operations that satisfy Boolean logic algebra with a suitable, readable input 
and output set are defined as logic gate. The computer science in the last century use 
the simplest logic operations, integrate them to build highly complex computational 
skills and electronic devices. In digital electronics in general, the input or output data 
are taken as descrete bands and a threshold level is defined to prevent noise and other 
unwanted small fluctuations.  
This analogy is first used in chemical counterparts in 1993 by de Silva.1 This is the 
first logic gate that works as an AND operation with chemical inputs and spectral 
outputs. Anthracene emission is restored only when effective PET from amine and 
crown ether moieties is blocked by protonation and sodium binding respectively. The 
truth table for AND and other basic logic operations are given in Scheme 12. From 
the first introduction of first chemical logic gate, a number of simple and more 
complex integrated logic operations have been developed. Some of the examples 
with quiet complex logic behaviour are shown in Scheme 13 together with the 
pioneering work of de Silva (compound A).  
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Scheme 12. Basic logic gates, schematic representations and truth tables 
The first molecular calculator was developed by de Silva et al. and composed of two 
different molecules performing AND and XOR logic operations separately 
(compound B).77 Molecules use same imputs Ca2+ and H+ but AND gate is 
constructed by hindering of the PET pathway by the inputs while in XOR gate these 
inputs results in spectral shift of the anthracene transmittance in opposite direction. 
The output of the former logic is used as ‘carry’ for the addition algebra. Credi et al. 
used 8-methoxyquinoline as both a demultiplexer and multiplexer logic gate.78 A 
multiplexer (MUX) is a data-selector device that selects one of the multiple inputs to 
an output. A demultiplexer (DEMUX) on the other hand, does the opposite and takes 
one input and selects between different outputs. The selection in both logic gates is 
done in the presence of another input called control or address input. Protonation of 
compound C shifts the absorbance and emission peak of the compound. Two 
wavelengths of excitation, each exciting protonated and neutral compound 
selectively are taken as MUX input and relative acid concentration as control input. 
Output is 474 nm emissions. Switch between the two excitation energy is chosen by 
the acid to obtain the output as emission. In the case of DEMUX logic gate, isobestic 
absorbance point (262 nm) is taken as input and acid enables a selection between the 
two emission states, protonated and neutral. Thus, with the use of a very simple 
compound a rather complex logic operation is obtained.      
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Scheme 13. Molecular logic gate examples 
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Photochromic compounds are widely used in logic gate era and make all-photonic 
systems possible.79 In this type of information processing, the character of input and 
output is essentially light thus there is no input-output inhomogeneity unlike in the 
case of most chemical logic gates. Light induced reversible change in the shape and 
spectroscopic properties of the molecules provides manufacture of advance 
molecular logic operations. Andreasson and Pischel et al. developed the first 
molecular D-Flip Flop logic gate using fulgimide (compound D).2 D-Flip Flop 
consists of a clock input that determines the output-input relation and builds a 
memory device. If this input is 1, the output takes the value of input. If not, then the 
previous output survives. Fulgimide is emissive in the closed form (640 nm) which is 
quantitatively generated upon 4 min UV-irradiation from E-form. E-form of the 
compound absorbs maximally at 374 nm while closed form absorbs at 523 nm. Two 
light source of 532 nm and 1064 nm were used as input, the former being the clock 
and emission at 644 nm is followed as output. If none of the inputs are present, the 
output remains the same due to lack of photochromism in the absence of light. When 
the clock is 1 but the other input is 0, then nonfluorescent E form dominates. As a 
result output always reads 0 (same as input). When both inputs are present (both 
lights are on), third harmonic generating crystals converts them to 355 nm light 
which has enough energy for the formation of emissive closed form. Thus, the input 
(value 1) is reproduced by the output (value 1). When only 1064 nm input is present, 
for the same reason, previous output reads as the next output. Hence, the past of the 
device has a role in its future. Taking advantage of photochromic character of the 
compounds and with rational combination of optical inputs, scientists are able to 
develop a highly complex logic operation.  
Finally, Akkaya et al. showed that two logic gates can be concatenated to form a 
more complex integrated logic device.80 Zn2+ and H2+ sensitive chromophores are 
cliked together to form an energy transfer donor-acceptor dimer (compound E). Zn2+ 
and light is used as an input to construct an AND gate for the first part of the 
molecule. Presence of Zn2+ blocks the PET process and enables emission. In the 
covalently bound molecules, the energy is an output through a FRET for the next 
molecule. Upon binding of Hg2+ to FRET acceptor, hypsochromic shift in absorption 
from 680 nm to 640 nm increases the spectral overlap and emission intensity at 660 
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nm increases. This approach of integrating multiple logic gates opens a path for 
developing complex functionalities out of chemical logic devices like their silicon 
counterparts. 
 
Scheme 14. Logic gates for smart drug design 
Although most of the molecular logic gates are introduced without significant 
functionality but a mimick of digital logic gates, some have important functional 
meaning. Upon them, two therapeutic approaches are examplified in Scheme 14. In 
compound A, developed by Akkaya et al. is a BODIPY photosensitizer that is 
actively generates toxic 1O2 in organic solvent only in the presence of tumor related 
inputs acid and Na+.15 Basically, binding of Na+ to the crown ether blocks PET and 
protonation shifts the absorbance to excitation wvelength. Hence an AND logic is 
generated. Compound B is introduced by Shabat et al. and mutual enzymatic activity 
of two different biomolecules (catalytic antibody Ab38C2 and penicillin G amidase 
PGA) at two different sites generates an amine nucleophile which attacks the 
carbamate and liberates anti-cancer drug doxorubicin.17 Thus, an OR gate is built for 
smart drug release. Improvements of such kind would be a hope for intelligent drug 
design and release strategies.  
 
2.6  Photodynamic Therapy 
Photodynamic therapy (PDT) is a method clinically used for the remedy of certain 
cancers such as ocular melanoma, basal cell carcinoma, pancreas, lung, genitourinary 
cancers and diseases such as papillomas, rheumatoid arthritis and age-related 
macular degeneration.81 It basically requires generation of toxic singlet oxygen upon 
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excitation of a photosensitizer (PS) by light of appropriate energy. In the vicinity, 
reaction with the biomolecules and irreversible oxidative damage induces cell death. 
Short lifetime in aqueous solutions (< 40 ns) and short diffusion distance (< 2 nm) in 
accordance, makes the therapy non-invasive and promising.82  
 
2.6.1 Photophysics and Biochemistry of Photodynamic Therapy 
 
Scheme 15. Jablonski diagram of 1O2 generation 
The photophysical pathways involved in 1O2 generation is given in Scheme 15. 
Following the excitation of the molecule to singlet excited state, among other 
pathways transition to triplet state (intersystem crossing) is required. This is 
enhanced in the presence of heavy atoms or exciton coupling. Perpendicular 
orientation of bichromophoric molecules with respect to one another also helps this 
transition.29 This step is required to enable a normally spin forbidden process, 
transition of ground state triplet oxygen to singlet excited state. Molecular oxygen 
indeed has two excited singlet states with quite different energies and orbital 
occupancies. Higher energy singlet state has shorter lifetime and relaxes to the lower 
singlet state. Phosphorescence from the longer-lived excited state can be followed at 
1270 nm with an IR detector.  
The singlet oxygen reacts readily with biomolecules within the cell. If the primary 
reactant is the excited PS, hydroxyl radicals, superoxide anion, hydrogen peroxide 
are formed afterwards; the reaction is defined as type I.83 The generated radicalic 
compounds react further with other biomolecules or molecular oxygen to form 1O2. 
In type II reaction, 1O2 generated upon sensitization is the primary reactant. PDT 
response involves both types of reactions.84 Oxidative damage given by 1O2 is 
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basically lipid peroxidation, oxidation of thiol and amine groups, genotoxic damage 
such as DNA strand breaks and cross-linking which leads to mutation at the end.85 
Lipid peroxidations by 1O2 influence the lipid fluidity and membrane leakage. 
Oxidatin of the thiol and amines on amino acids, thus proteins, interfere with their 
proper folding hence functionality. One intriguing result of thiol oxidation is 
believed to be the conversion of mitochondrial membrane into a leaky, more 
permeable form allowing the passage of mitochondrial constituents which persuade 
cell death.86 Each oxidative reaction of 1O2 generates reactive products which 
amplify the initial effect leading to cell death decision. Thymine groups on DNA are 
the main targets of hydroxyl radicals produced by this cascade.87 Since the proper 
functioning of the repair enzymes are eradicated, mutations accumulate to trigger 
apoptosis.88  
Biological response of PDT is related to oxidative damage and all lead to cell death 
(apoptosis or necrosis depending on the localization of the PS), shut down of tumor 
microvasculature and stimulation of the immune system.89 The last response is quite 
unique to PDT and enables the development of new concepts such as cancer vaccine. 
Singlet oxygen mediated damage to membrane proteins and lipids disintegrate the 
membrane and phospholipids are liberated. Subsequent reactions of these lipid 
elements produce immune stimulatory molecules including leukotrienes.90 In 
addition PDT-induced overexpression of HSP70 chaperone proteins attract 
neutrophils to initiate an immune response.91 The immune stimulating property of 
the therapy is used to develop a potential cancer vaccine. Promising regression of the 
tumor was observed upon administration of previously PDT-applied cell lysates to 
model animal mice.92   
 
2.6.2 Requirements for a Photosensitizer 
Since a photosensitizer is prepared with the aim of a biomedical application, it 
should meet the critera of biocompatibity, acceptable water solubility or stable 
conjugation with an appropriate carrier moiety such as micelle or polymers and 
finally absence of dark toxicity. Besides, the main requirement for photodynamic 
therapy is efficient singlet oxygen generation. Since this process requires the spin-
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forbiden excitation of ground state triplet molecular oxygen to singlet excited state 
the molecule has to be modified to enhance this transition. Heavy atoms are known 
to facilitate this transition by the exertion of a magnetic torque by the nucleus of the 
heavy atom to spin momentum of the electron so-called spin-orbit coupling (SO 
coupling).  
The heavy atom effect on tetraarylazadipyrromethenes is studied extensively and 
results indicate that bromo-photosensitizer produce thousand-fold more singlet 
oxygen than heavy-atom free one. 93  
Since the activity in photodynamic therapy is initiated by light irradiation, 
photosensitizer is expected to be stable against bleaching. Toxic effect of the PS 
should be only exerted under light irradiation, namely the compound should not have 
any dark-toxicity. 
Finally, the energy of light used is also important for efficient PDT action. Since the 
organic compounds absorbs characteristically at certain wavelengths, the energy of 
light source is chosen in view of that. However, due to the presence of absorbing 
species in the tissue such as melanin, flavins, and haemoglobins, the penetration 
depth of light through the body is highly limited to NIR-region specifically between 
620-850 nm.94,95 This range is called therapeutic window of the body and 
photosensitizers should be chosen or functionalized to be efficiently excited with 
light of this wavelength.  
Apart from playing with the absoption properties of the photosensitizer, there are 
other ways to overcome this problem. Among them, use of upconverting systems96 
or chemiluminescent coupled photosensitizations97 worth attention. The former 
requires an upconverting system that activates a photosensitizer with shorter 
wavelength absorption by a lower energy light. Upconversion is enabled by a 
nonlinear anti-Stoke phenomenon created by the lanthanide lattice of the inorganic 
nanoparticles. In the latter case, energy of activation is provided by a 
chemiluminescence of a nearby oxalate ester.  
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2.6.3 Activatable Photosensitizers 
Activation of photodynamic therapy agent only in the presence of light and oxygen 
makes the method already non-invasive without any side-effect reported. In addition, 
due to leaky vasculature of the tumor tissue, photosensitizers tend to accumulate 
selectively in the tumor tissue. This phenomenon is called enhanced permeation and 
retention (EPR) and is a kind of passive targeting. Even though the accumulation is 
more prominent in tumor tissue, nearby healthy cells are still affected from this 
therapy and further selectivity is required.  
With the wish of more selective therapy, in combination with the EPR-dependent 
targeting, it is important to develop photosensitizers to be activated only in the 
presence of certain disease parameters. The deactivation of the PS in the absence of 
the disease microenvironment can be through a number of different mechsnisms. The 
simplest form of controlling PDT action spatially is by means of targeting 
chemical/biochemical groups. With the improved knowledge in molecular biology 
and genetics of diseases, the genes and gene products associated with a syndrome 
can be determined. For tumor tissue, overexpression of surface receptors and 
transporters are well-established. Among them, folate receptor and glucose 
transporters are important targets. Hence, photosensitizers with 2-deoxyglucose 
and/or folic acid in their structures tend to accumulate selectively in tumor site.98  
Alongside the control on tissue accumulation, activity of the photosensitizer can be 
controlled as well. A PS can be controlled at any time of its photophysical journey 
depending on the character of the quenching. PS can be quenched before triplet state 
transition by means of singlet-singlet energy transfer or the quenching can occur 
through the self-quenching of the PS itself. Photoinduced electron transfer at excited 
state may be a way to deactivate the photosensitizer. After ISC, singlet oxygen 
scavangers can be used to decrease phodynamic action. Some important examples 
from literature involving activatable photosensitizers with different mechanisms of 
action are given in Figures 4-7 in following sections.  
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2.6.3.1  FRET-based Quenching of the PS 
 
Figure 4. Energy transfer based quenching of 1O2 production 
Excitated photosensitizers can transfer its energy to an adjacent molecule with 
appropriate spectral properties. If the requirements for a dynamic quenching 
phenomenon process are met such as spectral overlap between emission of energy 
donor and absorption of acceptor; and short-enough separation between the two 
interacting species (essentially < 10 nm); then, FRET efficiency do increases. 
Cleavage or dissociation of the quencher from the PS and diffusional drifting away 
from the active zone of quenching leads to activation of the PS. FRET acceptor are 
usually chosen as non-emissive and the energy is dissipated as heat at the end. There 
are a number of different nonemissive quenchers with different absorption properties 
in literature and some are commercially available. In Figure 4, examples involving 
commercially available black-hole quenchers BHQ-1 (Q1) and BHQ-2 (Q2) are 
shown. Pyropheophorbide-a is conjugated to this quenchers through lysine linker and 
the quenching behaviour of these quenchers with different linker length and spectral 
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overlap are analyzed.99 Consistent with the FRET theory, shorter separation and 
greater spectral overlap facilitate the quenching process. The BHQ-3 is observed to 
be a better quencher. In a separate work, the linker is selected as a Matrix 
metalloproteinase 7 (MMP7) target.8 This protease is known to be overexpressed in 
tumor tissue and has important roles in extracellular matrix remodelling. Tumor 
metastasis is known to be associated with MMPs. It has been shown in vitro and in 
mouse animal models that the cleavage of the peptide linker with the enzyme 
releases the PS and activates it. The enzyme-dependent activity is proved also with 
the use of enzyme inhibitor. Similar construct with a linker which is substrate of 
tumor associated fibroblast activation protein is also reported with promising in vivo 
activity.100   
Enzymes are not the only activating disease parameters. Nucleic acids are also 
targeted for this purpose using the specific hybridization properties. Hybridization of 
the DNA strands tagged with PS and quenchers through base-pairing quenches the 
PS (Figure 4).101 Displacement of the strand with the target oligonucleotide liberates 
the PS and activatity is restored 
 
2.6.3.2  Deactivation Through Self-Quenching 
 
 
Figure 5. Deactivation of the PS through self-quenching 
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Ground state interactions between planar chromophores those are stacked in an 
aggregate usually produce a non-emissive or quenched product. This behaviour is 
usually followed with a change in electronic absorption spectra and called self-
quenching. This phenomenon is also used in literature for controlled PS deactivation. 
Figure 5 shows two PSs quenched by this mechanism. Chorin-e6 photosensitizer 
attached to one another via lysine linker on a polymer backbone displays decreased 
1O2 generation efficiency due to high density within the polyethylene matrix. 
However, once the linker is cleaved by the metalloprotease cysteine cathepsin, the 
PS is activated.102 Likewise, self-quenching of two 5-ethylamino-9-
diethylaminobenzo(a)phenothiazinium photosensitizers is eradicated by the activity 
of β-lactamase.103 This enzyme is responsible for the antibiotic resistance 
(ampicillin) and antibiotic resistant strain of Staphylococcus aureus becomes 
susceptible to PDT action and can be destroyed by the activation of the PS. Enzyme 
cleaves β-lactam ring to release the PS. 
 
2.6.3.3  Singlet Oxygen Quencher 
 
Figure 6. Quenching of PS through 1O2 scavanger 
Photodynamic action can be controlled after the generation of 1O2. This requires 
singlet oxygen quenchers. There are a number of different 1O2 quenchers that either 
act physically (azide, amines)104105 through charge transfer or show their effects 
through chemical reaction (thiols, ascorbate).106 Carotenoid, a physical 1O2 quencher 
is covalently attached to the pyropheophorbide-a photosensitizer through a caspase-3 
susceptible peptide linker and display a more efficient toxic effect upon cleavage by 
this apoptotic enzyme (Figure 6).107  
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2.6.3.4  Deactivation Through Electron Transfer 
 
Figure 7. PS deactivation by means of PET 
Photoinduced electron transfer is a widely-used fluorescence quenching or PDT 
deactivation method. With the mechanism described in previous sections, electron 
rich compounds adjacent to fluorophore or PS reduce the excited molecule and 
generate non-emissive fluorophore, inactive PS. Depending on the relative 
orientation of HOMO and LUMO levels of the electron donor and acceptor moieties 
direction of electron transfer may change. Block of PET pathway by means of 
disease associated molecules or malignant environment is used for PS activation. In 
Figure 7, the first aza-BODIPY is inactive due to PET from amine groups. Once the 
amine is protonated (pKa = 6.6), PET is no more effective since the HOMO of the 
electron donor is stabilized with respect to HOMO of the PS. This enables improved 
1O2 generation, more than 10-folds.108  
The second BODIPY dye conjugated to inositol 1,4,5-triphosphate, a ligand of the 
receptor of the same name (Figure 7).109 As extensively described by Markus’s 
theory, the PET process is highly dependent on the polarity and character of the 
solvent/microenvironment.110 Authors designed a PET pathway between the IP3 to 
BODIPY dye in polar solvent. However, once the electron acceptor moiety is burried 
within the cavity of the receptor, the non-polar environment with lower dielectric 
constant affect the PET process by stbilizing the S1 state of the PS and the 
photosensitizer is activated. This innovative work is proposed for the selective light-
induced inactivation of the receptor by means of PDT. 
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As described in previous sections, disease parameter-responsive PET and ICT 
coupled systems are designed to control the PS activity with and AND logic 
construct.15,16,17 
 
2.7 Tumor Biology and Disease Symptoms 
 
Effective, targeted therapy of any kind requires knowledge about the genetic profile 
and molecular biology of the disease. This knowledge is inevitable when cancer is in 
concern. Although a perfect medication of this disease is still not available, highly 
improved molecular knowledge is accumulated on this subject.  
Cancer is defined as unnatural cell proliferation that produces an uncontrollable 
growth and division of the cells and usually transformed cells invade other regions of 
the body through metastasis. The demography of this disease is frightening since the 
numbers indicate that the 13% of all human deaths are a result of this disease.111 
There are many different types of cancers and the genetic and molecular basis or 
outcomes of each differ. However, there are certain molecular signs quite common in 
all tumor types. Considering the altered expression profile of a gene or the activity of 
a protein, the main contributers are the ones that control cell division. Ras protein is 
one of such proteins and has role in signal transduction of cell proliferation. A single 
mutation results in an overactive protein that produces a proliferative signal 
constitutively. Some chromosomal defects such as gene amplification, chromosomal 
translocations do also contribute the development of this disease. Although the 
genetic change that leads to improved cell division is supposed to be the reason, 
other genetic cooperative mutations are usually required or occur as a result of 
genetic instability. These are either genetic defects in tumor suppressor genes (such 
as rb, p53) that normally function to suppress the expression of cancer-promoting 
genes or DNA repair enzymes that correct the mismatch defects. The lack of control 
over cell division by the suppressor genes leads or aids tumor development. 
Likewise, lack of proper activity of repair enzymes provokes accumulation of 
mutations and contributes to the disease development. Together with the molecular 
and genetic background explained above, lack of normal apoptotic activity, telomere 
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instability and many other factors all together or as a combination of some will result 
in the progress of the disease.112  
Beside this molecular data, particularly important contributers/symptoms are 
introduced in this section; low tumor pH and glutathione level. In the research which 
will be presented in the following sections uses these informations about tumor 
molecular biology.  
 
2.7.1 Walburg Effect and Low Tumor pH 
The energy metabolism of cancer cells are usually depends on the glycolysis and 
lactic acid production as described first by Nobel laureate Otto Heinrich Warburg.113 
In healthy cells, the oxidation process continues within the mitochondria to produce 
more energy. The reduced activity of pyruvate kinase enzyme in cancer cells 
prevents further oxidation of pyruvate and also reduces the production of reactive 
oxygen species. The latter activity decreases oxidative stress hence helps cell 
survival and proliferation. The lack of proper oxygen supply (hypoxia) to the tumor 
site and mitochondrial defects are hypothesized to be the cause of such high 
glycolysis rate. Cancer cells even still keep high glycolysis rate in the presence of 
oxygen. The main outcome of this metabolic shift is the change in the pH of the 
tumor microenvironment as a result of hypoxia, lactic acid accumulation and change 
in the ion transport character across the plasma membrane.114 The extracellular pH is 
reported to drop down to 6115,116 for some cancer types but for most tumors pH 
values between 6.5-7.0 are reported.117    
 
2.7.2 Redox Status of Tumor and Glutathione  
One of the other widespread tumor metabolic hallmark is increased level of 
intracellular reduced glutathione (GSH). Glutathione is an electron donor composed 
of tripeptide of cysteine, glycine and glutamate amino acids (Scheme 16) and is an 
important element of cellular redox homeostasis together with cysteine, nicotinamide 
dinucleotide (NADH, NADPH), thioredoxin, peroxiredoxin, flavin adenine 
dinucleotide (FAD) and oxidized forms of these compounds. Glutathione is 
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synthesized by successive activity of two different enzymes γ-glutamylcysteine 
synthetase and glutathione synthetase. The molecule is in balance with its oxidized 
disulfide form (GSSG) and it is regenerated from this form by glutathione reductase 
enzyme.  The oxidized glutathione produced within the cell is drained out of the cell 
and degradation of this compound occurs in extracellular medium. This balance is a 
determinant of protein activity and the progress of cell cycle. Reducing ability of 
GSH enables the maintenance of thiol proteins and regulates the signal transduction. 
In addition of its role as reducing agent, GSH also have active role in DNA synthesis 
and regulation of immune response.    
 
Scheme 16. Chemical structures of reduced (GSH) and oxidized (GSSG) glutathione.  
Under normal conditions, the interior of the cell is more reducing due to higher level 
of GSH compared to GSSG. Concentration of GSH in blood is about 2-4 µM118 
whereas the intracellular concentrations are thousand folds higher.119 The 
extracellular space of air-way fluid of the lung also has a GSH concentration as high 
as 200-400 µM.120 These values differ during cancer progression. Change in the 
redox balance of the cell interferes with cell proliferation and metastasis.121 In order 
for the cell to proliferate the reactive oxygen species should be lowered. This is 
maintained by the high level of NADPH and GSH. Both forms of reducing species 
are elevated in tumor tissue by the activity of cancer promoting biochemical changes. 
MYC, a cancer promoting transcription factor, increases glutamine uptake, a 
precursor in GSH synthesis pathway.122 Although, elevated cellular GSH helps the 
cells to develop resistance to chemotherapy, one can take advantage of this. Indeed, 
thiol exchange reaction with GSH or the reducing power of this compound is used a 
lot in literature for drug release purposes.123  
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CHAPTER 3 
6. Proof of Principle for a Molecular 1:2 
Demultiplexer to Function as an Autonomously 
Switching Theranostic Device124 
This work is partially described in the following publication 
Sundus Erbas-Cakmak, O. Altan Bozdemir, Yusuf Cakmak, Engin U. Akkaya  
Chem. Sci., 2013, 4, 858-862 
 
3.1. Objectives 
Although simple logic behaviour of the molecular logic devices have been examined 
a lot, most of them are not ascribed a meaningful functionality. To build a logic gate 
with a defined application is challenging though. Here, guided by the digital design 
concepts, a two-module molecular Demultiplexer (DEMUX) is synthesized where 
the output is switched between emission at near IR, and cytotoxic singlet oxygen, 
with light at 625 nm as the input (I), and acid as the control (c).  In the neutral form, 
the compound fluoresces brightly under excitation at 625 nm, however, acid addition 
moves the absorption bands of the two modules in opposite directions, resulting in an 
effective reversal of excitation energy transfer direction, with a concomitant upsurge 
of singlet oxygen generation and decrease in emission intensity.   
3.2 Introduction 
Ever since the seminal de Silva article was published in 1993,1 chemical logic gate 
research is in a process of rapid progress and evolution. Now closing in on its second 
decade, chemical equivalents of many two input logic gates were reported,125,126 
along with more complex digital systems featuring higher levels of virtual 
integration.127,128,129,130,131,132,133,134,135,136,137  Finding tangible applications for these 
molecular constructs with digital capabilities has been in the forefront of research in 
recent years.138 ,139  Progress in this field was essentially based on the premise that 
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molecular logic gates, while getting their inspiration from their silicon based 
counterparts in digital electronics, the limitations and potential opportunities do not 
necessarily show a one-to-one correspondence. Often stated limitation of “input-
output heterogeneity” can be molded into a distinct advantage, since the outputs can 
be molecular in nature which may interact with other, and more complex molecular 
and supramolecular phenomena such as metabolism, thus opening a new path to 
information processing therapeutic agents.140,141,142,143 In addition, certain design 
flexibilities available in molecular logic gates, have no counterparts in semiconductor 
based analogues. Functional/ virtual integration of logic gates and possibility of 
superposed logic gates are just two examples. These two uniquely molecular features 
are exploited in a typical design of molecular multiplexers144,78 (MUX) and 
demultiplexers145,78 (DEMUX).  In digital signal processing, a multiplexer is a 
combinatorial circuit which selects from a number of inputs and directs it to an 
output. Demultiplexer is a complementary device, taking a single input signal and 
switching it between multiple output signals. Both can be considered as controlled 
switches.146,147  
Previously, it has been shown15 that even a simple AND logic gate within the 
context of photodynamic therapy can bring in highly precious surplus value of 
enhanced selectivity.  Photodynamic therapy is a non-invasive methodology of 
treatment of various cancers and non-cancerous indications.148 This methodology is 
based on the excitation of a particular photosensitizer within the tumor tissue, 
generating singlet oxygen and other reactive oxygen species (ROS), and thus, 
regiospecifically destroying the targeted tumor. In recent years, combined diagnosis 
and therapy functions received particular attention, with a new buzz word to 
accompany this heightened interest: theranostics.  Diagnosis component obviously 
include, but not limited to imaging of the region of interest. As for all therapeutic 
methodologies, such multifunctional delivery agents would be useful for 
photodynamic therapy as well. 
It occurred that a molecular DEMUX device, which can switch between two outputs 
such as light and cytotoxic singlet oxygen can be very useful in a photodynamic 
theranostics context. Such a molecular device when directed to the tumor region, 
 
 
39 
 
may fluoresce brightly in the surrounding healthy tissue, and inside the tumor, appear 
dark while generating singlet oxygen on excitation. The switch can be made by the 
acidity difference between the tumors and the healthy tissue without any need to 
change the wavelength of excitation. It is widely known that most tumors are 
considerably acidic compared to neighbouring healthy tissues as a result of Warburg 
effect.113 If the design is made properly, the emission can be at the red or near IR 
region of the spectrum making imaging more valuable. 
 
3.3 Design of the Molecular Demultiplexer 
With these goals in mind, a proof-of-principle DEMUX logic is designed, which can 
operate in organic solvents, incorporating switchable through space energy transfer 
coupled to mutually exclusive generation of red/near IR emission or singlet oxygen 
generation depending on the acidity of the medium.  Here, the light at 625 nm 
(supplied by a LED array) is the input (I), and the acid (Trifluoroacetic acid, TFA) is 
the control (or address input). The target molecule is composed of two distyryl-
Bodipy modules clicked together by Huisgen cycloaddition (Scheme 17).  Previously 
examined distyryl-Bodipys37 taught that pyridylethenyl and dimethylaminophenyl 
ethenyl substituted Bodipys respond by opposite spectral shifts on protonation (blue 
shift with dimethylaminophenyl, and red shift with pyridyl) as a result of different 
ICT characteristics.  When excited at a fixed wavelength, it is reasonable to expect a 
switch in the direction of EET (Figure 8, 9).   Furthermore, one of the Bodipy 
modules (compound 12, FL module) is designed to be fluorescent, and especially 
more so on protonation.  The other one (compound 10, the PS module) carries heavy 
atoms (two iodine atoms at 2,6-positions) facilitating intersystem crossing to yield a 
higher rate of 1O2 generation. It is clear that the switch is not going to be absolute, 
i.e., both modules will be excited at varying degrees, nevertheless an inspection of 
Figure 8 reveals that at the optimal wavelength (635 nm), PS to FL absorptivity ratio 
changes from 2 to 0.5, altering the position of preferential initial excitation.  
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Scheme 17. Modular assembly of the molecular DEMUX device with two different outputs 
depending on the acidity of the medium. 
3.4 Results and Discussion 
The operation of the DEMUX can be broken down into superposed action of two 
modules clicked together. Compound 13 shows a broad band and it is difficult to 
assess spectral changes on the addition of control input TFA (Figure 8b). But, when 
the two components are separately studied as independent modules, the operation of 
compound 13 can be better understood. When no acid is added, maximum 
absorbance of the isolated PS module (10) in is at 647 nm and that of FL module 
(12) is at 681 nm, however, when TFA is added, the absorption peak of 10 shifts to 
671 nm, whereas that of 12 shifts to 647 nm (Table 1, Figure 8a). An opposite shift is 
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also observed in emission spectra of modules 10 and 12 (Figure 9b). While the 
difference seems to be small, adding the auxochromic nature of the protonation of 
12, it should not be surprising to see that the compound 13 works in accordance with 
the design expectations.  For compound 13, when there is no added acid (c = 0), on 
excitation at 625 nm, an intense emission at 715 nm from the FL module is observed 
in accordance with the operation of DEMUX device corresponding to input hν625 = 1, 
c = 0; therefore output is switched to output 1, which is hν715. The faster rate of 
excited state energy transfer process with respect to intersystem crossing was used99 
to quench the singlet oxygen generation near neutral pH and yield near IR emission 
instead (vide infra). 
Excitation energy transfer (EET) from the PS to FL in DEMUX compound 13 is 
confirmed by the decrease in the singlet oxygen generation capacity of the PS 
module (Figure 10, 11, Table 2), even though it actively generates 1O2 when that 
module alone was excited separately, both under acidic and neutral conditions 
(Figure 10, 11). On acid addition, (c = 1) and excitation at the fixed wavelength of 
625 nm, simultaneous ICT shifts in PS and FL change the direction of EET and 
cytotoxic singlet oxygen is then produced, while the emission of FL is quenched 
Figure 8. Absorbance spectra of equal concentrations (2 µM) of the photosensitizer (PS, 10) 
and the fluorophore (FL, 12) modules in the presence (dashed curves) and absence (solid 
curves) of added TFA in chloroform (a), absorbance spectra of compound 13 (2 µM) in 
chloroform in the absence (solid) and presence (dashed) of TFA. 
(a) (b) 
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(Figure 12). Energy transfer to PS module in compound 13 is also confirmed by the 
decrease in the excited state lifetime of protonated compound 13 (0.03 ns, χ2 = 1.43) 
compared to protonated donor FL module (3.62 ns, χ2 = 1.21) in CHCl3, indicating a 
very high energy transfer efficiency (99%). 
 
Table 1. Photophysical characterization of compounds 10, 12 and 13 in chloroform. 
Compound λabs 
[nm] 
ε 
 [M-1cm-1] 
λF 
[nm] 
φF[a] 
[λexc(nm)] 
τF[b] 
[ns] 
11 647 73000 665 0.22 1.71  
11 + H+ 671 53000 694 0.06 0.33 
2 681 68000 729 0.16 3.37 
12 + H+ 647 76000 665 0.41 3.62 
13 652 121000 715 0.42 4.05 
13 + H+ 650 105000 700 0.02 0.03 
a Quantum yields were calculated using Sulforhodamine 101 (excitation at 550 nm, in EtOH) 
as reference. All other compounds were dissolved in chloroform.b All measurements are 
taken in CHCl3 using 650 nm (for compounds 10 and 12) and 667 nm (for compound 13) 
NanoLEDS. 
a 
(b) 
 
Figure 9. Excitation spectra (a) of 2 µM of molecular demultiplexer (compound 13) in the 
absence and presence of acid in chloroform. Overlapping peaks result in the observed broad 
absorption peak. Emission was collected at 715 nm and at 700 nm for compound 13 and 
acid-added compound 13 respectively. Emission spectra of module compounds 10 and 12 
(2 µM) in acidic and neutral media in chloroform (b). 
 
(a) 
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Figure 10. Singlet oxygen mediated photobleaching of DPBF with molecular demultiplexer, 
(a.k.a, DEMUX device, compound 13, purple), compound 13 in acidic media (light green), 
PS (blue), PS in acidic media (green), DPBF alone (black), DPBF alone in acidic media 
(red), followed by decrease in its absorbance at 411 nm. 
 
Figure 11. Relative singlet oxygen generation efficiency of photosensitizer (compound 10, 
blue) alone or molecular demultiplexer (compound 13, red) in the presence or absence of 
light and/or TFA. 
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Three negative and two positive control experiments support the mutually exclusive 
character of near IR fluorescence emission and singlet oxygen generation (Table 2). 
In positive controls, singlet oxygen generation activity of 20 nM compound 10 (PS 
module, same concentration as the demultiplexer 13) was studied and found to be 
active in sensitization, both in the presence or absence of trifluoroacetic acid (Figure 
10, 11, Table 2). This shows that the decrease in the singlet oxygen generation rate is 
mostly due to the presence of fluorophore module as an energy sink.  The relative 
singlet oxygen generation efficiencies were calculated by normalizing the rate of 
initial decrease in the DPBF degradation/bleaching. In 10 (PS) alone case (positive 
control-1), the efficiency seems to decrease to 0.56 compared to compound 13 under 
acidic conditions.  
 
Figure 12. Emission spectra of the DEMUX device 13, under neutral (black, solid) and 
acidic (red, dashed) conditions excited at 625 nm in chloroform. 
This is probably due to the larger absorptivity of the protonated FL unit which leads 
to excitation of the PS in 13 by EET. PS under acidic conditions exhibits a decrease 
in the rate of singlet oxygen generation which is due to decrease in molar 
absorptivity at the wavelength of excitation (625 nm) as a result of bathochromic 
shift on protonation.  In addition, by using two negative controls, the amount of 
degradation of the trap molecule (diphenylisobenzofuran, DPBF) in the absence of 
photosensitizer under neutral and acidic conditions (Table 2) is determined. The third 
negative control was carried out to determine the extent of singlet oxygen generation 
of compound 13 under neutral conditions, i.e., in the absence of added acid. In this 
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experiment, due to effective reversed EET from the PS to FL, no singlet oxygen 
generation is observed as expected (Table 2). 
 
Control experiments with trap alone were performed to ensure the reliability of the 
data. In acidic conditions, reciprocal shifts in the absorbance of the two modules of 
the compound 13 leads to a change in the direction of electronic energy transfer.  The 
12 (FL) becomes the donor, and excitation energy is transferred to 10 (PS), which 
becomes activated and generates cytotoxic singlet oxygen effectively at 
concentrations as low as 20 nM (Figure 13, Table 3). Response of compound 13 and 
all other control experiments under neutral and acidic conditions in dark and under 
red LED irradiation at 625 nm is shown in Table 3. 
The overall working principle of the compound presented here as a molecular 
DEMUX device is as follows; in the absence of acid, there is an intense emission 
near IR at around 715 nm (Figure 12, 14). When the acid is added, the fluorescence 
of the compound 13 is completely quenched due to EET to non-emissive PS module. 
This decrease in emission is linked to the efficient generation of singlet oxygen. With 
pH-driven change in the EET direction, PS module becomes active and generates 
therapeutic output, singlet oxygen.  This action is dependent on change in EET 
direction, thus, with a similar demultiplexer based on this proof of principle, but with 
Figure 13. Singlet oxygen mediated photobleaching of DPBF (50 µM) in the presence of 20 
nM compound 13 and TFA (20 µl/3mL) in chloroform. 
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additional practical considerations in mind (solubility, pKa values of the acid 
sensitive groups), sensitization to produce singlet oxygen would be only in the acidic 
medium (as found in most tumors) and the boundaries of the tumor region can be 
imaged by the change in fluorescence intensity (which would appear as darker 
regions, as opposed to red/near IR fluorescence from the surrounding healthy 
tissues).  
 
Figure 14. Truth table (a), circuit diagram (b) and schematic switching operation (c) of the 
1:2 molecular DEMUX logic device. 
For the singlet oxygen generation experiments, the compounds in each solutions 
were 20 nM and the trap was 50 µM. Measurements were done in the dark for the 
first 25 min. Samples were then irradiated with 625 nm LED starting at t=25 
minutes, and measurements were repeated in 5 minute intervals.   
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Table 2. Relative rates of singlet oxygen generation in positive and negative control 
experiments. 
Experiment 
Type 
DEMUX Positive 
1 
Positive 
2 
Negative 
1 
Negative 
2 
Negative 
3 
Negative 
4 
C
on
te
nt
s 
DPBFa 50 µM 50 µM 50 µM 50 µM 50 µM 50 µM 50 µM 
TFAb 20µl/3ml - 20µl/3ml - - 20µl/3ml 20µl/3ml 
10c - 20 nM 20 nM - - - - 
13d 20 nM - - 20 nM - - 20 nM 
Irradiation 
(625 nm) 
Light Light Light Dark / 
Light 
Dark / 
Light 
Dark/ 
Light 
Dark 
Relative Rate 
of 1O2 
Generation 
1 1 0.56 ~0/0 ~0 ~0 0.14 
a DPBF: 1,3-diphenylisobenzofuran, b TFA: Trifluoroacetic acid, c PS: photosensitizer, 
compound 10, d Molecular Demultiplexer 
 
Figure 15. Reversibility of fluorescence of compound 13 in the presence of acid and base in 
chloroform followed at 715 nm. The first measurement was done in neutral conditions, for 
each following measurements TFA and piperidine were added in 50 µl portions, times of 
addition were given as numbers following the name of reagents. 
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The demultiplexer device described in this work acts reversibly and retains most of 
its fluorescence intensity even after 5 cycles of pH oscillations (Figure 15). 
 
Table 3. Experimental data for the generation of photonic and chemical outputs in response 
to the input acted by the address switch. 
Compound 
 
Irradiation (625 
nm) 
H+ 
(Address Input) 
Relative Emission 
Intensity 
(715 nm) 
Relative 1O2 
Generation 
Efficiencya 
13 0 0 0 0 
13 1 0 1 0.14 
13 0 1b 0 < 0.01 
13 1 1b 0.21 1.0 
10 0 0 - 0 
10 1 0 - 1 
10 0 1 - < 0.01 
10 1 1 - 0.56 
a aRelative singlet oxygen generation was calculated by setting the rate of DPBF 
degradation at input=1, address=1 case to be 1.   b20 μL TFA was added to 3 mL of each 
sample. Details of calculations were given in Supporting Information. 
 
The importance of multifunctional drugs and delivery systems are well appreciated, 
and in this work, we demonstrated that the two critical functions, i.e., diagnostic and 
therapeutic actions can be in principle, implemented using a single molecular agent. 
We expect this proof of principle model of a demultiplexer to pave the way to 
multifunctional molecular systems, which would interactively deliver the therapeutic 
agent, while offering diagnostic imaging possibilities. The work described here 
suggest that even at a relatively rudimentary stage, information processing molecules 
can produce unprecedented capabilities, such as autonomous decision making to 
switch between diagnostic and therapeutic modes. And this is made possible by a 
unimolecular superposed logic operation with no semiconductor counterpart. The 
future of molecular logic gate research looks very bright. 
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3.5 Experimental Details 
3.5.1 General 
All chemicals and solvents purchased from Sigma-Aldrich were used without 
further purification. Spectra of 1H NMR and 13C NMR were recorded using a Bruker 
DPX-400 in CDCl3 with TMS as internal reference. Splitting in the spectra are 
shown as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), and br (broad). 
 Absorption spectrometry was performed using a Varian spectrophotometer. 
Steady state fluorescence measurements were conducted using a Varian Eclipse 
spectrofluorometer. Column chromatography of all products was performed using 
Merck Silica Gel 60 (particle size: 0.040–0.063 mm, 230–400 mesh ASTM). 
Reactions were monitored by thin layer chromatography using fluorescent coated 
aluminum sheets. Solvents used for spectroscopy experiments were 
spectrophotometric grade. Flourescence life time measurements were determined on 
a HORIBA Jobin Yvon fluorolog, FL-1057. HORIBA Scientific NanoLEDs at 650 
and 667 nm (pulse width < 250 ps) was used. The instrument response function was 
measured with an aqueous Ludox solution.  The decays were analyzed with a multi-
exponential fitting function by iterative reconvolution and chi-square minimization. 
Mass spectra were recorded on Agilent Technologies 6530 Accurate-Mass Q-TOF 
LC/MS.  
 
3.5.2  Determination of FRET Efficiencies 
Energy transfer efficiencies between donor and acceptor moieties are determined 
using the fluorescence lifetimes of modules and molecular demultiplexer. The 
following formula is used for this purpose:   
 
     E = 1- τDA/τD    Equation 4 
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where τD and τDA refer to excited state decay time (lifetime) of protonated donor 
(protonated compound 12) alone and donor as a part of molecular demultiplexer 
(protonated compound 13) respectively. Both measurements were done in the 
presence of trifluoroacetic acid (TFA) and absorbance values are all below 0.1 to 
avoid inner filter effect. 
 
3.5.3  1O2 Generation Experiments 
For 1O2 measurements, bleaching of singlet oxygen trap molecule 1,3-
diphenylisobenzofuran (DPBF) was used. The corresponding reaction with 1O2 is 
given in scheme. 625 nm emitting LED is used as a light source with 10 cm 
separation from the sample cuvette. Solution containing DPBF (50 µM), compound 
13 (20 nM) and TFA (20µl/3ml) is prepared in CHCl3. Two negative control 
solutions are prepared with DPBF alone (50 µM) (with TFA and without TFA) and 
DPBF (50 µM) with compound 13 (20 nM) (without TFA). As positive control, a 
solution with DPBF (50 µM) and photosensitizer (compound 10) (20 nM) is 
prepared. Solutions are aerated for 5 minutes prior to each experiment. Then, 
absorption spectra are recorded in 5 minutes intervals while the solutions are either 
kept under dark (first 15 min) or irradiated with 625 nm light.  
The decrease in absorbance of DPBF at 411 nm is used to calculate relative singlet 
oxygen generation efficiencies. Slope of the graph of absorbance vs time are 
calculated and normalized with respect to photosensitizer or protonated compound 
13. The experimental artifact resulting from decomposition of DPBF by 
trifluoroacetic acid is corrected by subtracting the slope of this control graph from 
TFA containing solutions.  
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3.5.4  Synthesis 
 
Synthesis of Compound 1: 3, 5-dihydroxybenzylalcohol (2 g, 14.3 mmol) and 2-
ethylhexyl bromide (5.8 ml, 28.56 mmol) were dissolved in 50 ml acetone. K2CO3 
(16 g, 112 mmol) and catalytic amount of 18-crown-6 were added. The reaction 
mixture was refluxed for 12h. Then, acetone was evaporated in vacuum evaporator; 
the crude product was extracted with water and chloroform. Organic layer was 
collected, dried with Na2SO4 and evaporated in vacuo. The product was obtained as 
viscous yellow liquid (13.73 mmol, 4.98 g, 96%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.54 (d, 2H, J = 2.2 Hz; ArH), 6.41 (t, 1H, J = 
2.2 Hz; ArH), 4.64 (s, 2H, CH2O) 3.85 (dd, 4H, J = 3.64 Hz; OCH2), 3.50 (1H, 
CH2OH), 1.76 (m, 2H; OCH2CH), 1.3-1.6 (m, 16H; CH2), 0.9-1.0 (m, 12H; CH3). 
 
Synthesis of Compound 2: 3, 5-di(2-ethylhexyl)benzylalcohol, compound 1 (4.2 g, 
11.6 mmol) and pyridinium chlorochromate (5 g, 20 mmol) were dissolved in 50 ml 
dichloromethane. The reaction mixture was stirred at room temperature for 30 
minutes. Then, the crude product was filtered from celite, filtrate was collected, 
vacuum evaporated. The product was purified by silica gel column chromatography 
using CHCl3 as mobile phase. Fraction containing compound 2 was collected then 
the solvent was removed under reduced pressure (3.91 g, 10.8 mmol, 93%). 
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1H NMR (CDCl3, 400 MHz, δ ppm) 9.92 (s, 1H), 7.02 (d, 2H, J = 2.16 Hz; ArH), 
6.73 (t, 1H, J = 2.00 Hz; ArH), 3.90 (dd, 4H, J = 3.64 Hz; OCH2), 1.76 (m, 2H; 
OCH2CH), 1.3-1.6 (m, 16H; CH2), 0.9-1.0 (m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 191.5, 160.9, 138.4, 107.8, 107.3, 70.6, 39.3, 
30.5, 29.0, 23.8, 23.0, 14.0, 11.0.   
 
Synthesis of Compound 3: CH2Cl2 (300 ml) was purged with Ar for 30 min. 3,5-
di(2-ethylhexyl)benzaldehyde, compound 2 (1.76 g, 4.85 mmol) and 2,4-dimethyl 
pyrrole (1 ml, 9.71 mmol) were added. The color of the solution turned into red after 
the addition of 3 drops of trifluoroacetic acid. The reaction mixture was stirred at 
room temperature for 12h. Then, tetrachloro-1,4-benzoquinone (1.192 g, 9.7 mmol) 
was added and the reaction mixture was stirred at room temperature for 45 min. Then 
triethyl amine (6 ml) and boron trifluoride diethyl etherate (6 ml) were added 
sequentially. After stirring at room temperature for 30 min, it was extracted with 
water. Organic layer was dried with Na2SO4 and evaporated under reduced pressure. 
The product was purified by silica gel column chromatography using CHCl3/Hexane 
(50:50/v:v) as mobile phase. Fraction containing compound 3 was collected then the 
solvent was removed under reduced pressure (673.5 mg, 1.16 mmol, 24%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.58 (t, 1H, J = 2.2 Hz; ArH), 6.45 (d, 2H, J = 
2.2 Hz; ArH), 6.01 (s, 2H; ArH), 3.85 (dd, 4H, J = 3.64 Hz; OCH2), 2.60 (s, 6H; 
ArCH3), 1.75 (m, 2H; OCH2CH),  1.60 (s, 6H; ArCH3), 1.3-1.6 (m, 16H; CH2), 0.9-
1.0 (m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.4, 155.4, 143.2, 136.4, 121.0, 113.2, 110.0, 
106.3, 102.3, 71.0, 39.3, 30.5, 29.1, 23.8, 23.0, 14.6, 14.2, 14.1, 11.1. 
 
 
53 
 
HRMS (TOF-ESI): m/z calcd for C35H51BF2N2O2: 579.3933 [M-H]-; found: 
579.4002 [M-H]-, Δ = 11.8 ppm.  
 
Synthesis of Compound 4:  Compound 3 (300 mg, 0.516 mmol) and I2 (328 mg, 
1.29 mmol) were dissolved in ethanol (150 ml). Iodic acid, HIO3 (181.6 mg, 1.32 
mmol) was dissolved in a few drops of water and adde into previous solution. The 
reaction mixture was stirred at 60oC for a few hours untill all reeactant was 
consumed. After the reaction was completed, saturated sodium thiosulfate solution 
was added (50 ml) and it was stirred at room temparature for additional 30 min. 
Following that, it was extracted with CHCl3 and water. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica 
gel column chromatography using CHCl3/Hexane (50:50, v/v). Fraction containing 
compound 4 was collected, the solvent was removed under reduced pressure (280 
mg, 0.34 mmol, 66%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.60 (t, 1H, J = 2.2 Hz; ArH), 6.40 (d, 2H, J = 
2.2 Hz; ArH), 3.81 (dd, 4H, J = 3.94 Hz ;OCH2), 2.68 (s, 6H; ArCH3), 1.73 (m, 2H; 
OCH2CH), 1.60 (s, 6H; ArCH3), 1.2-1.5 (m, 16H; CH2), 0.91 (m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 55161.7, 156.7, 145.4, 141.5, 136.0, 131.0, 
106.0, 102.6, 85.5, 71.1, 39.3, 30.5, 29.1, 23.9, 23.0, 16.9, 16.0, 14.1, 11.1. 
HRMS (TOF-ESI): m/z calcd for C35H49BF2I2N2O2: 831.1866 [M-H]-; found: 
831.1951 [M-H]-, Δ = 10.0 ppm. 
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Synthesis of Compound 5: CH2Cl2 (300 ml) was purged with Ar for 30 min. 3, 5-
di(2-ethylhexyl)benzaldehyde, compound 2 (1.3 g, 3.57 mmol) and 2,4-dimethyl-5-
ethyl pyrrole (0.96 ml, 7.14 mmol) were added. The color of the solution turned into 
red after the addition of 3 drops of trifluoroacetic acid. The reaction mixture was 
stirred at room temperature for 12h. Then, tetrachloro-1,4-benzoquinone (878 mg, 
3.57 mmol) was added and the reaction mixture was stirred at room temperature for 
45 min. Then triethyl amine (7 ml) and boron trifluoride diethyl etherate (7 ml) were 
added sequentially. After stirring at room temperature for 30 min, it was extracted 
with water. Organic layer was dried with Na2SO4 and evaporated under reduced 
pressure. The product was purified by silica gel column chromatography using 
CHCl3 as mobile phase. Fraction containing compound 5 was collected then the 
solvent was removed under reduced pressure (394 mg, 0.62 mmol, 17%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.58 (t, 1H, J =2.3 Hz; ArH), 6.45 (d, 2H, J =2.3 
Hz; ArH), 3.82 (dd, 4H, J = 3.7 Hz; OCH2), 2.55 (s, 6H; ArCH3), 2.33 (q, 4H, J 
=11.3 Hz; ArCH2CH3), 1.73(m, 2H; OCH2CH), 1.49 (s, 6H; ArCH3), 1.2-1.6(m, 
16H; CH2), 1.02(t, 6H, J=16.0 Hz; ArCH2CH3), 0.8-1.0 (m, 12H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.4, 153.6, 140.3, 138.4, 137.2, 132.6, 130.5, 
106.6, 102.2, 71.0, 39.3, 30.5, 29.1, 23.9, 23.1, 17.1, 14.6, 14.1, 12.5, 11.5, 11.1. 
HRMS (TOF-ESI): m/z calcd for C39H59BF2N2O2: 635.4559 [M-H]-; found: 
635.4643 [M-H]-, Δ = 13.0 ppm. 
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Synthesis of Compound 6: 4-hydroxybenzaldehyde (2.45 g, 20 mmol) and propargyl 
bromide (2.5 g, 30 mmol) were dissolved in 100 ml acetonitrile. K2CO3 (5.5 g, 
mmol) and a few crystals of benzo-18-crown-6 were added. The reaction was 
refluxed until all 4-hydroxybenzaldehyde was consumed. The solvent was 
evaporated in vacuo, extracted with water and CHCl3. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica 
gel column chromatography using CHCl3/Hexane (50:50, v/v). Fraction containing 
compound 6 was collected then the solvent was removed under reduced pressure 
(2.85 g, 17.8 mmol, 89%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.92 (s, 1H), 7.87 (d, J=8.92 Hz, 2H, ArH), 7.11 
(d, J=8.72 Hz, 2H, ArH), 4.80 (d, J=2.44 Hz, OCH2), 2.58 (t, J=2.48 Hz, 1H, 
OCH2CCH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.8, 162.4, 131.9, 130.0, 115,2, 77.5, 76.4, 
55.9.  
HRMS-ESI: calculated for M+Na 183.0422, found 183.0422, ∆= 0 ppm.  
 
Synthesis of Compound 7: 4-hydroxybenzaldehyde (5 g, 41 mmol) and 1,6 
dibromohexane (2 g, 82 mmol) were dissolved in acetonitrile (150 ml). K2CO3 (17.2 
g, 123 mmol) and catalytic amount of benzo-18-crown-6 were added. The reaction 
mixture was refluxed for 12h. Then, acetonitrile was evaporated in vacuo and 
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extracted with water and chloroform. Organic layer was dried with Na2SO4 and 
evaporated in vacuo. The product was purified by silica gel column chromatography 
using CHCl3/Hexane (75:25, v/v). Fraction containing compound 7 was collected 
then the solvent was removed under reduced pressure (13.4 mmol, 3.82 g, 32% )  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.7 (s, 1H), 7.68 (d, J= 8.64 Hz, 2H, ArH), 6. 82 
(d, J= 8.76 Hz, 2H, ArH), 3.88 (t, J= 6.4 Hz, 2H, OCH2), 3.4 (t, J= 6.68 Hz, 2H, 
CH2Br), 1.65 (m, 4H, CH2CH2Br), 1.35 (m, 4H, OCH2CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.6, 164.1, 131.9, 129.7, 114.7, 68.1, 44.9, 
32.4, 28.8, 26.5, 25.2.   
HRMS (TOF-ESI): m/z calcd for C13H17BrO2: 285.04902 [M+H]+; found: 285.05413 
[M+H]+, Δ = 17.9 ppm. 
 
Synthesis of Compound 8: 4-(6-bromohexoxy)benzaldehyde, compound 7 (1.5 g, 
5.3 mmol) was dissolved in 25 ml DMSO. Sodium azide (1.37 g, 21.2 mmol) was 
added and the reaction mixture was stirred at 60oC for 2.5 hours. Then, it was 
extracted with water and CHCl3 a few times and organic layer was collected, dried 
with Na2SO4 and evaporated under reduced pressure. No further purification was 
required.  
 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.86 (s, 1H), 7.82 (d, J= 8.80 Hz, 2H, ArH), 
7.00 (d, J=8.76 Hz, 2H, ArH ), 4.05 (t, J=6.40 Hz, 2H, OCH2), 3.28 (t, J=6.80 Hz, 
2H, N3CH2), 1.75-1.85 (m, 2H, N3CH2CH2), 1.55-1.65 (m, 2H, OCH2CH2), 1.4-1.55 
(m, 4H, CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.8, 164.1, 132.0, 129.8, 114.7, 68.1, 51.3, 
28.9, 28.7, 26.4, 25.6.  
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HRMS (TOF-ESI): m/z calcd for C13H17N3O2: 248.13990 [M+H]+; found: 248.14573 
[M+H]+, Δ = 23.5 ppm. 
 
Synthesis of Compound 9: Compound 4 (200 mg, 0.24 mmol) and compound 6 (31 
mg, 0.19 mmol) were dissolved in benzene (40 ml). Piperidine (0.3 ml) and acetic 
acid (0.3 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all aldehyde was consumed. After the reaction was completed, it was 
extracted with CHCl3 and water. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using CHCl3/Hexane (50:50, v/v). Fraction containing compound 9 
was collected then the solvent was removed under reduced pressure (73 mg, 0.074 
mmol, 39%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.11 (d, 1H, J = 16.6 Hz; CH), 7.61 (d, 2H, J = 
8.8 Hz; ArCH3), 7.55 (d, 1H, J = 16.8 Hz ; CH), 7.02 (d, 2H, J = 8.8 Hz; ArH), 6.60 
(t, 1H, J =2.2 Hz ; ArH), 6.41 (d, 2H, J = 2.2 Hz; ArH), 4.71 (d, 2H, J =2.4 Hz; 
OCH2), 3.85 (dd, 4H, J = 3.8 Hz; OCH2), 2.70 (s, 3H; ArCH3), 2.55 (t, 1H, J = 2.4 
Hz ; CH), 1.75 (m, 2H; OCH2CH), 1.65(s, 3H; ArCH3), 1.60(s, 3H; ArCH3), 1.2-1.5 
(m, 16H; CH2), 0.8-1.0 (m, 12H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.7, 158.5, 156.9, 150.4, 146.1, 145.1, 140.2, 
138.6, 136.3, 132.0, 131.7, 130.4, 129.1, 117.1, 115.3, 106.3, 102.6, 106.3, 102.6, 
86.1, 82.1, 78.3, 75.8, 71.1, 55.9, 39.3, 30.5, 29.1, 23.8, 23.0, 17.3, 16.9, 16.2, 14.1, 
11.1. 
HRMS (TOF-ESI): m/z calcd for C45H49BF2I2N2O2: 973.2285 [M-H]-; found: 
973.2347 [M-H]-, Δ = 6.4 ppm. 
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Synthesis of Compound 10, PS: Compound 9 (75 mg, 0.075 mmol) and 4-
pyridinecarboxaldehyde (17 mg, 0.15 mmol) were dissolved in benzene (40 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was 
refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3/MetOH (95:5, v/v). 
Fraction containing 10 (PS) was collected then the solvent was removed under 
reduced pressure (35 mg, 0.033 mmol, 44%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.67(d, 2H, J = 5.8 Hz; ArH), 8.23(d, 1H, J = 
16.8 Hz; CH), 8.01(d, 1H, J = 16.8 Hz; CH), 7.86(d, 1H, J = 16.7 Hz; CH), 7.65(d, 
2H, J = 8.8 Hz; ArH), 7.62(d, 1H, J = 16.9 Hz; CH), 7.52(d, 2H, J = 6.0 Hz; ArH), 
7.06(d, 2H, J = 8.8 Hz; ArH), 6.61(t, 1H, J = 2.2 Hz; ArH), 6.42(d, 2H, J = 2.2 Hz; 
ArH), 4.79(d, 2H, J = 2.4 Hz; CH2), 3.75(dd, 4H, J = 3.8 Hz; CH2), 2.48(t, 1H, J = 
2.3 Hz; CH), 1.65(m, 2H; OCH2CH), 1.58(s, 3H; ArCH3), 1.53(s, 3H; ArCH3), 1.2-
1.5(m, 16H; CH2), 0.7-0.9(m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.8, 158.9, 152.7, 150.3, 148.1, 147.5, 144.9, 
144.3, 140.7, 139.9, 136.3, 134.8, 130.1, 129.5, 123.3, 121.5, 116.9, 115.4, 106.4, 
102.7, 78.2, 75.9, 71.1, 55.9, 39.3, 30.5, 29.7, 29.1, 23.9, 23.0, 17.7, 17.1, 14.1,11.1.  
HRMS (TOF-ESI): m/z calcd for C51H58BF2I2N3O3: 1062.2550 [M-H]-; found: 
1062.2625 [M-H]-, Δ = 7.1 ppm. 
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Synthesis of Compound 11: Compound 5 (200 mg, 0.314 mmol) and 4-
dimethylaminobenzaldehyde (37.5 mg, 0.25 mmol) were dissolved in benzene (40 
ml). Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture 
was refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3/Hexane (75:25, v/v). 
Fraction containing compound 11 was collected then the solvent was removed under 
reduced pressure (0.039 mmol, 30 mg, 16%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.60(d, 1H, J = 16.6 Hz; CH), 7.54(d, 2H, J = 
8.8 Hz; ArH), 7.22(d, 1H, J = 16.7 Hz; CH), 6.73(d, 2H, J = 8.6 Hz; ArH), 6.57(t, 
1H, J = 2.2 Hz; ArH), 6.48(d, 2H, J = 2.2 Hz; ArH), 3.85(dd, 4H, J = 3.6 Hz; OCH2), 
3.03(s, 6H; N(CH3)2), 2.64(q, 2H, J = 11.1 Hz; ArCH2), 2.59(s, 3H; ArCH3), 2.36(q, 
2H, J = 11.3 Hz; ArCH2), 1.74(m, 2H; OCH2CH), 1.52(s, 3H; ArCH3), 1.49(s, 3H; 
ArCH3), 1.2-1.5(m, 16H; CH2), 1.19(t, 3H, J = 6.0 Hz; ArCH2CH3), 1.03(t, 3H, J = 
6.0 Hz; ArCH2CH3), 0.9-1.0(m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.5, 150.9, 150.8, 139.0, 138.5, 137.5, 136.2, 
133.0, 132.7, 131.8, 131.1, 131.0, 128.7, 115.8, 115.7, 112.2, 107.0, 102.2, 71.0, 
40.4, 39.3, 30.5, 29.1, 23.8, 23.0, 18.5, 17.2, 14.7, 14.1, 14.0, 12.6, 11.5, 11.3, 11.1 
HRMS (TOF-ESI): m/z calcd for C61H83BF2N6O3: 767.5373 [M]; found: 767.5446 
[M+H], Δ = 9.5 ppm. 
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Synthesis of Compound 12, FL: Compound 11 (30 mg, 0.039 mmol) and compound 
8 (11.6 mg, 0.047 mmol) were dissolved in benzene (40 ml). Piperidine (0.2 ml) and 
acetic acid (0.2 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all aldehyde was consumed. After the reaction was completed, it was 
extracted with CHCl3 and water. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using CHCl3/Hexane (75:25, v/v). Fraction containing compound 12 
(FL) was collected then the solvent was removed under reduced pressure (0.022 
mmol, 21.5 mg, 56 %). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.70 (d, 1H, J = 16.6 Hz; CH), 7.65(d, 1H, J = 
17.0 Hz; CH). 7.56(m, 4H; ArH), 7.27(d, 1H, J = 18.0 Hz; CH), 7.18(d, 1H, J = 16.6 
Hz; CH), 6.94(d, 2H, J = 8.4 Hz; ArH), 6.75(d, 2H, J = 8.2 Hz; ArH), 6.58(s, 1H; 
ArH), 6.49(s, 2H; ArH), 4.03(t, 2H, J = 6.4 Hz; OCH2CH2), 3.85(d, 4H, J = 5.8 Hz; 
OCH2CH), 3.31(t, 2H, J = 6.8 Hz; CH2N3), 3.07(s, 6H; N(CH3)2), 2.65(m, 4H; 
ArCH2CH3), 1.85(m, 2H; OCH2CH2), 1.2-1.9(m, 24H; CH2), 1.51(s, 6H; ArCH3), 
1.20(t, 6H, J = 6.5 Hz; ArCH2CH3), 0.95(m, 12H; CH3) 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.4, 159.4, 151.8, 150.9, 149.1, 139.0, 137.7, 
137.1, 136.7, 134.4, 133.7, 133.0, 132.3, 131.7, 130.6, 128.9, 128.7, 125.9, 124.6, 
118.4, 115.8, 114.7, 112.2, 107.2, 102.2, 71.1, 67.9, 51.4, 40.4, 39.4, 30.5, 29.2, 29.1, 
28.8, 26.5, 25.7, 23.8, 23.0, 18.5, 14.1, 14.1. 
HRMS (TOF-ESI): m/z calcd for C61H83BF2N6O3: 996.65878 [M]; found: 996.67410 
[M], Δ = 15.4 ppm. 
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Synthesis of Compound 13, the Molecular Demultiplexer: 10 (PS) (22 mg, 21 
µmol) and 12 (FL) (16 mg, 16 µmol) were dissolved in CHCl3/acetonitrile mixture 
(10 ml: 10 ml). Triethylamine (20 µl) was added. Saturated aqueous solutions of 
CuSO4.5H2O (1 ml) and Sodium ascorbate (1 ml) were prepared in separate viels. 
Then, 0.15 ml of each solution were added to reaction mixture.  A small piece of Cu 
(0) wire was added. The mixture was stirred overnight at room temperature. Then, it 
was extracted using CHCl3 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using CHCl3/MetOH (96:4, v/v). Fraction containing 13 
was collected then the solvent was removed under reduced pressure (10 µmol, 21 
mg, 63% ). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.67(d, 2H, J = 6.1 Hz; ArH), 8.23(d, 1H, J = 
16.4 Hz; CH), 8.00(d, 1H, J = 16.8 Hz; CH), 7.85(d, 1H, J = 16.8 Hz; CH), 7.69(d, 
1H, J = 17.2 Hz; CH) 7.8-7.4(m, 11H; CH, ArH), 7.25(d, 1H, J = 16.6 Hz; CH), 
7.17(d, 1H, J = 17.1 Hz; CH), 7.08(d, 2H, J = 8.8 Hz; ArH), 6.92(d, 2H, J = 8.8 Hz; 
ArH), 6.73(d, 2H, J = 8.9 Hz; ArH), 6.61(d, 2H, J = 2.2 Hz; ArH), 6.57(d, 2H, J = 2.2 
Hz; ArH), 6.47(d, 2H, J = 2.2 Hz; ArH), 6.42(d, 2H, J = 2.2 Hz; ArH), 5.30(s, 2H; 
OCH2), 4.42(t, 2H, J = 7.2 Hz; NCH2), 4.02(t, 2H, J = 6.3Hz; OCH2CH2), 3.85(m, 
8H; OCH2CH), 3.03(s, 6H; N(CH3)2), 2.63(m, 4H; ArCH2CH2), 2.00(m, 2H; 
NCH2CH2), 1.82(m, 2H; OCH2CH2), 1.8-1.7(m, 4H; CH2), 1.70(s, 3H; ArCH3), 
1.68(s, 3H; ArCH3), 1.52(s, 6H; ArCH3), 1.5-1.2(m, 32H; CH2), 1.16(m, 6H; 
ArCH2CH3), 1.0-0.8 (m, 24H; CH3) 
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13C NMR (CDCl3, 400 MHz, δ ppm) 161.8, 161.3, 159.7, 159.4, 150.9, 150.2, 143.8, 
140.8, 137.7, 136.8, 136.2, 134.8, 134.3, 133.7, 133.0, 130.6, 129.8, 128.9, 128.7, 
125.8, 122.6, 121.5, 118.4, 116.7, 115.8, 115.2, 114.8, 112.1, 107.2, 106.3, 102.7, 
102.2, 71.1, 67.7, 62.2, 50.4, 40.3, 39.4, 30.5, 30.2, 29.7, 29.1, 26.3, 25.6, 23.8, 23.0, 
18.5, 17.6, 17.2, 14.1, 11.3, 11.1, 8.6.  
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CHAPTER 4 
Control of PDT Action with an Implemented AND 
Logic Operation; Glutathione and pH Dual 
Activatable Photosensitizer  
 
Sundus Erbas-Cakmak, Fatma Pir, Engin U. Akkaya  
 
4.1 Objectives 
Molecular logic gates are primitive mimics of their electronic counterparts and are a 
promising research area. Even a number of two input logic operations and a number 
of more advanced operations such as key-pad-lock3, flip-flop logics2 are constructed; 
their use in place of traditioal computational methodology is still not realistic. On the 
contrary, use of such logic operations in other research areas such as in biology, 
using wet chemistry is heighly promising since biochemical processes has this 
intrinsic property as well. In the research presented in this part, an AND logic gate is 
designed with a photosensitizer to control its activity in a biologically meaning 
media. Two inputs glutathione (GSH) and acidity, associated with cancer are used to 
control the selective activitation of photosensitizer under real disease conditions. 
 
4.2 Introduction 
Use of molecular logic gates for diagnosis149and therapeutic16,17 purposes is 
introduced into the literature by a number of different groups. Among the examples, 
control of singlet oxygen generation through an AND logic gate is remarkable.15 In 
this work, photodynamic activity depends on the sodium dependent abolishing of 
PET process and protonation induced spectral shift in absorbance. Although choice 
of inputs are realistic in this proof-of-principle study, the response range is not 
meaningful since neither the sodium concentration is that high nor the pH is that low 
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in tumor tissue. In another proof-of concenpt work, the DEMUX124 logic gate is 
implemented on a photosensitizer and fluorophore and the presence of acid enables 
the switch between emission to photodynamic activity under irradiation which is 
interpretted as imaging and therapy.  Still, the inputs are beyond the range of 
biological importance and for realistic arguments, the inputs should be chosen 
rationally or the sensitivityof the receptor to those inputs should be optimized 
accordingly.  
Considering this, the project aims to optimize the input responsiveness of the logic 
gate to develop a more realistic activatable photosensitizer with a potential use as 
photodynamic therapeutic agent.  
 
4.3 Design of the AND Logic Gate 
Molecular AND logic construct of photosensitizer is designed taking the two of the 
cancer related input into consideration; high glutathion concentration and low pH. 
Upon these inputs, pH sensitivity is attained by an ICT character on the BODIPY by 
means of pH responsive functional groups. GSH responsiveness is maintained by 
building an electronic energy transfer system with the use of a lower energy 
BODIPY chromophore to quench the photosensitizer before the generation of toxic 
1O2. Scheme 18 shows representative activation of the photosensitizer.  
 
 
Scheme 18. Representative illustration of cleavage of the disulfide bond and protonation of 
the photosensitizer by glutathione and acid respectively. 
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Scheme 19. Structures of compounds bearing different pH-sensitive groups 
A spectral shift with a huge extinction coefficient change upon protonation is 
required for the photosensitizer to be activated only in the acidic conditions. Besides, 
the pKa of the compound should be in biologically relevant range which is above 6.5 
for most tumors.117 Most of the pH responsive groups in literature have a pKa value 
below 6 which makes them unsuitable for therapeutic purposes unless the highly 
acidic intracellular organelles such as lysosome are targeted. To optimize the pKa 
value, a number of different water soluble compounds have been synthesized. The 
semi-schematic representations of these compounds are given in Scheme 19, the 
complete chemical structures and their synthesis can be found in experimental part of 
this chapter. General approach for pKa optimization in the project is to incorporate 
electron donating or withdrawing groups into the structure to attain desired 
sensitivity and spectral properties.  
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Scheme 20. Chemical structure of AND logic construct of photosensitizer with GSH and pH 
responsive moieties shown in red and blue respectively. 
 
With the intention of GSH responsiveness, a near-IR absorbing energy acceptor 
BODIPY dye with an appropriate spectral character for EET is attached to the 
photosensitizer through a bioreducible disulfide linker. For reasonable reaction 
conditions the quenching module and the photosensitizer are attached to oneanother 
through disulfide bridge using Huisgen 1,3-dipolar cycloaddition, namely ‘click’ 
reaction. The BODIPY dye used as an energy sink is prepared by the Sonogashira 
coupling at 2,6-positions together with Knoevenagel condensation to increase the 
conjugation furher.  
The structure of the final AND logic construct is given in Scheme 20 where each 
functional moiety is color-coded. The quencher moiety is shown in purple, the 
reducible disulfide bridge in red, the photosensitizer in green and finally the pH 
responsive phenolic moiety in blue. To increase the solubility of the compound 
throughout the reaction pathways, triethyleneglycol and 2-ethylhexyl moieties are 
attached to the structure.  
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4.4 Experimental Results and Discussion 
4.4.1 pH Optimization 
With the pH of tumor tissue in mind, water soluble BODIPYs with pH responsive 
groups with an ICT character have been synthesized and the pKa values are 
determined in aqueous solutions. As a start, compound 17 a distyryl-BODIPY with 
4-pyridinecarboxaldehyde was synthesized and the pKa value is determined to be 
3.42 with a protonation-induced bathochromic shift from 594 nm to 615 nm (Figure 
16). Since the pH of biological media is not suitable for the protonation of the PS, a 
strategy to increase the pKa has been adapted. This strategy is basically to attach 
electron donating groups into the structure of the pH responsive moiety to enhance 
its basicity and as a consequence to raise the pKa. As electron donating group methyl 
and methoxy set have been chosen and 2,6-modified pyridinecarboxaldehyde were 
synthesized bearing these groups.        
Upon these candidates, compound 23 with 2,6-methylpyridine in its structure is able 
to show the desired spectral shift in absorbance, namely, protonation induces a large 
hypsochromic shift in absorbance from 723 nm to 601 nm (Figure 17). However, the 
pKa of the compound is experimentally determined to be 4.21 and the compound is 
pH-responsive essentially in the range 3.5 to 5. Although, consistent with the design 
Figure 16. Electronic absorption spectra of protonated and neutral compound 17 in water (a) and 
the pH titration curve of the same compound (b). 
(a) (b) 
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strategy an increase in pKa is observed, the value it reaches is not still truly 
biologically significant.  
 
The PS with 2,6-dimethoxypyridine, compound 33 fails to display a observable 
spectral shift upon protonation below pH 8 and the pKa can not be determined using 
UV-Vis absorbance since the compound decomposes rapidly at higher pH solutions. 
(Figure 18). The compound absorbs maximally at 626 nm.  
 
Figure 18. Electronic absorption spectra of protonated and neutral compound 33 in 40% 
THF in water. 
Figure 17. Electronic absorption spectra of protonated and neutral compound 23 in water (a) 
and the pH titration curve of the same compound (b).  
(a) (b) 
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Since the quinoline has a pKa of 4.85150 and the value for the related compound 4-
methylquinoline (lepidine) is 5.67151, the BODIPY construct of this nominee worths 
trying. For this reason, compound 36 is synthesized. In spite of the applicable 
spectral shift in absorbance upon protonation, the compound fails to display a 
significant pKa (Figure 19). The pKa is calculated to be 2.62 and the absorbance 
maxima reallocates from 636 nm to 660 nm upon protonation in 40% THF in water. 
Thus the compound has not met the criteria of the desired PS.  
 
Figure 19. Electronic absorption spectra of protonated and neutral compound 36 in water (a) and 
the pH titration curve of the same compound (b). 
(a) (b) 
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In literature, monostyryl BODIPY with a 3-chloro-4-hydroxyphenyl moiety was 
reported to have a pKa of 7.6.75 As a final attempt, a new version of this compound 
with an improved electron withdrawing group is designed with an expectation of 
decrease in pKa. Compound 38 and 54 with a nitro group in place of chloro is 
synthesized in view of that. The pH response of compound 38 is investigated within 
a micelle in aqueous solution since this compound and the final AND logic gate 
construct is not soluble in water.  Fortunately and with the exertion of rational 
design, the compound is determined to have a pKa assessment of 6.92 in cremophor 
EL micelle with a tremendous spectral change in absorbance from 649 nm to 730 nm 
on account of deprotonation (Figure 20). 
Figure 20. Electronic absorption spectra of deprotonated and neutral compound 38 in micelle in 
water (a) and the pH titration curve of the same compound (b). 
(a) (b) 
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To understand if the pH response is consistent in non-micellar system, a water 
soluble version (compound 54) is pH-titrated in 40% THF in water and the pKa is 
determined to be 6.62 (Figure 21). 0.3 unit difference may result from the fact that, 
relatively more hydrophobic microenvironment within the micelle may encumber the 
deprotonation process since the charged species can not solvated easily and the 
process is less favourable accordingly. The absorption spectrum of deprotonated 
compound is essentially the same as in micelle. The pKa values and pH dependent 
spectral shifts in absorption of all compounds are given in Table 4.  
Table 4. Absorbance values of compounds in water 
Compound  λmax1a λmax2b pKa 
17 615 594 3.42c 
23 601 723 4.21c 
33 626 626 -d 
36 660 636 2.62e 
38 649 730 6.92f 
54 649 731 6.62c 
a the value for fully protonated compound, b value for fully deprotonated compound, c the 
measurement was done in water, d the value can not be calculated accurately since the 
compound decomposes beyond pH 8 in 40% THF in water, e the measurement was done in 
40% THF in water, f the measurement was done in water using the micellar form of the 
compound. 
Figure 21. Electronic absorption spectra of deprotonated and neutral compound 54 in 40% THF in 
water (a), and the pH titration curve of the same compound (b). 
(a) (b) 
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With the results obtained from pKa optimization study as described above, pH 
dependent component of the molecular AND logic gate is built with 4-hydroxy-3-
nitrophenyl moiety. 
 
4.4.2 Photophysical Characterization  
 UV-Vis absorption and emission spectra of deprotonated and neutral forms of 
compounds 38, 51 and 55 in THF are given in Figure 22, Table 5. Energy transfer to 
a chromophore in the vicinity is expected to compete singlet oxygen generation by 
the photosensitizer. For that, the emission of the donor (photosensitizer) has to have 
spectral overlap with the absorption of the energy acceptor (quencher) in close 
proximity. As shown in Figure 23, this criterion is met in the molecule. Absorption 
of the quencher part, as represented by compound 51 overlaps well with the emission 
of photosensitizer part (compound 38). In deprotonated forms, the spectral 
compatibility is less pronounced, however since in this form the compound is not 
truly excited at the chosen wavelength (625 nm LED is used for photodynamic 
measurements), and is already quenched by other deactivation pathways (as observed 
by a dramatic decrease in emission) this incoherence is not an immense drawback.   
Figure 22. Electronic absorption (a) and fluorescence (b) spectra of 7.5 µM of neutral 
(solid) and deprotonated (dash) compounds 55 (black), 51 (red) and 38 (blue) in THF. 
Piperidine is used to deprotonate the compounds and the excitation is done at 625 for 
fluorescence measurements. 
(a) (b) 
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Figure 23. Normalized electronic absorption spectra of compound 51 in neutral (red) and 
basic (blue) conditions, and emission spectra of compounds 38 in THF. Piperidine is used as 
base and the compound 38 is excited at 625 nm for fluorescence measurements.   
Table 5. Photophysical characterization of compounds 38, 51 and 55 in THF. 
Compound  Absorption Emission ε (M-1cm-1) φF 
λmax1a λmax2b λmax1a λmax2b λmax1a λmax2b max1
a λmax2b 
38 645 720 667 - 40000 30000 0.13 - 
51 685 685 707 - 57000 63000 0.76 - 
55 640 
685 
687 654 
707 
707 
 
42000 
56000 
70000 0.24 0.15 
a the value for fully protonated compound, b value for fully deprotonated compound. 
 
The UV-Vis absorption of micellar compound 55 in water is given in Figure 24a. 
Two peaks corresponding to two absorbing modules converge to give an almost 
single one at higher wavelength upon deprotonation. For equal concentrations of 
compounds 55 and 38, emission spectra shows a decrease in the emsission of PS part 
compared to free compound 38, Figure 24b, which indicates energy transfer. Since 
the deprotonated form of free PS, compound 38 is non-emissive, the same analysis 
can not be performed for this form. The energy transfer is not proved clearly with 
excitation spectra, no observable change is detected which may be due to low 
emission intensity of each modeule and close absorption properties.   
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Figure 24. Electronic absorption spectra of neutral (black) and deprotonated (red) forms of 
micellar compound 55 in aqueous solution (a), comparison of fluorescence spectra of neutral 
compounds 38 and 55 in micelle in water (excited at 625 nm).  
4.4.3 Analysis of Reduction by Glutathion 
The cleavage of the disulfide bond is analyzed by incubating the micellar compound 
55 for 12 hour at room temperature and comparing it with the GSH-free compound 
55 both through spectroscopic analysis and High Resolution Mass Spectra (HRMS). 
As shown in Figures 25 and 26, the compound is successfully cleaved by GSH and 
thiol form of the free photosensitizer and disulfide form of quencher are detected by 
HRMS.   
 
 
Figure 25. The cleavage of quencher from the photosensitizer as analyzed by HRMS, (∆ = 
8.8 ppm) after incubation with GSH for 12 h.  
(a) (b) 
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Figure 26. The cleavage of quencher from the photosensitizer as analyzed by HRMS, (∆ = 
4.65 ppm) after incubation with GSH for 12 h. 
After resolving the reduction of the disulfide linker by GSH through HRMS analysis, 
a spectral examination is also performed to understand energy transfer. Since the 
EET efficiency is expected to decrease upon release of the energy donor part, the 
emission of this part is predicted to increase. Unsurprisingly, an increase in emission 
of the photosensitizer part is clearly observed in fluorescence spectra, Figure 27a, 
which indicates that the energy transfer is less effective in the free form. However, 
the excitation spectra do not show a clear distinction between GSH containing and 
GSH-free samples (Figure 27b).   
 
Figure 27. Emission spectra of compound 55 in the absence (black) and the presence of 
GSH (red) in micelle, in water. The spectrum is taken by excitation at 625 nm. The 
compound 55 is incubated with 2.5 equivalents of GSH over 12 h in water (a). Excitation 
spectra of micellar compound 55 in the presence (black, solid) and absence (red, dashed) of 
GSH in acidic aqueous solution (b).  
(a) (b) 
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4.4.4 Photodynamic Activity Measurements and AND Logic Gate  
In order the compound to behave as an AND logic operation it needs to show more 
efficient photodynamic activity in the presence of two inputs, GSH and acid. The 
photodynamic activities are measured with the micellar forms of the compounds 38 
and 55 in water and pH was adjusted to deprotonate the compounds in certain 
experiments. Compound 38 is used for the GSH-cleaved situation since the presence 
of excess GSH interferes with the singlet oxygen generation experiments.  
 
Figure 28. Control experiment with the solution containing trap molecule only in acidic 
(black) and basic (red) acqueous conditions (a) Comparison of 1O2 generation of micellar 
forms of molecular AND logic construct (7.5 µM) in the presence of different combinations 
of inputs as followed by the decrease in 1O2 trap absorbance at 378 nm in water (b). In the 
first 15 min, the samples are in dark whereas they are irradiated with a 625 nm LED from 
that time on.  
1O2 generation experiment was done with the use of a trap molecule. The reaction of 
this molecule with 1O2 is described in experimental section. Absorbance decrease at 
378 nm is followed as a measure of 1O2 production. First, to show that the trap 
molecule does not decompose in the absence of photosensitizer, control experiments 
under dark and 625 nm irradiation are performed in similar conditions. Result in 
Figure 28a, display that trap is stable under experimental conditions. On the other 
hand, the photosensitizer free from quencher shows a greater extent of 1O2 in the 
presence of slightly acidic media, Figure 28b. Although compound 55 produces 
singlet oxygen to some extent in the absence of GSH, still this is less efficient 
(a) (b) 
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compared to free photosensitizer. The results are depicted as relative 1O2 generation 
efficiency in Figure 29 as measured by percent decrease of trap absorption at 378 nm 
in each experimental condition.  The treshold value of 1O2 generation efficiency for 
AND logic gate is determined to be 4 and none of the input combinations but one 
manage to reach this value. Thus, the PS actively produces 1O2 only in the presence 
of both inputs acid and GSH, as expected.  
 
Figure 29. Comparison of relative 1O2 generation as measured by the percent decrease in 
absorbance of trap molecule and the threshold level determined for AND logic.  
 
Figure 30. Comparison of initial 1O2 generation rate as measured by the percent decrease in 
absorbance of trap molecule within 5 min of light irradiation. 
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Looking at the initial rates of 1O2 production, GSH and H+ both input case shows a 
distinct rate compared to other combinations of inputs (Figure 30). Since the 1O2 
generation is dependent on the dissolved O2 concentration, the PDT action slows 
down in time. In real tissue, the O2 supply is expected to be constant within the time 
scale of experiment. Thus, initial rates may be more valuable to compare the relative 
singlet oxygen generation efficiency.  
  
4.5 Experimental Details 
4.5.1 pKa Determination of Compounds 17, 23, 33, 36, 38 and 54 
Aqueous solutions of each compound were prepared and were titrated with aliquots 
of acid (HCl) and base (NaOH) solutions. Each time, pH of the solution was 
measured with the aid of a pH meter and the spectra are recorded.Since there are two 
different absorbing species, one protonated/deprotonated and one neutral, two 
different peak absorbance wavelengths are observed. Plotting pH versus the ratio of 
absorbance at these two wavelengths and subsequent non-linear curve fit in Origin 
software gives the experimental pKa values in water. For some compounds 33, 36 
and 54 40% THF was used to increase solubility.  
Since compound 38 is the true module of the target compound (compound 55) and is 
not soluble in water, the pKa measurements were performed after the formation of 
micelle.  
 
4.5.2 Preparation of Micelle   
Micelles of compounds 38 were prepared with Cremophor EL using the procedure in 
literature.152 50 mg Cremephor EL and compound 38 (6 mg, 5 µmol) or compound 
55 (14 mg, 5 µmol) were dissolved in 330 ml freshly distilled tetrahydrofuran. The 
solution was sonicated for 30 min, while the sonication water bath was kept below 35 
oC. Then, THF was evaporated under reduced pressure and the remaining compounds 
were dissolved in water (5 ml). The suspension was filtered through 0.45 µm PTFE 
filter. For each measurements micelles were prepared freshly. Concentrations of 
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solutions of the compounds in micelles were predicted using their extinction 
coefficients in THF.   
GSH (2.5 equivalent) was added to the solution of compound 55 before the 
preparation of the micelle and the sample was incubated at RT for 12 h, before 
HRMS and spectroscopic analysis were performed.  
 
4.5.3 1O2 Generation Experiments 
1O2 dependent degradation of water soluble trap, 2,2'-(anthracene-9,10-
diylbis(methylene)dimalonic acid was used to measure photodynamic activity since 
the absorption of this compound decreases indicating the generation of 1O2.153 
Corresponsing reaction is given in Scheme 21.  
 
 
Scheme 21. Reacion of trap molecule with 1O2.  
Since the water solubility of the anthracene-based trap is poor in water, samples were 
sonicated for 15 min to obtain clear solutions. Measurements were performed using 
625 nm LED and samples were irradiated with the light source from a 5 cm distance. 
All samples were aerated for 5 min prior to experiments. After incubation under dark 
for 15 min, light was irradiated for 60 min and UV-Vis spectra were recorded at each 
5 min intervals. Relative singlet oxygen efficiency was calculated by the percent 
decrease in trap absorbance at 378 nm within 60 min light irradiation period.  
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4.5.4 Synthesis  
 
Synthesis of Compound 14154: CH2Cl2 (300 ml) was purged with Ar for 30 min. 4-
(prop-2-ynyloxy) benzaldehyde 6 (1 g, 6.2 mmol) and 2,4-dimethyl pyrrole (1.2 g, 
12.6 mmol) were added. The color of the solution turned into red after the addition of 
3 drops of trifluoroacetic acid. The reaction mixture was stirred at room temperature 
for 12h. Then, tetrachloro-1,4-benzoquinone (1.52 g, 6.2 mmol) was added and the 
reaction mixture was stirred at room temperature for 45 min. Then triethyl amine (6 
ml) and boron trifluoride diethyl etherate (6 ml) were added sequencially. After 
stirring at room temperature for 30 min, it was extracted with water. Organic layer 
was dried with Na2SO4 and evaporated  under reduced pressure. The product was 
purified by silica gel column chromatography using CHCl3. Fraction containing 
compound 14 was collected then the solvent was removed under reduced pressure (260 
mg, 0.68 mmol, 11% ). 
1H NMR (CDCl3, 400 MHz, δ ppm) 1.43 (s, 6H), 2.56-2.58 (m, 6H+1H), 4.77 (d, 
J=2.4 Hz, 2H), 5.99 (s, 2H), 7.10 (d, J=8.7 Hz), 7.21 (d, J=8.7 Hz, 2H).   
13C NMR (CDCl3, 400 MHz, δ ppm) 14.5, 14.6, 56.0, 75.9, 78.0, 115.6, 121.2, 
128.0, 129.2, 131.8, 141.5, 143.1, 155.4, 158.1.  
HRMS-ESI: calculated for M+Na 401.1617, found 401.1644, ∆= 6.7 ppm. 
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Synthesis of Compound 15: 1,3,5,7-Tetramethyl-8-(4-Propargyloxiphenyl)-4,4-
difloroboradiaza-s-indacene 14 (150 mg, 0.39 mmol) and I2 (249 mg, 0.99 mmol) 
were dissolved in ethanol (100 ml). Iodic acid, HIO3 (138 mg, 0.78 mmol) was 
dissolved in a few drops of water and added into previous solution. The reaction 
mixture was stirred at 60oC for a few hours untill all reactant was consumed. Then, 
saturated sodium thiosulfate solution was added (50 ml) and it was stirred at rrom 
temparature for additional 30 min. Then, it was extracted with CHCl3 and water. 
Organic layer was dried with Na2SO4 and evaporated  under reduced pressure. The 
product was purified by silica gel column chromatography using CHCl3/Hexane 
(50/50, v/v). Fraction containing compound 15 was collected then the solvent was 
removed under reduced pressure (218 mg, 0.35 mmol, 90 % ). 
1H NMR (CDCl3, 400 MHz, δ ppm) 1.36 (s, 6H), 2.49 (s, 1H), 2.56 (s, 6H), 4.70 (s, 
2H), 7.04 (d, J=8.8 Hz, 2H), 7.09 (d, J=8.8 Hz, 2H).  
13C NMR (CDCl3, 400 MHz, δ ppm) 16.0, 17.1, 56.1, 76.1, 85.8, 100.1, 116.0, 
127.8, 129.1, 131.6, 141.4, 146.0, 156.7, 158.6.  
HRMS-ESI: calculated for M+Na 652.9550, found 652.9515, ∆= 5.4 ppm.  
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Synthesis of Compound 16: Compound 15 (120 mg, 0.19 mmol) and 4-
pyridinecarboxaldehyde (51 mg, 0.48 mmol) were dissolved in benzene (40 ml). 
Piperidine (0.4 ml) and acetic acid (0.4 ml) were added. The reaction mixture was 
refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3/MeOH (95:5, v/v). 
Fraction containing compound 16 was collected then the solvent was removed under 
reduced pressure (0.09 mmol, 75 mg, 49%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.69 (4, 2H, J = 6.0 Hz; CH), 8.08 (d, 2H, J = 
16.7 Hz; ArH), 7.84 (d, 2H, J = 16.7 Hz; CH), 7.50 (d, 4H, J = 6.0 Hz; ArH), 7.22 (d, 
2H, J = 8.4 Hz; ArH), 7.18 (d, 2H, J = 8.4 Hz; ArH), 4.81 (d, 2H, J = 2.4 Hz; OCH2), 
2.60 (t, 1H, J = 2.4 Hz; OCH2CH), 1.50 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 158.8, 150.3, 149.9, 147.1, 143.7, 141.4, 136.6, 
133.9, 129.3, 127.5, 122.8, 121.5, 116.2, 83.7, 77.7, 76.2, 56.1, 17.8.  
HRMS (TOF-ESI): m/z calcd for C34H25BF2I2N4O: 809.0252 [M+H]+; found: 
809.0290 [M+H]+, Δ = 4.70 ppm. 
 
 
Synthesis of Compound 17: Compound 16 (50 mg, 62 µmol) and azide 
functionalized polyethylene glycol monomethylether (2000MW, 124 mg, 62 µmol) 
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were dissolved in tetrahydrofuran (2 ml). Triethylamine (430 µl) and CuI (24 mg, 
0.126 mmol) were added. The reaction mixture was stirred for 12 h at room 
temperature. After the reaction was completed, it was extracted with CHCl3 and 
brine. The organic layer was collected and dried over Na2SO4, followed by 
evaporation of the solvent under reduced pressure. The product was purified by silica 
gel column chromatography using CHCl3/MeOH (95:5, v/v) as mobile phase. 
Fraction containing compound 17 was collected then the solvent was removed under 
reduced pressure (34 µmol, 100 mg, 54%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.62 (4H; CH), 8.04 (d, 2H, J = 16.72 Hz; CH), 
7.80 (d, 2H, J = 16.80 Hz; CH), 7.51 (d, 2H, J = 5.52 Hz; ArH), 7.19 (2H + 2H; 
ArH), 5.25 (2H; OCH2), 4.58 (t, 2H, J = 5.08 Hz; NCH2), 3.90-3.30 (PEG, 
OCH2CH2O), 1.50 (s, 6H; ArCH3). 
 
Synthesis of Compound 18155: 2,6-lutidine (5 g, 47 mmol) was dissolved in 60 ml 
acetone. m-chloroperbenzoic acid (13 g, 75 mmol) was dissolved in 60 ml acetone 
and was added to previous mixture dropwise during the course of 10 minutes. The 
reaction mixture was stirred for 90 min. at room temperature. Then, it was cooled 
using an ice bath for 30 min. Following this, 20 ml of ice cold diethyl ether was 
added and HCl gas was bubbled through the reaction for 10 min. The solid produced 
as a result of bubbling was filtered, washed two times with ether. Then, salt was 
dissolved in 20 ml of water; pH was adjusted to be above 10 using NaHCO3. Finally, 
the solution was extracted with CHCl3, solvent was evaporated to yield liquid 
colorless compound 18 (40 mmol, 4.9 g, 85%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.18 (d, 2H, J = 7.24 Hz; ArH), 7.00 (t, 1H, J = 
7.56 Hz; ArH), 2.45 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 148.7, 124.4, 123.8, 18.1. 
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Synthesis of Compound 19: Compound 18 (6 g, 32 mmol) was dissolved in 100 ml 
dichloromethane. Equal amount of trimethyloxonium tetrafluoroborate (32 mmol, 
7.05 g) was added and the reaction mixture was stirred for 5h at RT. Solvent was was 
vacuum evaporated to yield a white solid (quantitative, used without further 
purification).  
1H NMR (D2O, 400 MHz, δ ppm) 8.18 (t, 1H, J = 7.92 Hz; ArH), 7.75 (d, 2H, J = 
7.96 Hz; ArH), 4.22 (s, 3H; OCH3), 2.81 (s, 6H; ArCH3). 
13C NMR (D2O, 400 MHz, δ ppm) 153.6, 143.8, 128.0, 66.6, 16.7. 
 
Synthesis of Compound 20: Compound 19 (5.19 g, 23.1 mmol) was dissolved in 65 
ml MeOH. Potassium peroxodisulfate (1.53 g, 5.65 mmol) was dissolved in 6 ml 
H2O and was added to previous reaction mixture. The solution was refluxed for 30 
min while it was irradiated with light. Following this, more of potassium 
peroxodisulfate (3.06 g, 11.30 mmol) was added and the resction was refluxed for 
additional 30 min. The excess K2S2O2 was filtered off and the solvent was vacuum 
evaporated to yield brown oil. The product was further purified by column 
chromatography using CHCl3:MeOH (90/10; v/v) as mobile phase (yellow oil, 0.86 
g, 6.3 mmol, 27%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.48 (s, 2H; ArH), 4.91 (s, 1H; CH2OH), 2.60 
(s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.6, 152.5, 121.1, 61.5, 18.5. 
 
 
 
85 
 
 
Synthesis of Compound 21156: Compound 20 (864 mg, 6.3 mmol) was dissolved in 
2.5 ml CHCl3 and 1 ml methanol. The solution was heated to 35oC to dissolve the 
compound. Then, 1.1 equivalents of MnO2 (0.61 g, 7 mmol) was added at RT. After 
stirring 2h at RT, additional amount of MnO2 (0.51 g) was added. After 2h, the solid 
precipitates were removed by filtering over celite. The solvent was removed by 
vacuum evaporation. Then the product was prufied further by precipitation of the 
impurities in CHCl3. (white solid, 101 mg, 0.75 mmol, 12%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.93 (s, 1H), 7.30 (s, 2H; ArH), 2.53 (s, 6H; 
ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 192.1, 159.5, 124.1, 119.0, 24.3.  
 
 
Synthesis of Compound 22: Compound 15 (93 mg, 0.15 mmol) and 2,6-dimethyl-4-
pyridinecarboxaldehyde (60 mg, 0.44 mmol) were dissolved in benzene (15 ml). 
Piperidine (0.4 ml) and acetic acid (0.4 ml) were added. The reaction mixture was 
refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3/MeOH (95:5, v/v) as 
 
 
86 
 
mobile phase. Fraction containing compound 22 was collected, then the solvent was 
removed under reduced pressure (0.07 mmol, 61 mg, 47%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.00 (d, 2H, J = 16.73 Hz; CH), 7.78 (d, 2H, J = 
16.69 Hz; CH), 7.21 (d, 2H, J = 8.80 Hz; ArH), 7.18 (d,s, 2H + 1H, J = 8.91 Hz; 
ArH), 4.81 (d, 2H, J = 2.36 Hz; OCH2), 2.6 (s, 12H, ArCH3), 2.5 (1H, CH), 1.52 (s, 
6H, ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 158.3, 150.1, 147.0, 144.4, 141.1, 137.2, 133.8, 
129.3, 127.5, 122.3, 118.8, 118.4, 116.2, 105.9, 77.8, 76.2, 56.1, 24.1, 17.7.  
HRMS (TOF-ESI): m/z calcd for C38H34BF2I2N4O+: 865.0878 [M+H]+, found: 
865.07406 [M+H]+, Δ = 1.59 ppm. 
 
 
Synthesis of Compound 23: Compound 22 (42 mg, 49 µmol) and azide 
functionalized polyethylene glycol monomethylether (2000MW, 84 mg, 62 µmol) 
were dissolved in tetrahydrofuran (2 ml) and water (0.1 ml). Triethylamine (50 µl) 
was added and the reaction was stirred for 5 min. Then, CuSO4.5H2O (4 mg, 29 
µmol) and sodium ascorbate (6 mg, 29 µmol) were added. The reaction mixture was 
stirred for 12 h at room temperature. After the reaction was completed, it was 
extracted with CHCl3 and brine. The organic layer was collected and dried over 
Na2SO4, followed by evaporation of the solvent under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3/MeOH (92:8, v/v) as 
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mobile phase. Fraction containing compound 23 was collected then the solvent was 
removed under reduced pressure (6 µmol, 18 mg, 12%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.00 (d, 2H, J = 16.73 Hz; ArH), 7.96 (s, 1H; 
ArH), 7.81 (d, 2H, J = 16.76 Hz; ArH), 7.25-7.15 (m, 2H + 2H + 4H; ArH), 5.29 (s, 
2H; OCH2), 4.12 (t, 2H, J = 4.72 Hz; NCH2), 2.60 (s, 12H; ArCH3), 1.52 (s, 6H; 
ArCH3). 
HRMS (TOF-ESI): Distribution around 2800 with separation of 44 corresponding to 
etylene glycole unit. 
 
Synthesis of Compound 24157: 2,6-dichloronicotinic acid (500 mg, 2.6 mmol) was 
dissolved in 5.2 ml MeOH. 78 µl concentrated H2SO4 was added. The reaction 
mixture was refluxed for 1h. Then, the reaction was cooled to RT and was quenched 
with NaHCO3. It was extracted with CHCl3 and water. The organic layer was 
collected and dried over Na2SO4, followed by evaporation of the solvent under 
reduced pressure. The product was purified by silica gel column chromatography 
using CHCl3 as mobile phase. Fraction containing compound 24 was collected then 
the solvent was removed under reduced pressure (white solid, 2.4 mmol, 490 mg, 
92%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.84 (s, 2H; ArH), 4.01 (s, 3H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.2, 151.5, 142.4, 122.6, 53.3. 
 
Synthesis of Compound 25: Compound 24 (250 mg, 1.21 mmol) was dissolved in 10 
ml of anhydrous dimethylformamide. Ar was purged in the solution for 15 min. 
Potassium methoxide (255 mg, 3.64 mmol, 864 µl) was added to the reaction mixture 
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and it was refluxed for 12h. Then, the reaction mixture was neutralized with HCl 
solution. It was extracted with CHCl3 and water. The organic layer was collected and 
dried over Na2SO4, followed by evaporation of the solvent under reduced pressure. 
The product was purified by silica gel column chromatography using 
CHCl3/Hexanes (3/2; v/v) as mobile phase. Fraction containing compound 25 was 
collected then the solvent was removed under reduced pressure (white solid, 0.51 
mmol, 100 mg, 42%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.87 (s, 2H; ArH), 3.96 (s, 6H; ArOCH3), 3.92 
(s, 3H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 165.6, 163.8, 142.7, 101.2, 53.9, 52.5. 
 
Synthesis of Compound 26: Compound 25 (800 mg, 4.06 mmol) and 2 equivalents 
of NaBH4 (309 mg, 8.12 mmol) were dissolved in 10 ml dioxane. It was refluxed for 
1h. Then, the reaction was cooled to RT and quenched with ice cold water. It was 
extracted with CH2Cl2. The organic layer was collected and dried over Na2SO4, 
followed by evaporation of the solvent under reduced pressure (686 mg, 
quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.30 (s, 2H, ArH), 4.62 (s, 2H; ArCH2), 3.91 (s, 
6H; ArOCH3), 1.93 (b, 1H; ArCH2OH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.5, 155.6, 98.3, 63.8, 53.6. 
 
Synthesis of Compound 27: Compound 26 (172 mg, 1.02 mmol) was dissolved in 6 
ml of CHCl3. 1.1 equivalents of MnO2 (98 mg, 1.12 mmol) was added, and the 
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reaction mixture was stirred at RT for 12 h. After completion of the reaction as 
followed by thin layer chromatography, the reaction mixture was filtered over celite 
to get rid of MnO2 by products. Solvent was removed under reduced pressure to yield 
compound 27 (yellow solid, 118 mg, 68%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.94 (s, 1H), 6.73 (s, 2H; ArH), 4.00 (s, 6H; 
ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 191.2, 164.3, 147.5, 100.7, 54.0. 
HRMS (TOF-ESI): m/z calcd for C8H10NO3+: 168.0655 [M+H]+, found:168.06143 
[M+H]+, Δ = 2.42 ppm. 
 
Synthesis of Compound 28: Hydroquinone (2 g, 18.2 mmol) was dissolved in 30 ml 
acetone. 5 equivalents of K2CO3 (12.6 g, 91 mmol) was added and the reaction 
mixture was refluxed for 30 min. Then, 3 equivalents of propargyl bromide (6. 48 g, 
54.6 mmol) was added dropwise. The reaction mixture was refluxed for additional 12 
h. Then, it was  cooled to RT. Following the extraction with CHCl3, the organic layer 
was collected and dried over Na2SO4, followed by evaporation of the solvent under 
reduced pressure. Crude product was crystallized in hexanes to yield compound 28 
(white solid, quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.94 (s, 2H; ArH), 4.67 (d, 4H, J = 2.44 Hz; 
ArOCH2), 2.53 (t, 2H, J = 2.44 Hz; CCH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 152.4, 116.0, 78.8, 75.4, 56.5. 
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Synthesis of Compound 29: CH2Cl2 (300 ml) was purged with Ar for 30 min. 
Compound 8 (1.1 g, 4.45 mmol) and 2,4-dimethyl pyrrole (0.96 ml, 9.4 mmol) were 
added. The color of the solution turned into red after the addition of 3 drops of 
trifluoroacetic acid. The reaction mixture was stirred at room temperature for 12h. 
Then, tetrachloro-1,4-benzoquinone (1.09 g, 4.45 mmol) was added and the reaction 
mixture was stirred at room temperature for 45 min. Then triethyl amine (5 ml) and 
boron trifluoride diethyl etherate (5 ml) were added sequencially. After stirring at 
room temperature for 30 min, it was extracted with water. Organic layer was dried 
with Na2SO4 and evaporated under reduced pressure. The product was purified by 
silica gel column chromatography using CHCl3. Fraction containing compound 29 was 
collected then the solvent was removed under reduced pressure (400 mg, 0.86 mmol, 
19% ). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.20 (d, 2H, J = 8.60 Hz; ArH), 7.01 (d, 2H, J = 
8.64 Hz; ArH), 6.00 (s, 2H; ArH),  4.05 (t, 2H, J = 6.44 Hz; OCH2), 3.31 (t, 2H, J = 
6.80 Hz; NCH2), 2.58 (s, 6H; ArCH3), 1.86 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 
(m, 4H; CH2), 1.45 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 159.6, 155.2, 143.2, 141.9, 131.9, 129.2, 126.9, 
121.1, 115.1, 67.9, 51.4, 29.1, 28.8, 26.6, 25.7, 14.6, 14.5. 
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Synthesis of Compound 30: Compound 29 (270 mg, 0.58 mmol) and I2 (368 mg, 
1.45 mmol) were dissolved in ethanol (100 ml). Iodic acid, HIO3 (204 mg, 1.16 
mmol) was dissolved in a few drops of water and added into previous solution. The 
reaction mixture was stirred at 60oC for a few hours untill all reeactant was 
consumed. Then, saturated sodium thiosulfate solution was added (50 ml) and it was 
stirred at rrom temparature for additional 30 min. Then, it was extracted with CHCl3 
and water. Organic layer was dried with Na2SO4 and evaporated under reduced 
pressure (415 mg, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.22 (d, 2H, J = 8.68 Hz; ArH), 7.02 (d, 2H, J = 
8.68 Hz; ArH), 4.04 (t, 2H, J = 6.36 Hz; OCH2), 3.30 (t, 2H, J = 6.80 Hz; NCH2), 
2.63 (s, 6H; ArCH3), 1.85 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 (m, 4H; CH2), 1.45 
(s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.1, 156.6, 145.5, 141.6, 131.8, 129.1, 126.6, 
115.5, 85.8, 68.0, 51.4, 29.1, 28.8, 26.6, 25.7, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C25H27BF2I2N5O-: 716.03716 [M-H]-, found: 
716.06297 [M-H]-, Δ = 36.0 ppm. 
 
 
 
92 
 
Synthesis of Compound 31: Compound 28 (519 mg, 2.8 mmol) and compound 30 
(200 mg, 0.28 mmol) were dissolved in CHCl3 (3 ml) and THF (3 ml). Triethylamine 
(200 µl) was added and the reaction was stirred for 5 min. Then, saturated solutions 
of CuSO4.5H2O (200 µl) and sodium ascorbate (200 µl) were added. Catalytic 
amount of Cu (0) was added. The reaction mixture was stirred for 12 h at room 
temperature. After the reaction was completed, it was extracted with CHCl3 and 
organic layer was evaporatd under reduced pressure. It was purified by silica gel 
column chromatography using CHCl3 as mobile phase. Fraction containing 
compound 31 was collected then the solvent was removed under reduced pressure 
(0.27 mmol, 241 mg, 96%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.60 (s, 1H; ArH), 7.21 (d, 2H, J = 8.12 Hz; 
ArH), 7.02 (d, 2H, J = 8.17 Hz; ArH), 6.93 (s, 4H; ArH), 5.16 (s, 2H; OCH2), 4.62 
(d, 2H, J = 1.52 Hz; OCH2), 4.48 (t, 2H, J = 7.12 Hz; NCH2), 4.01 (t, 2H, J = 6. 28 
Hz; OCH2), 2.63 (s, 6H; ArCH3), 2.02 (t, 1H, J = 1.40 Hz; CH), 1.96 (m, 2H, CH2), 
1.82 (m, 2H, CH2), 1.55 (m, 2H, CH2), 1.44 (s, m, 6H + 2H, ArCH3 + CH2).   
13C NMR (CDCl3, 400 MHz, δ ppm) 160.0, 156.5, 153.1, 152.1, 145.4, 144.4, 141.7, 
131.7, 129.1, 126.6, 122.5, 116.1, 115.8, 115.4, 78.8, 75.4, 67.9, 62.7, 56.5, 50.3, 
30.2, 29.0, 26.3, 25.6, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C37H38BF2I2N5NaO3+: 926.1017 [M+Na]+, found: 
926.08227 [M+Na]+, Δ = 20.98 ppm. 
 
Synthesis of Compound 32: Compound 31 (125 mg, 0.14 mmol) and 2,6-dimethoxy-
4-pyridinecarboxaldehyde (92 mg, 0.56 mmol) were dissolved in benzene (30 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was 
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refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3 as mobile phase. 
Fraction containing compound 32 was collected, then the solvent was removed under 
reduced pressure (62 µmol, 75 mg, 44%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.94 (d, 2H, J = 16.68 Hz; CH), 7.72 (d, 2H, J = 
16.64 Hz; CH), 7.59 (s, 1H; ArH), 7.16 (d, 2H, J = 8.57 Hz; ArH), 7.04 (d, 2H, J = 
8.64 Hz; ArH), 6.93 (s, 4H; ArH), 6.57 (s, 4H; ArH), 5.20 (s, 2H, OCH2), 4.65 (d, 
2H, J = 2.44 Hz; OCH2), 4.41 (t, 2H, t, J = 7.12 Hz; NCH2), 4.04 (t, 2H, J = 6.32 Hz; 
OCH2), 3.98 (s, 12H, OCH3), 2.52 (t, 1H, J = 2.42 Hz; CH), 2.01 (m, 2H, CH2), 1.85 
(m, 2H, CH2), 1.62 (s, 6H; ArCH3), 1.48 (m, 4H; CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.8, 160.21, 153.1, 152.2, 150.0, 149.0, 
146.7, 144.5, 137.2, 133.8, 129.3, 128.3, 126.6, 122.4, 122.3, 116.1, 115.8, 115.5, 
99.3, 78.8, 75.4, 67.9, 62.8, 56.5, 53.7, 50.3, 30.2, 29.0, 26.3, 25.6, 17.8. 
HRMS (TOF-ESI): m/z calcd for C53H52BF2I2N7NaO7+: 1224.1971 [M+Na]+, found: 
1224.1762 [M+Na]+, Δ = 17.07 ppm. 
 
 
Synthesis of Compound 33: Compound 32 (17 mg, 14 µmol) and azide 
functionalized polyethylene glycol monomethylether (2000MW, 31 mg, 16 µmol) 
were dissolved in CHCl3 (1 ml) and THF (1 ml). Triethylamine (50 µl) was added 
and the reaction was stirred for 5 min. Then, saturated solutions of CuSO4.5H2O (150 
µl) and sodium ascorbate (150 µl) were added. Catalytic amount of Cu (0) was 
added. The reaction mixture was stirred for 12 h at room temperature. After the 
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reaction was completed, the crude product was applied to silica gel column 
chromatography using CHCl3/MeOH (90:10, v/v) as mobile phase. Fraction 
containing compound 33 was collected then the solvent was removed under reduced 
pressure (8 µmol, 26 mg, 58%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.96 (d, 2H, J = 16.72 Hz; CH), 7.83 (s, 1H; 
ArH), 7.73 (d, 2H, J = 16.64 Hz; CH), 7.62 (s, 1H; ArH), 7.17 (d, 2H, J = 8.76 Hz; 
ArH), 7.05 (d, 2H, J = 8.28 Hz; ArH), 6.93 (s, 4H; ArH), 6.54 (s, 4H; ArH), 5.19 (s, 
2H; OCH2), 5.17 (s, 2H; OCH2), 4.58 (t, 2H, J = 5.00 Hz; NCH2), 4.41 (t, 2H, t, J = 
7.64 Hz; NCH2), 4.10-3.30 (PEG), 2.01 (m, 2H, CH2), 1.85 (m, 2H, CH2), 1.62 (s, 
6H; ArCH3), 1.48 (m, 4H; CH2).  
HRMS (TOF-ESI): Distribution around 3000 with separation of 44 corresponding to 
etylene glycole unit. 
 
Synthesis of Compound 34158: 4-methylquinone (1.32 ml, 10 mmol) was dissolved 
in 1,4-dioxane (12 ml). Selenium dioxide (1.12 g, 10.12 mmol) was added to the 
reaction mixture and it was refluxed for 8h. Then, solvent was removed under 
reduced pressure and the crude product was applied to silica gel column 
chromatography using ethyl acetate as mobile phase. Fraction containing compound 
34 was collected, then the solvent was removed under reduced pressure (946 mg, 6 
mmol, 60%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 10.50 (s, 1H), 9.19 (d, 1H, J = 4.24 Hz; ArH), 
9.00 (dt, 1H, J1 = 0.64 Hz, J2 = 7.03 Hz; ArH), 8.21 (dt, 1H, J1 = 0.36 Hz, J2 = 7.24 
Hz; ArH), 7.70-7.85 (m, 3H,; ArCH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 192.8, 150.4, 149.3, 136.7, 130.2, 130.0, 129.4, 
125.8, 124.4, 123.8.  
HRMS (TOF-ESI): m/z calcd for C10H8NO+: 158.0600 [M+Na]+, found: 158.05593 
[M+Na]+, Δ = 25.75 ppm. 
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Synthesis of Compound 35: Compound 31 (91 mg, 0.1 mmol) and quinoline-4-
carboxaldehyde, compound 34 (40 mg, 0.25 mmol) were dissolved in benzene (25 
ml). Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture 
was refluxed using Dean Stark apparatus until all aldehyde was consumed. After the 
reaction was completed, it was extracted with CHCl3 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using EtOAc as mobile phase. 
Fraction containing compound 35 was collected, then the solvent was removed under 
reduced pressure (84 µmol, 99 mg, 84%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.01 (d, 2H, J = 4.64 Hz; ArH), 8.96 (d, 2H, J = 
16.56 Hz; CH), 8.32 (d, 2H, J = 8.40 Hz; ArH), 8.18 (d, 2H, J = 8.36 Hz; ArH), 7.94 
(d, 2H, J = 16.53 Hz; CH), 7.81 (d, 2H, J = 4.60 Hz; ArH), 7.77 (t, 2H, 7.48 Hz; 
ArH), 7.62 (t, 2H, j = 7.76 Hz; ArH), 7.22 (d, 2H, J = 8.41 Hz, ArH), 7.09 (d, 2H, J = 
8.44 Hz; ArH), 6.95 (s, 4H; ArH), 5.20 (s, 2H; OCH2), 4.64 (d, 2H, J = 2.04 Hz; 
OCH2), 4.43 (t, 2H, J = 7.12 Hz; NCH2), 4.05 (t, 2H, J = 6.17 Hz; OCH2), 2.52 ( t, 
1H, J = 1. 84 Hz; CH), 2.02 (m, 2H; CH2), 1.88 (m, 2H, CH2), 1.60 (m, 8H, ArCH3 + 
CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.8, 160.2, 153.1, 152.2, 150.0, 149.0, 146.7, 
144.5, 137.2, 133.8, 129.3, 128.3, 126.6, 122.4, 122.3, 116.1, 115.8, 115.5, 99.3, 
78.8, 75.4, 67.9, 62.8, 56.5, 53.7, 50.3, 30.2, 29.0, 26.3, 25.6, 17.8.  
HRMS (TOF-ESI): m/z calcd for C57H48BF2I2N7NaO3+: 1204.1861 [M+Na]+, found: 
1204.1620 [M+Na]+, Δ = 20.01 ppm. 
 
 
96 
 
 
Synthesis of Compound 36: Compound 35 (20 mg, 17 µmol) and azide 
functionalized polyethylene glycol monomethylether (2000MW, 37 mg, 19 µmol) 
were dissolved in CHCl3 (2 ml) and THF (2 ml). Triethylamine (150 µl) was added 
and the reaction was stirred for 5 min. Then, saturated solutions of CuSO4.5H2O (250 
µl) and sodium ascorbate (250 µl) were added. Catalytic amount of Cu (0) was 
added. The reaction mixture was stirred for 12 h at room temperature. After the 
reaction was completed, the crude product was applied to octadecyl functionalized 
silica gel column chromatography using CHCl3 as mobile phase. The mobile phase 
was changed to CH2Cl2/MeOH (80:20; v/v) after the starting compound was eluted 
from the column.  Fraction containing compound 36 was collected then the solvent 
was removed under reduced pressure (13 µmol, 40 mg, 76%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.02-8.9 (m, 2H + 2H; ArH), 8.31 (d, 2H, J = 
8.17 Hz; ArH), 8.17 (d, 2H, J = 8.16 Hz; ArH), 7.93 (d, 2H, J = 16.85 Hz; ArH), 
7.85-7.70 (m, 2H + 2H + 1H; ArH), 7.60 (s + d, 1H + 2H; J = 8.24 Hz; ArH), 7.20 
(d, 2H, J = 8.16 Hz; ArH), 7.09 (d, 2H, J = 8.37 Hz; ArH), 6.92 (s, 4H, ArH), 5.16 (s, 
2H; OCH2), 5.13 (s, 2H; OCH2),  4.54 (t, 2H, J = 4.76 Hz; NCH2), 4.40 (t, 2H, J = 
6.92 Hz; NCH2), 3.90-3.30 (PEG), 2.00 (m, 2H; CH2), 1.85 (m, 2H; CH2), 1.40 (m, 
4H; CH2), 1.30 (s, 6H; ArCH3).  
HRMS (TOF-ESI): Distribution around 3000 with separation of 44 corresponding to 
etylene glycole unit. 
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Synthesis of Compound 37159: 4-hydroxybenzaldehyde (1.22 g, 10 mmol) was 
dissolved in 20 ml acetonitrile. Acetic acid (10 ml) and nitric acid (0.75 ml) were 
added and the reaction was refluxed for 3h. Then, it was cooled to RT and extracted 
with EtOAc and water. Organic layer was collected and dried with Na2SO4, solvent 
was evaporated under reduced pressure. (9.1 mmol, 1.52 g, 91%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 11.05 (s, 1H; ArOH), 9.98 (s, 1H), 8.68 (s, 1H, 
ArH), 8.17 (d, 1H, J = 8.61 Hz; ArH), 7.34 (d, 1H, J = 8.68 Hz; ArH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 188.7, 159.3, 136.4, 128.6, 126.2, 121.3, 115.7.  
 
Synthesis of Compound 38: Compound 31 (200 mg, 0.22 mmol) and 4-hydroxy-3-
nitrobenzaldehyde, compound 37 (110 mg, 0.66 mmol) were dissolved in benzene 
(20 ml). Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction 
mixture was refluxed using Dean Stark apparatus until all aldehyde was consumed. 
After the reaction was completed, it was extracted with CH2Cl2 and water. Organic 
layer was collected and dried with Na2SO4, evaporated under reduced pressure. The 
product was purified by silica gel column chromatography using EtOAc as mobile 
phase. After the impurities are eluted from the column, the mobile phase was 
changed to CH2Cl2/MeOH/AcOH (90/5/5; v/v). Fraction containing compound 38 
was collected, then the solvent was removed under reduced pressure (0.15 mmol, 180 
mg, 68%). 
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1H NMR (38 + AcOH: CDCl3, 400 MHz, δ ppm) 8.79 (s, 2H; ArH), 8.19 (d, 2H, J = 
16.81 Hz; ArH), 7.97 (d, 2H, J = 8.80 Hz; ArH), 7.60 (d + s, 2H + 1H, J = 16.65 Hz; 
ArH), 7.23 (d, 2H, J = 8.80 Hz; ArH), 7.19 (d, 2H, J = 7.44 Hz; ArH), 7.05 (d, 2H, J 
= 8.24 Hz; ArH), 6.93 (s, 4H; ArH), 5.20 (s, 2H; OCH2), 4.64 (s, 2H; OCH2), 4.41 (t, 
2H, J = 7.12 Hz; NCH2), 4.05 (t, 2H, J = 5.84 Hz; OCH2), 2.52 (s, 1H; CH), 1.85 (m, 
2H, CH2), 1.60-1.40 (m, 12H, CH2 + ArCH3).  
13C NMR can not be recorded due to poor solubility.   
HRMS (TOF-ESI): m/z calcd for C51H43BF2I2N7O9- 1200.1278 [M-H]-, found: 
1200.13078 [M-H]-, Δ = 2.48 ppm. 
 
 
Synthesis of Compound 39160: mercaptoethanol (5 g, 64 mmol) was dissolved in 
DMSO (20 ml). The reaction mixture was stirred at 80oC for 12h. Then, it was 
cooled to RT and was extracted with brine and EtOAc. Organic layer was collected 
and dried with Na2SO4, evaporated under reduced pressure. The product was purified 
by silica gel column chromatography using Hexanes/EtOAc 75/25; v/v) as mobile 
phase. Fraction containing compound 39 was collected, then the solvent was 
removed under reduced pressure (29 mmol, 4.5 g, 86%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 3.90 (t, 4H, J = 5.84 Hz; OCH2), 7.30 (t, 4H, J = 
5.88 Hz; SCH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 60.4, 41.3.  
 
 
Synthesis of Compound 40160: 2-hydroxyethyldisulfide, compound 39 (1 g, 6.5 
mmol) was dissolved in 20 ml CH2Cl2 and 2 ml Et3N. In a dropper, p-toluene 
sulfonyl chloride (1.44 g, 13 mmol) was dissolved in CH2Cl2 10 ml and was added to 
the previous solution dropwise while the reaction mixture was being cooled with ice 
bath. It was stirred for 12h. After the extraction with water, organic layer was 
 
 
99 
 
collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3 as mobile phase. 
Fraction containing compound 40 was collected, then the solvent was removed under 
reduced pressure (white solid, 6.5 mmol, 3 g, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.83 (d, 4H, J = 8.04 Hz; ArH), 7.38 (d, 4H, J = 
7.93 Hz; ArH), 4.21 (t, 4H, J = 6.61 Hz; OCH2), 2.85 (t, 4H, J = 6.53 Hz; SCH2), 
2.48 (s, 6H, ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 145.2, 130.0, 128.0, 67.5, 36.9, 21.7.   
HRMS (TOF-ESI): m/z calcd for C18H22NaO6S4+ 485.0191 [M+Na]+, found: 
485.0104 [M+Na]+, Δ = 17.94 ppm. 
 
 
Synthesis of Compound 41: Compound 40 (1.2 g, 2.6 mmol) was dissolved in 10 ml 
DMSO and sodium azide (12 mmol, 780 mg) was added to the reaction mixture. It 
was stirred 2h at 60 oC. After cooling to RT, it was extracted with EtOAc. Organic 
layer was collected and dried with Na2SO4, evaporated under reduced pressure. 
(yellow oil, 2.47 mmol, 0.5 g, 95%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 3.63 (t, 4H, J = 6.76 Hz; NCH2), 2.89 (t, 4H, J = 
6.76 Hz; SCH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 49.9, 37.6.  
 
Synthesis of Compound 42: 4-hydroxybenzaldehyde (4 g, 33 mmol), 2-ethylhexyl 
bromide (6.7 ml, 36 mmol) and catalytic amount of benzo-18-crown-6 were 
dissolved in 60 ml acetonitrile. K2CO3 (13.6 g, 98 mmol) was added and the reaction 
mixture was refluxed for 12 h. The solvent was evaporated under reduced pressure 
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and the crude product was extracted with CH2Cl2. Organic layer was collected and 
dried with Na2SO4, evaporated under reduced pressure. (yellow oil, 7.7 g, 
quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.88 (s, 1H), 7.83 (d, 2H, J = 8.24 Hz; ArH), 
7.01 (d, 2H, J = 8.33 Hz; ArH), 3.94 (d, 2H, J = 5.64 Hz; OCH2), 1.77 (m, 1H; CH), 
1.45 (m, 4H; CH2), 1.32 (m, 4H; CH2), 0.93 (m, 6H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.7, 164.5, 131.9, 129.7, 114.8, 70.9, 39.3, 
30.4, 29.0, 23.8, 23.0, 14.0, 11.1. 
HRMS (TOF-ESI): m/z calcd for C15H23O2+ 235.16926 [M+H]+, found: 235.17327 
[M+H]+, Δ = 17.1 ppm. 
 
Synthesis of Compound 43: CH2Cl2 (400 ml) was purged with Ar for 30 min. 
Compound 42 (2.4 g, 10.24 mmol) and 2,4-dimethyl pyrrole (2.3 ml, 22.53 mmol) 
were added. The color of the solution turned into red after the addition of 3 drops of 
trifluoroacetic acid. The reaction mixture was stirred at room temperature for 12 h. 
Then, tetrachloro-1,4-benzoquinone (2.52 g, 10.24 mmol) was added and the reaction 
mixture was stirred at room temperature for 1 h. Then triethyl amine (9 ml) and 
boron trifluoride diethyl etherate (9 ml) were added sequencially. After stirring at 
room temperature for 1 h, it was extracted with water. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica 
gel column chromatography using CHCl3 and then EtOAc/Hexanes (20/80; v/v) as 
mobile phase. Fraction containing compound 43 was collected then the solvent was 
removed under reduced pressure (810 mg, 1.8 mmol, 18%). 
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1H NMR (CDCl3, 400 MHz, δ ppm) 7.17 (d, 2H, J = 8.76 Hz; ArH), 7.01 (d, 2H, j = 
8.80 Hz; ArH), 5.99 (s, 2H; ArH), 3.92 (d, 2H, J = 5.93 Hz, OCH2), 2.55 (s, 6H, 
ArCH3), 1.79 (m, 1H, CH), 1.60-1.40 (m, s, 4H + 6H; CH2 + ArCH3), 1.37 (m, 4H; 
CH2), 0.96 (m, 6H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.0, 155.2, 143.2, 142.1, 131.9, 129.1, 126.8, 
121.1, 114.8, 70.9, 39.4, 30.6, 29.1, 23.9, 23.0, 14.6, 14.1, 11.2.  
 
Synthesis of Compound 44: Compound 43 (330 mg, 0.73 mmol) and I2 (389 mg, 
1.53 mmol) were dissolved in ethanol (200 ml). Iodic acid, HIO3 (256 mg, 1.46 
mmol) was dissolved in a few drops of water and added into previous solution. The 
reaction mixture was stirred at 60oC for 1 h untill all reeactant was consumed. Then, 
saturated sodium thiosulfate solution was added (50 ml) and it was stirred at room 
temparature for additional 30 min. Then, it was extracted with CHCl3 and water. 
Organic layer was dried with Na2SO4 and compound 44 was obtained by evaporation 
of the solvent under reduced pressure (514 mg, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.12 (d, 2H, J = 8.68 Hz; ArH), 7.03 (d, 2H, j = 
8.72 Hz; ArH), 3.92 (d, 2H, J = 5.88 Hz, OCH2), 2.64 (s, 6H, ArCH3), 1.79 (m, 1H, 
CH), 1.60-1.40 (m, s, 4H + 6H; CH2 + ArCH3), 1.36 (m, 4H; CH2), 0.96 (m, 6H, 
CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.2, 156.7, 145.8, 142.1, 132.1, 129.8, 126.8, 
115.8, 85.9, 71.2, 39.6, 31.0, 24.3, 17.6, 16.3, 14.3, 11.7. 
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Synthesis of Compound 45: Compound 44 (100 mg, 0.14 mmol) was dissolved in 
tetrahydrofuran (30 ml) and triethylamine (5 ml). Argon was purged for 30 min. 
Then, 15% mole equivalent of Pd(PPh3)4 (24 mg, 21 µmol) was added. 4-(Tert-
butyl)phenylacetylene (88 µl, 0.49 mmol) was added via syringe and the reaction 
mixture was stirred 12 h at 60oC. After it was cooled to RT, it was extracted with 
CH2Cl2 and brine. Organic layer was dried with Na2SO4 and evaporated under 
reduced pressure. The product was purified by silica gel column chromatography 
using EtOAc/Hexanes (10/90; v/v) as mobile phase. Fraction containing compound 45 
was collected then the solvent was removed under reduced pressure (92 mg, 0.12 mmol, 
86%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.43 (d, 4H, J = 8.16 Hz; ArH), 7.37 (d, 4H, j = 
8.48 Hz; ArH), 7.18 (d, 2H, J = 8.52 Hz; ArH), 7.06 (d, 2H, J = 8.61 Hz; ArH), 3.95 
(d, 2H, J = 5.76 Hz, OCH2), 2.73 (s, 6H, ArCH3), 1.80 (m, 1H, CH), 1.60-1.30 (m, 
4H + 6H + 18H; CH2 + ArCH3 + CCH3), 0.96 (m, 6H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 158.1, 151.4, 143.9, 142.7, 131.7, 131.1, 
129.1, 126.2, 125.4, 120.4, 116.2, 115.4, 96.5, 81.0, 70.9, 39.4, 34.8, 31.2, 30.6, 29.2, 
23.9, 23.1, 14.1, 13.7, 13.6, 11.2.  
HRMS (TOF-ESI): m/z calcd for C51H60BF2N2O+ 765.4761 [M+H]+, found: 
765.4540 [M+H]+, Δ = 28.87 ppm. 
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Synthesis of Compound 46: triethyleneglycol monomethyl ether (10 g, 61 mmol) 
was dissolved in 100 ml CH2Cl2 and 13 ml Et3N. In a dropper, p-toluene sulfonyl 
chloride (12 g, 63 mmol) was dissolved in CH2Cl2 (20 ml) and was added to the 
previous solution dropwise while the reaction mixture was being cooled with ice 
bath. It was stirred for 12 h. After the extraction with water, organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. (yellow oil, 55 
mmol, 17.5 g, 90%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.78 (d, 2H; J = 8.24 Hz; ArH), 7.32 (d, 2H, J = 
8.04 Hz; ArH) 4.15 (t, 2H; J = 4.77 Hz; OCH2), 3.67 (m, 4H; OCH2), 3.60 (m, 4H; 
OCH2), 3.51 (m, 2H; OCH2). 3.34 (s, 3H; OCH3), 2.42 (s, 3H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 144.8, 133.0, 129.8, 127.9, 71.9, 70.7, 70.5, 
70.5, 69.3, 68.6, 59.0, 21.6.  
HRMS (TOF-ESI): m/z calcd for C14H22NaO6S+ 341.1029 [M+Na]+, found: 
341.10639 [M+Na]+, Δ = 10.23 ppm. 
 
Synthesis of Compound 47: methyl-3,4,5-trihydroxybenzoate (2.75 g, 15 mmol), 
compound 46 (15g, 47 mmol) and catalytic amount of benzo-18-crown-6 were 
dissolved in 60 ml acetone. K2CO3 (8.3 g, 60 mmol) were added and the reaction 
mixture was refluxed for 18 h.  Then, solvent was removed under reduced pressure 
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and the crude product was extracted with EtOAc and brine. Organic layer was dried 
with Na2SO4 and evaporated under reduced pressure. The product was purified by 
silica gel column chromatography using EtOAc as mobile phase. Fraction containing 
compound 47 was collected then the solvent was removed under reduced pressure 
(colorless liquid, 6 g, 9.6 mmol, 64%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.30 (s, 2H; ArH), 4.22 (m, 2H + 4H; OCH2), 
3.88 (m, 4H + 3H; OCH3 + OCH2), 3.80 (m, 2H; OCH2), 3.74 (m, 6H; OCH2). 3.65 
(m, 12H; OCH2), 3.56 (m, 6H; OCH2), 3.38 (s, 9H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 166.5, 152.3, 142.6, 124.9, 109.0, 72.4, 71.9, 
70.8, 70.7, 70.6, 70.5, 69.6, 68.8, 52.1.  
 
Synthesis of Compound 48: Compound 47 (3 g, 4.8 mmol) was dissolved in freshly 
distilled THF (20 ml) while rhe flask was being cooled within ice bath. To this 
solution, LiAlH4 (347 mg, 9.6 mmmol) was added portionwise. Then the reaction 
mixture was stirred 12 h at RT. The excess LiAlH4 was carefully quenched with cold 
water and it was extracted with EtOAc and brine. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica 
gel column chromatography using EtOAc as mobile phase. Fraction containing 
compound 48 was collected then the solvent was removed under reduced pressure 
(colorless liquid, 2.5 g, 4.2 mmol, 88%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.63 (s, 2H; ArH), 4.58 (s, 2H; OCH2), 4.15 (m, 
2H + 4H; OCH2), 3.84 (t, 4H, J = 5.29 Hz; OCH2), 3.79 (t, 2H, J = 5.44 Hz; OCH2), 
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3.73 (m, 6H; OCH2). 3.65 (m, 12H; OCH2), 3.54 (m, 6H; OCH2), 3.38 (s, 9H; 
OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 152.7, 137.8, 136.7, 106.6, 72.3, 71.9, 70.8, 
70.7, 70.5, 69.8, 68.9, 65.2, 59.0.   
 
Synthesis of Compound 49: Compound 48 (2.4 g, 4 mmol) was dissolved in CH2Cl2 
(25 ml). Pyridinium chlorochromate (2.15 g, 10 mmol) was added to the reaction 
mixture and it was stirred for 40 min ar RT. Then, it was directly applied to silica 
column chromatography using EtOAc/MeOH (95/5; v/v) as mobile phase. Fraction 
containing compound 49 was collected then the solvent was removed under reduced 
pressure (colorless oil, 2.37 g, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.82 (s, 1H), 7.14 (s, 2H; ArH), 4.21 (m, 6H; 
OCH2), 3.89 (m, 4H; OCH2), 3.82 (m, 2H; OCH2), 3.80-3.50 (m, 24H; OCH2), 3.38 
(s, 9H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 191.0, 153.0, 144.1, 131.6, 109.0, 72.5, 71.9, 
70.8, 70.7, 70.6, 70.5, 69.6, 68.9, 59.0.   
HRMS (TOF-ESI): m/z calcd for C28H48NaO13+ 615.2987 [M+Na]+, found: 
615.28633 [M+Na]+, Δ = 20.10 ppm. 
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Synthesis of Compound 50: Compound 45 (150 mg, 0.2 mmol) and compound 49 
(100 mg, 0.17 mmol) were dissolved in benzene (45 ml). Piperidine (0.3 ml) and 
acetic acid (0.3 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all aldehyde was consumed. After the reaction was completed, it was 
extracted with CH2Cl2 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc/MeOH (85/15; v/v) as mobile phase. Fraction 
containing compound 50 was collected, then the solvent was removed under reduced 
pressure (41 µmol, 55 mg, 21%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.34 (d, 1H, J = 16.24 Hz; ArH), 7.62 (d, 1H, J 
= 16. 21 Hz; ArH), 7.50-7.30 (m, 8H; ArH), 7.21 (d, 2H, J = 8.60 Hz; ArH), 7.06 (d, 
2H, J = 8.65 Hz; ArH), 6.87 (s, 2H; ArH), 4.25 (m, 6H; OCH2), 3.95 (d, 2H, J = 4.56 
Hz; OCH2), 3.90 (t, 4H, J = 5.37 Hz; OCH2), 3.85 (t, 2H, J = 4.40 Hz; OCH2), 3.80-
3.50 (m, 24H; OCH2), 3.38 (s, 9H; OCH3), 2.77 (s, 3H; ArCH3), 1.8 (m, 1H; CH), 
1.65 (s, 3H; ArCH3), 1.63 (s, 3H; ArCH3), 1.60-1.40 (m, 6H; CH2), 1.40-1.20 (m, 
18H + 2H; CH3 + CH2), 0.95 (m, 3H + 3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 152.9, 151.7, 151.5, 141.4, 140.0, 138.8, 
132.5, 131.1, 130.8, 129.3, 126.4, 125.5, 125.4, 120.5, 120.4, 115.4, 107.5, 98.1, 
96.7, 83.3, 81.0, 72.5, 72.0, 71.9, 71.0, 70.9, 70.7, 70.6, 69.8, 69.0, 59.0, 39.4, 34.8, 
31.2, 30.6, 29.2, 23.9, 23.0, 14.1, 13.7, 13.4, 11.2.  
HRMS (TOF-ESI): m/z calcd for C79H105BF2N2NaO13+ 1361.7570 [M+Na]+, found: 
1361.7296 [M+Na]+, Δ = 20.12 ppm. 
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Synthesis of Compound 51: Compound 50 (45 mg, 30 µmol) and compound 6 (9 
mg, 56 µmol) were dissolved in benzene (25 ml). Piperidine (0.2 ml) and acetic acid 
(0.2 ml) were added. The reaction mixture was refluxed using Dean Stark apparatus 
until all aldehyde was consumed. After the reaction was completed, it was extracted 
with CH2Cl2 and water. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using EtOAc/MeOH (90/10; v/v) as mobile phase. Fraction 
containing compound 51 was collected, then the solvent was removed under reduced 
pressure (27 µmol, 40 mg, 90%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.49 (d, 1H, J = 16.24 Hz; ArH), 8.34 (d, 1H, J 
= 16.16 Hz; ArH), 7.74 (d, 1H, J = 16.60 Hz; ArH), 7.65 (s + d + d, 1H + 2H + 2H; 
ArH), 7.50-7.30 (m, 8H; ArH), 7.21 (d, 2H, J = 8.09 Hz; ArH), 7.10-7.00 (m, 2H + 
2H; ArH), 6.90 (s, 2H; ArH), 4.77 (2H; OCH2), 4.25 (m, 6H; OCH2), 4.00- 3.50 (m, 
32H; OCH2), 3.40 (s, 3H; OCH3), 3.37 (s, 6H; OCH3), 2.60 (1H; CH), 1.80-1.20 (m, 
23H; CH3 + CH2), 0.98 (m, 3H + 3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 158.6, 152.9, 151.7, 145.3, 140.2, 139.7, 
138.8, 132.7, 130.8, 130.7, 129.6, 129.2, 126.6, 125.6, 125.5, 120.6, 120.5, 115.3, 
107.9, 98.4, 98.2, 83.4, 83.1, 77.4, 77.1, 76.7, 75.9, 72.5, 72.0, 71.9, 69.9, 69.2, 59.0, 
59.0, 59.0, 55.9, 39.4, 34.8, 31.2, 30.6, 29.2, 23.9, 23.1, 14.1, 11.2. 
HRMS (TOF-ESI): m/z calcd for C89H111BF2N2NaO14+ 1503.7989 [M+Na]+, found: 
1503.7684 [M+Na]+, Δ = 20.28 ppm. 
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Synthesis of Compound 52: Compound 51 (45 mg, 30 µmol) and compound 41 (62 
mg, 300 µmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Saturated 
solutions of CuSO4.5H2O (100 µl) and sodium ascorbate (100 µl) were added. 
Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
room temperature. After the reaction was completed, it was extracted with CH2Cl2 
and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography 
using EtOAc/MeOH (85/15; v/v) as mobile phase. Fraction containing compound 52 
was collected, then the solvent was removed under reduced pressure (18 µmol, 30 
mg, 60%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.48 (d, 1H, J = 16.32 Hz; ArH), 8.34 (d, 1H, J 
= 16.28 Hz; ArH), 7.75-7.60 (d+ s + d + d, 2H + 1H + 1H + 2H; ArH), 7.50-7.30 (m, 
8H; ArH), 7.21 (d, 2H, J = 8.33 Hz; ArH), 7.08 (d, 2H, J = 3.49 Hz; ArH), 7.05 (d, 
2H, J = 3.40 Hz; ArH), 6.91 (s, 2H; ArH), 5.31 (s, 2H; OCH2), 4.73 (t, 2H, J = 6.64 
Hz; NCH2), 4.25 (m, 6H; OCH2), 4.00- 3.50 (m, 32H; OCH2), 3.40 (s, 3H; OCH3), 
3.37 (s, 6H; OCH3), 3.22 (t, 2H, J = 6.64 Hz; NCH2), 2.89 (m, 2H + 2H; SCH2),  
1.80-1.20 (m, 23H; CH3 + CH2), 0.98 (m, 3H + 3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 159.3, 153.0, 151.8, 145.3, 144.4, 140.1, 
139.6, 138.9, 133.4, 132.7, 132.2, 131.9, 130.8, 130.4, 129.6, 128.6, 126.7, 125.5, 
123.6, 120.6, 118.4, 117.1, 116.1, 115.3, 114.0, 107.9, 107.2, 98.4, 98.2, 83.3, 72.5, 
71.9, 70.9, 70.8, 70.7, 70.5, 70.4, 69.8, 69.2, 68.9, 62.1, 59.0, 49.9, 48.9, 39.5, 37.7, 
34.9, 31.3, 30.6, 29.2, 23.9, 23.1, 14.1, 13.5.  
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Synthesis of Compound 53: Compound 15 (127 mg, 0.2 mmol) and azide 
functionalized polyethylene glycol monomethylether (2000MW, 800 mg, 0.4 mmol) 
were dissolved in tetrahydrofuran (2 ml). Triethylamine (1.4 ml) and CuI (77 mg, 0.4 
mmol) were added. The reaction mixture was stirred for 12 h at room temperature. 
After the reaction was completed, the crude product was purified by silica gel 
column chromatography using CHCl3/MeOH (93:7, v/v) as mobile phase. Fraction 
containing compound 53 was collected then the solvent was removed under reduced 
pressure (red oil, 0.11 mmol, 300 mg, 55%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.93 (s, 1H, ArH), 7.12 (b, 2H + 2H), 5.24 (s, 
2H; OCH2), 4.58 (t, J = 4.84 Hz; NCH2), 3.90-3.40 (PEG), 3.35 (s, 3H; OCH3), 2.60 
(s, 6H; ArCH3), 1.40 (s, 6H; ArCH3).  
HRMS (TOF-ESI): Distribution around 2500 with separation of 44 corresponding to 
etylene glycole unit. 
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Synthesis of Compound 54: Compound 54 (120 mg, ~45 µmol) and compound 37 
(23 mg, 135 µmol) were dissolved in benzene (25 ml). Piperidine (0.2 ml) and acetic 
acid (0.2 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all aldehyde was consumed. After the reaction was completed, the 
crude product was purified by silica gel column chromatography using 
CH2Cl2/MeOH (85/15; v/v) as mobile phase. Fraction containing compound 54 was 
collected, then the solvent was removed under reduced pressure (30 µmol, 90 mg, 
66%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.24 (s, 2H; ArH), 8.06 (d, 2H, J = 16.72 Hz; 
ArH), 7.93 (m, 2H + 2H; ArH), 7.56 (d, 2H, J = 16.69 Hz; ArH), 7.20 (m, 2H + 2H + 
2H; ArH), 5.28 (s, 2H, OCH2), 4.60 (t, 2H, J = 4.36 Hz; NCH3), 3.90-3.40 (PEG), 
3.35 (s, 3H; OCH3), 1.50 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 159.6, 155.8, 149.8, 146.7, 143.2, 140.4, 136.2, 
135.3, 133.7, 129.5, 127.2, 124.5, 124.4, 120.7, 119.3, 115.9, 94.3, 83.6, 72.0, 70.6, 
69.6, 62.2, 59.0, 50.7, 50.4, 17.7.  
HRMS (TOF-ESI): Distribution around 2800 with separation of 44 corresponding to 
etylene glycole unit. 
 
Synthesis of Compound 55: Compound 52 (40 mg, 24 µmol) and compound 38 (45 
mg, 37 µmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Saturated 
solutions of CuSO4.5H2O (100 µl) and sodium ascorbate (100 µl) were added. 
Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
room temperature. After the reaction was completed, it was extracted with CH2Cl2 
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and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography 
using EtOAc/MeOH (85/15; v/v) as mobile phase. Fraction containing compound 55 
was collected, then the solvent was removed under reduced pressure (12 µmol, 35 
mg, 50%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.48 (d, 1H, J = 15.92 Hz; ArH), 8.32 (d, 1H, J 
= 15.84 Hz; ArH), 8.29 (s, 2H; ArH), 8.09 (d, J = 16.52 Hz, 2H; ArH), 7.95 (d, J = 
8.04 Hz, 2H; ArH), 7.8-7.5 (m, 10H; ArH), 7.50-7.30 (m, 10H; ArH), 7.25-7.10 (m, 
6H; ArH), 7.10-7.0 (m, 5H; ArH), 6.90 (m, 6H; ArH), 5.30 (s, 2H, OCH2), 5.15 (s, 
4H, OCH2), 4.65 (s, 4H, NCH2), 4.40 (m, 2H, OCH2), 4.2 (m, 6H; OCH2), 4.10-3.50 
(m, 36H, OCH2), 3.30 (s + s, 6H + 3H; OCH3), 3.15 (m, 4H; SCH2), 2.05 (m, 18H; 
CH3), 1.8 (m, 4H), 1.60-1.0 (21H), 0.95 (m, 6H). 
13C NMR (CDCl3, 400 MHz, δ ppm) 167.8, 160.3, 160.2, 159.2, 158.6, 155.6, 152.8, 
151.7, 149.8, 146.6, 138.8, 136.2, 135.4, 133.7, 132.7, 130.8, 130.3, 129.6, 129.5, 
129.4, 129.3, 126.6, 125.6, 125.5, 124.4, 123.7, 120.7, 120.4, 119.4, 115.9, 115.8, 
115.5, 115.3, 107.8, 72.4, 71.9, 70.9, 70.8, 70.6, 70.5, 69.8, 69.1, 59.0, 58.9, 48.9, 
40.6, 39.4, 31.2, 30.6, 30.2, 29.2, 26.3, 25.6, 23.9, 23.0, 17.8, 14.1, 13.5, 11.2.  
HRMS (TOF-ESI): m/z calcd for C144H162B2F4I2N15O23S2- 2884.9 [M-H]-, found: 
2884.9 [M-H]. 
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CHAPTER 5 
Turn-on BODIPY-based Fluorescent Sensor with a Large Dynamic 
Range for Measuring Chloride Level in Acidic Media 
Sundus Erbas-Cakmak, Kevin P. McDonald, Amar H. Flood 
 
5.1. Objective 
There are only a few fluorescent chloride anion sensors in literature and most of 
them lack anion selectivity. Among anion binding motifs, novel triazolophane 
structures worth attention since they display strong and size-selective interaction 
with chloride anion. Here, a turn-on chloride sensor was created by combining a 
BODIPY fluorophore with a triazolophane from which was discovered a large 
dynamic range. The sensor employed protonated pyridine (pyrH+) to quench 
BODIPY emission by photoinduced electron transfer (PET) to the pyH+ cation. 
Selective chloride binding into the cavity bearing the pyrH+ destabilized the PET 
acceptor orbital allowing the BODIPY emission reinstated. Chloride binding 
properties in acidic and neutral organic solvents were investigated and the 
macrocycle was found to be responsive to chloride concentrations across the range of 
0.2 µM to 80 mM in acidic dichloromethane with an increase in quantum yield from 
0.06 (no chloride) to 0.73 (90 mM chloride). Apart from a simple 1:1 binding to 
triazolophane cavity, a second binding motif was observed which suggests possible 
contributions of anion induced deprotonation and/or charge transfer interactions 
between anion and electron deficient pyridinium moiety. By introducing this bright 
sensor into the era of anion detection, potential applications and improvements are 
discussed. 
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5.2. Introduction 
Cations and anions are essential elements of human beings and other living 
organisms both for the normal functioning of biochemical processes and the survival 
of the organism itself. The main contribution of rare earth metals are their unique 
coordination properties that built up a reaction microenvironment within the active 
cavity of enzymes. Mg2+, Fe2+, Mn2+ would be the most common examples of such 
coordination dependent activity. Besides controlling the activity of enzymes, in some 
cases, binding of a cation to a protein would change the functionality or signaling 
event succeeded by this assembly. Calcium binding proteins are of great examples 
for such systems. Some cations assist the stability of a structure such as G-
quadruplex structures in telomeres to control the cell cycle etc. The role of Na+ and 
K+ are well known in electrophysiological events such as neuron 
activation/deactivation and cognitive functionalities.  Hence, determining real-time 
concentrations and consequent roles of inorganic compounds in physiological 
processes is challenging and without any doubt this challenge would give clues for a 
molecular level understanding of a number of diseases161 and biochemical 
processes162. Upon the detection methods, fluorescence is accepted to be the easiest 
and one of the most accurate technique.163 Basically, in this technique, a fluorophore 
is responsive to the analyte of interest and either a change in the fluorescence 
intensity or a spectral shift is required for the sensing. For biological applications, the 
wavelengths of excitation (λexc) and detection (λF), biocompatibility and the 
reliability of ensuring data are important. Here, as a start in dichloromethane, we 
address some of these requirements and designed and synthesized a fluorescent 
chloride sensor based on a BODIPY dye164 and a triazolophane receptor165,166,167 that 
is excited by light in visible region of the spectrum and the dynamic response spans a 
large concentration range.  
Although chloride is one of the most abundant anions in the body (0.13 M in blood 
serum), its physiological roles in many different biological processes, such as the 
development of cystic fibrosis168, cell volume and pH regulation169, and in a number 
of different biological processes170 and diseases are yet to be determined precisely. 
The level of this anion changes in cellular organelles and the exact level in acidic 
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organelles such as lysosomes are not well-known yet. For this reason, our attempt in 
this research is to develop a sensor that initiates an efford to detect chloride at acidic 
media.  
Considering chloride sensors in literature, one of the early demonstrations by Illsley 
and Verkman employed 6-methoxy-N-(3-sulfopropyl) quinolinium (SPQ) as a 
chloride sensor.42-44 Although it can detect across relevant concentrations among 
other competing anions (not quenched by bicarbonate, phosphate, sulfate), it requires 
excitation and detection in the UV region involving energetic light, known to be 
hazardous, increase mutagenesity and give oxidative photodamage to cells. Quantum 
dots employing thiourea as the binding motif was used as a turn-off chloride sensor 
(λexc = 425, λF = 620 nm) to measure chloride level in epithelial cells.171 Lucigenin, 
being the most widely-used one for applications, is a turn-off sensor with an 
excitation wavelength of 430 nm.172 These are “turn-off” sensors, where the 
fluorescence intensity is quenched by the analyte. Consequently, there is usually no 
way to eliminate spurious quenching by solvents, other molecules in the media or 
photobleaching of the fluorophore. Turn-on sensors are also being developed. For 
example, urea-functionalized phenanthrolines, but they require UV excitation and the 
dynamic range is limited to the submilimolar region (less than 1 mM). The presence 
of other anions also interferes with their fluorescence output by quenching the 
fluorophore, which decreases the reliability of the data obtained from live media.173 
Genetically-encoded fused proteins (clomeleon) were used as ratiometric sensors to 
monitor chloride concentrations during neuronal development in rat cells.174 A 
ratiometric chloride sensor was developed using a pyrene-modified calixarene (λexc = 
340 nm) by Diamond et al.175 Therein, excimer emission was abolished upon 
chloride binding and the monomer emission increases in response. However, 
detection is limited to micromolar concentrations (50 - 150 µM), which are very low 
compared to physiological values.  
The concept of using a co-analyte, either to increase the binding strength of the 
analyte or modulate sensing, is another common strategy.53 For instance, dipicolyl 
amine receptors are coordinated to Zn2+ for the detection of phosphate derivatives.54 
Recently, this approach was extended to gene silencing by taking advantage of the 
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interaction between the picolyl-bound Zn2+ and the phosphate groups of small 
interfering RNA (siRNA).176 In the case of chloride sensing, a solvent molecule, 
dimethylsulfoxide (DMSO) present in the active site of a tetra-urea porphyrin 
chemosensor was shown to increase selectivity in favour of Cl−.177 Zhang et al. used 
a phenanthroline-Cu2+ complex to sense chloride selectively in organic solvents.52 
Complexation with Cu2+ quenches the complex’s emission at 402 nm and subsequent 
Cl− binding restores it selectively. Severin et al. used a pyranine chromophore whose 
association with rhodium(III) results in a non-emissive dye.178 However, the 
emission intensity at 510 nm increases more than three folds upon addition of Cl− up 
to 30 mM. Mechanically interlocked squaraine rotaxanes were shown to be 
responsive to Cl− both in solution and in a reverse-phase silica gel plate.179 Within 
this rotaxane format, the tetralactam macrocycle which normally stabilizes the 
excited triplet state, chloride binding shifts the relative location of the macrocycle, in 
favor, the emission intensity and singlet excited state lifetime increases (λexc = 365). 
Recently, “turn-on” and “turn-off” responses resulting from different ethynylpyridine 
derivatives was examined by Johnson and Haley et al. in organic solvents.55 In these 
works, hydrochloric acid but not trifluoroacetic acid (TFA) was shown to increase 
emission intensity (φF = 0.02) on account of chloride binding that accompanied 
protonation. While a lot of approaches have been examined, there still remains a 
need to explore other sensors. Here, we take advantage of the chloride selectivity of 
triazolophanes.60  
 
5.3. Design of the Fluorescent Chloride Sensor 
In this work, we describe a turn-on sensor for chloride concentrations in organic 
media as a pre-cursor to test the feasibility of appending a BODIPY dye to a 
chloride-selective triazolophane. We employ a proton as a “co-ligand” and 
consequently aim to develop a chloride sensor that works under commensurate 
conditions such as those of low pH in organic solvent. The structures of macrocycles 
and their BODIPY precursors are given in Scheme 22.  
With acidic media in mind, we employed a BODIPY dye substituted in the meso 
position with a pyridine that is incorporated as one of the four aryl rings of a 
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triazolophane. Charge transfer quenching of the protonated and methyl-quaternized 
forms of similarly pyridine-substituted BODIPY dyes have been extensively studied 
by Ziessel and others.180,181,182The triazolophane scaffold, which provides size-
selective binding for chloride, has not yet been investigated for the purpose of 
fluorometric anion sensing. The molecular design (Scheme 22) was envisioned to 
allow sensing of chloride using a turn on mechanism. Briefly, the co-ligand, H+, will 
generate a pyridinium cation that will cause quenching of the BODIPY’s emission by 
PET to the lowest unoccupied molecular orbital (LUMO) of pyridine. Addition of 
Cl− will destabilize the LUMO of the pyridinium moiety, shutting off PET and 
turning the BODIPY emission back on. Therefore, as a long term goal, the use of the 
H+ allows us to target acidic organelles (trans-Golgi network, lysosomes, late 
endosome, exosomes, secretory granules) with lower pH, thought to have Cl− 
concentrations less than plasma concentrations of 130 mM.  
As a starting point, we examine the sensitivity towards H+ and Cl− in organic 
solvents where we find a clear turn-on response exhibited in acidic dichloromethane 
and discovered an unexpectedly wide dynamic range (0.2 µM - 80 mM). 
The macrocycle M1 was designed as principle fluorescent sensor for chloride with 
protonatable pyridine moiety which constitutes a size-selective chloride binding 
cavity together with other triazole-linked aryl groups. M2 was synthesized to 
examine the chloride binding properties of pyridine free macrocycles. Besides, two 
BODIPY precursors BOD1 and BOD2 that lack a chloride binding triazolophane 
binding motif are synthesized for control purposes. 
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Scheme 22. Structures of BODIPY building blocks and the derived triazolophane 
macrocycles 
5.4. Results and Discussion 
5.4.1. Photophysical Characterization 
 
Figure 31. Normalized absorption and emission spectra of BODIPY building blocks and 
macrocycles in CH2Cl2.  
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Both BOD1 and M1 display BODIPY-based absorption in the visible region at 532 
nm (Figure 31, Table 6) whereas BOD2 and M2 show absorption maxima are at 529 
nm. BODIPY band positions do not change upon formation of the macrocycle since 
the bulky phenyl at the meso-position of the BODIPY do not contribute to the 
conjugation a lot. As is the case with most BODIPY dyes, there is a small Stoke’s 
shift in the emission maxima (Table 6). The smaller Stoke’s shift displayed by M1 
and M2 indicates that macrocyclic structure is less stabilizing towards the BODIPY 
excited states. Table 1 shows photophysical characterizations of the compounds. A 
decrease in quantum yield of M1 from 0.66 to 0.06 upon protonation is observed 
which is restored back to 0.73 by the addition of 90 mM tetrabutylammonium 
chloride. 
Table 6. Photophysical properties of BODIPY building blocks and macrocycles 
Compound        ΦFa ε(M−1cm-1)d λmax (abs, emm) 
BOD 1  0.62 58000 532, 558  
BOD 2 0.83 59000 529, 547 
M1 0.66 36000 533, 552 
M1•H+ 0.06 24000 541, 554 
M1•H+• Cl− b 0.73 36000 532, 553 
M2 0.59 39000 529, 545 
BOD-Q-1 0.01 44000 542, - 
BOD-Q-1. Cl− e 0.02 61000 539, 632 
BOD-Q-2 0.01 19000 538, - 
BOD-Q-2 Cl− f 0.54 39000 530, 542 
 
a see electronic supporting information for details of calculations b in the presence of 90 mM 
TBACl d extinction coefficient at maximum absorption and emission wavelengths. e in the 
presence of 60 mM TBACl, f in the presence of 8 mM TBACl. 
 
5.4.2. Acid-Responsive Behavior 
The compounds analyzed in this work are not designed to work under biologically 
appropriate solvents and acid concentration. Rather, as a start, we try to develop a 
system that helps us understand the behavior of such fluorophore-triazolophane 
conjugate in a similar contex in organic media. In order to understand the acid 
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response of macrocycle M1, trifluoroacetic acid (TFA) was titrated into CH2Cl2 
solutions.  
 
The electronic absorption spectrum (Figure 32a) shows a bathochromic shift of the 
BODIPY transition from 532 to 537 nm accompanied by peak broadening. 
Figure 32. UV-Vis absorption spectra of M1 (a), chloride-saturated M1 (b) and BOD1 (c) 
titrated with TFA in CH2Cl2. (a) M1 (10 µM) was titrated with 2.6 M TFA using 2 µl 
aliquots until there are no further spectral changes. (b) M1 (10 µM, previously saturated with 
2.5 equivalents of TBACl) was titrated with TFA until there are no further spectral changes. 
(c) BOD1 (9 µM) was titrated with 1.3 M TFA using 2 µl aliquots. 
(c) 
(a) (b) 
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Additionally a new peak grows in at 369 nm, which is attributed to the π-π* 
transition of BODIPY on the basis of the emergence of a similar peak with BOD1 at 
slightly shorter wavelengths and based on the assignments in literature (Figure 32a-
c).183 The same titration was performed with M1•Cl− where the macrocycle was 
previously saturated with chloride added as the tetrabutylammonium salt (TBACl). 
Similarly, a bathochromic shift from 529 to 534 nm was observed together with the 
new peak growing in at 375 nm (Figure 32b).  
Binding constants were determined by analyzing UV-Vis titration spectrums on 
Sivvu software (Table 7).184 The dissociation constants of trifluorocetic acid, 
tetrabutylammonium chloride, tetrabutylammonium trifluoroacetate were also 
included in analysis. Further, to eliminate the effect of trifluoroacetate binding to 
cavity, the binding constant of this anion to M1 was determined by titration with the 
tetrabutylammonium salt of this anion. Sivvu analysis for binding constants 
determination shows that the basicity, as reflected in the logβ of M1 increases from 
4.24 to 5.41 in the presence of chloride. When M1 is initially titrated with acid, the 
protonation is less effective.  However, when the macrocycle is first saturated with 
chloride, protonation seems to be favored more (∆G becomes −30.84 kJ/mol).  
 
Table 7. Binding constants and ∆G values of macrocycles for chloride or protona 
 
 
 
 
 
 
 
 
 
a see experimental part for details of calculations, b the data was obtained by titrating 
protonated M1 with TBACl. c the data was obtained by titrating chloride saturated M1 with 
TFA, d the ∆G value for this species is calculated from the M1. Cl− and (M1.Cl−). H+ 
equilibria. 
Compound  Log βa ∆G, (kJ/mol)a 
M1.Cl− 6.31 -35.99 ± 0.2 
(M1.H+). Cl−b 7.48 -42.68 ± 1.6 
(M1.Cl−). H+c 5.41 -30.84 ± 0.1 
M1.TFA− 5.39 -30.72 ± 0.4 
M1.H+d 4.24 -24.18  
M1.TFAH 2.51 -14.34 ± 0.03 
M2. Cl− 7.51 -42.86 ± 0.4 
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This type of behavior, namely an increase in the observed pKa in the presence of 
halides, was previously reported in bacteriorhodopsin.185In our case, this change is 
attributed to a modification in the pyridine microenvironment upon chloride binding. 
Highly electropositive cavity of the triazolophane obstructs a further positive charge 
inside. A similar phenomenon was extensively studied by Moore et al. on differently 
substituted ethynylpyridine oligomers where it was consistently shown that electron 
deficient environments destabilizes the pyridinium cation.55 In our case, chloride 
binding reduces the electropositivity character of the cavity and aids protonation.  
Fluorescence quenching profiles of BODIPY dyes in CH2Cl2 are given in Figure 33. 
Both BOD1 and M1 quenches almost entirely by the addition of 30 mM TFA. 
BOD2, which lacks a pyridine moiety in its structure, shows no acid response as 
expected. A small decrease (approximately 30%) in the emission of M2 upon TFA 
addition was also observed. This behavior may be attributed to triazolophane 
protonation. Although this hypothesis cannot be proved by MASS Spect analysis, the 
protonated triazolophanes may provide an alternative but less effective route for PET 
process. The UV-Vis absorbance spectrum of this compound also shows a 
bathochromic shift upon TFA titration (Figure 34). Trifluoroacetate binding to 
triazolophane and triazole protonation may give rise to such a spectral change. On 
the other hand, almost no change was observed in the emission of BOD2 upon TFA 
titration which confirms that the BODIPY core is not modified by TFA. In order to 
ensure that the compound had not decomposed after acid titration, chemical 
reversibility was also investigated using triethylamine (Et3N) as base. The UV-Vis 
absorbance spectrum was restored back to its original non-protonated form (Figure 
37). 
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Figure 33. Quenching profiles of BODIPY building blocks and macrocycles. Stern-Volmer 
plots of 2 µM of BOD1 (black), BOD2 (red) and M1 (blue) and M2 (green) with TFA in 
CH2Cl2 followed by maximum emission wavelengths. 
 
5.4.3. Chloride Binding 
A small hypsochromic shift was observed in the BODIPY absorption upon chloride 
binding to both macrocycles, from 532 to 529 nm in M1 and from 529 to 526 nm in 
M2 (Figure 35, 42). Consistent with prior studies on chloride binding to 
triazolophanes9-12, the region of the spectrum at 250 nm saw an increase in intensity. 
Figure 34. Titration of M2 (2 µM) with TFA before (a) and after (b) saturation with 4 
equivalents of TBACl in CH2Cl2. 
(a) (b) 
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Chloride binding constants of each macrocycles was estimated in the presence and 
absence of acid by fitting UV-Vis titrations using Sivvu software. For each analysis 
ion-pairing interactions were also included. The binding constants for chloride anion 
were determined to be 2.04 x 106 M−1 for M1 and 3.03 x 107 M−1 for M1 in the 
presence of acid. When the macrocycle is protonated, the positive charge inside the 
cavity increases the binding strength considerably due to an additional electrostatic 
benefit to the binding process. For M2, the binding constant was determined to be 
3.26 107 M−1. The chloride binding constants and ∆G values for corresponding ions 
are given in Table 7.  
 
Initial 1H NMR spectra of macrocycles M1 and M2 are broad and in both cases, 
there are three different triazole protons. 1H NMR spectra with variable 
concentrations (1 - 10 mM) shows no significant change in peak positions or 
resolution (Figure 36a). Also, no spectral change was observed on UV-Vis during 
serial dilution from 346 mM M1 to 2.7 µM (Figure 36b). This result suggests that the 
three triazoles resonances initially observed in M1 is not due to aggregation but 
instead a structural asymmetry. Geometry optimization (HF/3-214*) shows that the 
planarity of the triazolophane is distorted someway to break the symmetry of the 
triazoles closest to the western BODIPY side of the macrocycle. This distortion was 
removed upon Cl− binding as confirmed by NMR titration (Figure 38) and geometry 
Figure 35. Titration of M1 (4 µM) with TBACl  (0.6 mM) before (a) and after protonation (b) 
in CH2Cl2. 
(a) (b) 
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optimization of the complex (HF/3-214). This structural distortion is also seen in the 
1H NMR spectra and the calculated spectra of M2. The 1H NMR titration of M1 with 
TBACl displays an overall downfield shift with the most profound shifts observed 
for the triazoles and the east phenylene protons (proton with label c) within the 
macrocyle (Figure 38). A Job’s plot was generated using the chemical shift in proton 
c which indicates 1:1 binding of Cl− to M1.  
 
 
Figure 37. Characterization of the reversibility of the acid response of protonated M1 (10 
µM, CH2Cl2) by addition of Et3N. 
Figure 36. Concentration dependence of the 1H NMR spectrum of M1 (500 MHz, 298 K, CD2Cl2) 
(a), concentration dependence of the UV-Vis Absorbance spectrum of M1 (345.6 − 2.7 µM, 
CH2Cl2) as followed by the absorbance change at 375. 
(b) 
(c) 
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5.4.4. Turn-on Sensing and Binding Equilibria 
The overall reaction pathways between species accessible with protonation and Cl− 
complexation, their associated emission properties and their proposed orbital 
diagrams are shown in Figure 39. Initially, there is an intense emission from the 
BODIPY fluorophore (φF = 0.66). Along path 1, protonation is followed by the 
enhanced Cl− binding. Upon protonation, oxidative PET from excited BODIPY to 
Figure 38. A) 1H NMR titration of M1 (10 mM) with TBACl (0.2 M) in CD2Cl2. B) labeled 
chemical shifts, C) chemical shift in proton labeled as c within the macrocycle through TBACl 
titration D) Job’s plot for TBACl binding using shifts in proton c. 
(a) (b) 
(c) (d) 
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the pyridinium is believed to account for the quenching with the quantum yield 
decreasing to 0.06. Upon Cl− binding (Path 1b),  
 
 
 
Figure 39. Schematic representation of binding equilibria for M1 and the mechanism of 
action for turning on and off BODIPY emission. Path 1 represents sequential addition of acid 
then chloride whereas the order is reversed along path 2.  
electrostatic destabilization of the pyridinium-localized LUMO competes PET and 
emission is restored to increasing levels depending on the Cl− concentration such 
that, at Cl− concentrations of 90 mM, the emission becomes even more intense than 
non-protonated M1 (Table 6). In the second pathway, Cl− binding is followed by 
facilitated protonation. The principle reactions taking place along each path include 
those shown in Figure 39 as well those for dissociation of the TFA into the 
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trifluoroacetate anion and a proton, and, the disassociation of the TBACl salt into 
chloride and the TBA+ cation.   
The acidity of TFA was estimated by fitting the UV-Vis absorbance data obtained by 
diluting TFA in CH2Cl2 and the ∆G value for TBACl ion pairing in CH2Cl2 was 
taken as is from literature.42 The constant for ion pairing of tetrabutylamonium cation 
and trifluoroacetate anion was determined by titrating TFA with TBACl. To 
determine the binding affinity of trifluoroacetate, a counterion involved during 
protonation process, titration of M1 with tetrabutylammonium salt of this anion and 
subsequent Sivvu analysis were performed. 
Upon protonation of M1 (555 nm) emission is decreased by 97% and the quantum 
yield dropped from 0.66 to 0.06 upon addition of 120 mM TFA. PET processes 
usually require a spacer motif between the electron donor and acceptor moieties. In 
the previously reported pyridine BODIPYs, the two electronic systems are separated 
not in space but instead by the orientation, namely, pyridine at the meso-position of 
BODIPY is not coplanar with the BODIPY core. So, the two systems can behave as 
pseudo-independent electronic systems. In our case, the comparably bulky 
triazolophane orients almost perpendicular to BODIPY core on account of sterics. By 
analogy, intramolecular electron transfer between the covalently linked but 
electronically separated systems becomes possible. 
Figure 40. Restoration of emission of M1 (2 µM) by TBACl in CH2Cl2. (a) TBACl (0.6 
mM, 10 mM, 0.1 M, 0.5 M, 2 M) was added to the M1 (previously quenched by 120 mM 
TFA). (b) micromolar region of plot in A. 
(a) (b) 
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When the protonated receptor, M1.H+ was titrated with TBACl (Figure 40), a 
gradual increase in emission intensity was observed during addition of more than 80 
mM TBACl. The quantum yield of M1.H+ increased from 0.06 to 0.72 with 
increasing concentrations of chloride. The final quantum yield was even higher than 
the non-protonated macrocycle. Photophysical properties of the BODIPY building 
blocks and macrocycles are given in Table 6. The shape of the binding curve is 
interesting with two different sections, one below 4 µM (Figure 40b) and one over 6 
(Figure 40a). The overall dynamic range starts from sub-micromolar concentrations 
to above 80 mM. 
To help understand the origin of the two-step chloride response in M1 (Figure 40), 
BOD1 was titrated first with H+ (Figure 41a) and followed with TBACl (Figure 
41b). The emission was restored upon addition of 80 mM TBACl but the dynamic 
range of reaction starts at milimolar concentrations of chloride. Since this molecule 
lacks triazolophane binding pocket, the effect of chloride is unexpected! Halide 
induced quenching, rather than enhancing of quinolinium dyes are widely known in 
the literature and the reason for this quenching is explained by either halide induced 
intersystem crossing or by the collisional reduction of fluorophores. Structural 
similarity between the quinolinium dyes and the pyridinium moiety in M1 and 
BOD1 suggest a similar mechanism behind chloride induced turn on of the emission. 
This time however, the quaternized pyridine provides a PET route itself. Therefore, 
reduction of the pyridinium prevents PET and enables emission to be reinstated.  
Since BOD1 does not show a change in the presence of micromolar concentrations 
of chloride, two-step turn-on of the emission from M1.H+ can be explained as 
follows: The first step of the curve is associated with the saturation of the 
triazolophane’s binding pocket. Thus, incorporating the triazolophane into the 
sensor’s structure enables detection of chloride at micromolar concentrations. BOD1 
lacks this binding pocket and consequently, it lacks the sensitivity towards the µM 
range and its detection curve shows one response that matches with the second of 
M1.H+. In the second step, the proposed collisional reduction by halide emerges and 
it requires higher chloride levels, namely milimolar concentrations. The behavior of 
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BOD1.H+ and M1.H+ resemble each other at this range, suggesting a similar 
mechanism acting on both of them. 
To see if the dynamic/collisional process is nonspecific, tetrabutylammonium salts of 
other halides (F−, Br−, I−), acetate (AcO−) and hydrogen sulfate (HSO4−) were titrated 
(Figure 41). Addition of I− did not alter the quenched profile but the color of the 
solution turned to gold. An increase in the emission, in the presence of HSO4− was 
observed beyond 110 mM. Likewise, addition of more than 80 mM of Br−, led to an 
increases in the emission intensity. The most obvious increase in emission was seen 
in samples titrated with acetate and fluoride anions, where the response is even  
Figure 41. (a) Stern-Volmer plots of 2 µM solutions of BOD1 (black) and BOD2 (red) with 
TBACl; (b) Fluorescence titration of BOD1 (2 µM) with TBACl (red), TBABr (black), 
TBAI (green) and TBAHSO4 (blue); (c) Fluorescence titration of BOD1 (2 µM)with TBACl 
(blue), TBAF (red), TBAOAc (black) in CH2Cl2. 
(a) (b) 
(c) 
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higher than the one observed for chloride. If the proposed charge transfer mechanism 
is true, then the magnitude of the effect and the selectivity should depend on the 
reduction potentials or basicities of anions. For fluoride and acetate, their higher 
basicity could deprotonate the pyridinium, which would contribute to the increase in 
emission intensity or it may even be the basis of the process. If the effect of F− and 
AcO− is due to their basicity, then, similarities between the absorbance spectra of 
neutral BOD1 and M1, and the acidic solutions of the same compounds in the 
presence of excess F− or AcO−, can be explained solely by anion-induced 
deprotonation.  
The tetraphenylene triazolophane in M2 is not expected to show an acid response 
since the only possible protonation sites are triazoles and they are known to have 
very low pKa values (1.17 for free triazoles).186 However, when M2 was titrated with 
TFA there was an obvious response in both the UV-Vis (Figure 34) and fluorescence 
spectra (Figure 33). There is a bathochromic shift in the absorbance spectra of M2 
both in the absence and presence of TBACl, (from 526 to 537 nm and from 529 to 
537 nm, respectively).  
Fluorescence titrations of M2 with TFA also show an interesting result; it exhibits 
quenching upon acid titration accompanied by a bathochromic shift from 545 to 553 
nm. However, the quenching is not as effective as M1 (Figure 33). More acid (550 
mM) is required compared to the amount required for M1 (30 mM) to quench 80% 
of the initial emission in the case of M2. Knowing that BODIPY building-block does 
not get quenched with acid (Figure 33), this behavior can be attributed to protonation 
of the triazole nitrogens and generation of an additional route for the PET quenching 
process. During the period of the titration where the macrocycle M2.H+  is saturated, 
there is an increase in emission intensity up to around 5 µM TBACl, then, there is an 
decrease in emission intensity at 30 µM chloride (Figure 44). This decrease may be 
explained by considering the protonation of the triazole facilitated in the presence of 
chloride within the macrocycle. Since there is incomplete quenching in the 
beginning, the presence of chloride may complete the process. However, unlike M1, 
the potential protonation sites face outwards, and thus they should be affected less by 
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the presence of chloride. Both quenching and chloride response of M2 seems to be 
less effective than M1.   
 
Figure 42. Titration of M2 (2 µM, CH2Cl2) with TBACl up to 4 equivalents. 
In an attempt to understand the ground state behavior of the BODIPY fluorophore in 
the presence of high concentrations of Cl−, UV-Vis absorbance spectra of BOD1, 
M1 and M2 were recorded under various conditions (Figure 43). Each sample was 
subjected to different concentrations of TFA that are sufficient to saturate the 
compounds based on the knowledge obtained from the fluorescence experiments. 
These values are 25 µl (109 µM) for BOD1and M1, and, 120 µl (522 mM) for M2. 
For M2 and neutral M1 no significant change in absorbance was observed after the 
initial saturation of the macrocycle with TBACl (~ 3 µM, Figure 43b, c). This 
suggests that after binding of chloride to the cavity of the macrocycle, the BODIPY 
core is not affected by excess TBACl in M2 and neutral M1. However, BOD1.H+ 
and M1.H+ show a dramatic change in their spectra accompanying the addition of 
large amounts of TBACl. Considering the band structure of the BODIPY’s core 
absorbance at 532 nm, the final spectra of BOD1.H+ and M1.H+ look as if the 
compounds are no longer protonated after excess TBACl addition (Figure 45). Apart 
from the spectral change in the visible region, the UV region shows the most obvious 
increase. A sharp peak grows in around 360 nm in both macrocycles and BOD1 
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during the addition of excess TBACl. The intensity of this new peak is not high in 
neutral M1 relative to BODIPY core absorbance at 532 nm. Titrating TFA with 
excess TBACl explains the origin of these growing peaks since a similar increase in 
the spectrum was obtained thus attributed to ion pairing of tetrabutylammonium 
cation and trifluoroacetate anion.  
 
 
Figure 43. UV-Vis Spectra of 2 µM solutions of BOD1, M1 and M2 in the presence of excess 
TBACl in CH2Cl2. Except for the titration of M1 in (c), TFA was added to the samples prior to 
TBACl titrations (25, 25 and 120 µl to BOD1, M1 and M2 respectively).  D) Absorbance change at 
367 nm upon TBACl titration of BOD1 and M1. 
(a) (b) 
(c) (d) 
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Figure 45. UV-Vis absorbance spectra of M1 (black), protonated M1 (red), protonated M1 
titrated with excess TBACl (blue) and M1 titrated with 4 equivalence of TBACl (green). 
 
Figure 44. Acid and chloride fluorescence response of M2 (2 µM, CH2Cl2). A) Fluorescence 
quenching and bathochromic shift upon TFA addition up to approximately 250000 
equavalents. B) Titration of protonated M2 (M2•H+) with TBACl (0.6 mM, 10 mM, 0.5 M, 2 
M) as followed by intensity change at emission wavelength of 545 nm. 
(a) (b) 
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Scheme 23. Structures of methyl-quaternized BODIPY dyes 
The response of M1 and BOD1 to higher concentrations of chloride (mM region) 
was thought to be a result of deprotonation by anions. Comparison of absorbance 
change of M1 in the presence of excess chloride shows that the final spectrum 
(excess chloride added to protonated M1) is quite similar to chloride-bound non-
protonated macrocycle (Figure 45). This may show that anions act as base to 
deprotonate pyridinium, thus let to the increase in emission in mM-region of the 
spectrum. To understand this further, we synthesized two methyl quaternized model 
compounds, methyl-pyridinium BODIPY (BOD-Q-1) and methyl-quinolinium 
BODIPY (BOD-Q-2). These dyes are essentially non-emissive with a PET process 
taking place between BODIPY core and quaternized electron poor 
pyridinium/quinolinium moieties. Since they lack a protonation site we expect to see 
no response related to anion basicity. Surprisingly however, an increase in the 
emission of both of these fluorophores was observed. The increase is not as 
promising as in M1 and BOD1 considering the dynamic range and fluorescence 
intensity but still the response is in mM concentration region and can be seen by 
naked eye.  In both quaternized BODIPYs a bathochromic shift in UV-Vis 
absorbance accompanies an increase in extinction coefficient (Table 6, Figure 46). 
Quantum yield increases obviously upon addition of TBACl (Table 6). The effect of 
TBACl is more promising in the case of BOD-Q-2, the quantum yield increases from 
0.01 to 0.54. On the other hand, the maximum response ranges are smaller compared 
to M1, the values for maximum concentrations of TBACl that induces a fluorescent 
response are approximately 60 mM for BOD-Q-1 and 8 mM for BOD-Q-2.   
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Regarding these results, we suggest the contribution of a further process in the 
recognition event, namely charge transfer interaction between anion and electron 
deficient pyridinium or quinoliniums. Such charge transfer interactions between 
anions and electron deficient napthalenediimide systems were extensively analyzed 
by Saha et al.187 Here, we argue the possible contribution of such processes in 
blockage of PET process. 
 
5.4.5. Conclusions 
In this work we have designed a chloride sensor by rationally combining the 
knowledge of protonation-induced PET in pyridine BODIPY dyes with the strong 
and selective chloride binding ability of the triazolophane. Two different processes 
involved in the recognition and emission sensitivity provide an unexpectedly large 
Figure 46. UV-Vis Absorbance and emission spectra of BOD-Q-1 and BOD-Q-2 before and 
after TBACl addition in CH2Cl2. 
(a) (b) 
(c) (d) 
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dynamic range (0.2 µM-80 mM). The first of these processes is the simple binding to 
the triazolophane pocket, which provides a sensitivity to chloride at parts per billion 
concentrations as low as 0.2 µM. At higher chloride concentrations, collision induced 
reduction was thought to be effective in the turn-on sensing process. This 
phenonmenon was studied in the literature with a number of different quinolinium 
dyes and other organic compounds.42,43,44 The possible explanation for the emission 
increase in the higher concentration regime could be the basicity of anions since 
acetate and fluoride also react at high concentrations. For long term biological 
application purposes, these competing anions may not be as interferig on account of 
the fact that their concentrations are much lower in the body. For compound M1, 
although the slope of response is different in the sub-micromolar and milimolar 
regions, the macrocycle is responsive to chloride practically between 0.2 µM - 80 
mM ranges which matches the chloride level in most acidic biological compartments. 
Enhancement in quantum yields is 875 fold and both the excitation and the bright 
emission is in visible region of the spectrum. To increase the dynamic range of 
fluorophores for the detection of Zn2+, Zhu et al. suggest multiple binding pockets 
with different affinities for Zn2+.188,189 This method allows a wider dynamic range 
since saturation of two different sites rather than one determines the detection range. 
The same analogy is present in our case with a slightly different strategy. Here, the 
large optical response to a wide range of chloride concentrations is offered by two 
different processes rather than two binding sites. The concentration dependency of 
the two processes differ a lot, which enables the extended recognition range for 
chloride. With the knowledge obtained in this work, second-generation PET sensors 
with water solubility or the ones with appropriate carriers (i.e. micelles, soluble 
nanoparticles) can be designed for biological applications.   
Although the sensor presented here is worked in organic solvent, further 
modification of such system may open a path in certain applications. For instance, 
long term biological relevance stems from the fact that, although the chloride 
concentrations in plasma, airways and some early endosomal pathways are known, 
there is no accurate data for late endosomal compartments, which are thought to have 
an acidity below pH 5.5. Furthermore, there is evidence that a number of diseases 
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related to poor protein processing and sorting or to exocytosis, which normally takes 
place in these late endosomes and lysosomes may be related to Cl− channelopathies. 
As such, deficiencies in H+/Cl− exchangers within these compartments need to be 
more deeply understood. In addition to acidic eukaryotic organelles, chloride 
channels are known to have crucial roles in the maintenance of acid resistance for 
some bacteria that are able to survive in very harsh media with pH values below 3.52 
A chloride-dependent promoter in some gram-positive bacteria was also identified 
which is thought to be induced in highly acidic and chloride-rich environments such 
as in the human stomach.190 Genes associated with this promoter are expressed at 
low pH and high chloride levels. For these various reasons, developing chemosensors 
to determine chloride concentrations at low pH would be beneficial. 
The importance of sensing chloride level in acidic media was mentioned above. The 
acid resistance in bacteria, ion-transport and subsequent control of protein 
processing, sorting, and cell volume regulation are associated with chloride 
concentration in acidic media. Developing a sensor that is stable in acidic conditions 
and that shows a chloride response within the desired concentration range is highly 
important for understanding such biological processes and for developing therapeutic 
systems for related diseases i.e. cystic fibrosis.  
It is interesting to note that, the change in pKa upon chloride binding can be used for 
ion co-transport across a membrane using the concept of facilitated transport. 
Namely, a proton gradient can be generated across a bilayer using chloride 
concentration difference. As it can be seen in Table 7, chloride binding increases the 
pKa of pyridine within the structure of macrocycle. In this case, protonation becomes 
easier. When, the macrocycle is moved to a chloride-poor environment, dissociation 
of chloride would be expected to release proton as well, since the pKa drops under 
these conditions. A similar exchange process is actually believed to be happening in 
acidic organelles to regulate pH. These concepts are yet to be analyzed both in live 
media with natural channels and synthetic ones. The use of optimized version (both 
for biological relevancy and chloride and proton binding properties) of the acid-
chloride responsive macrocycle in those systems can be a way to understand and 
perform such facilitated anion co-transport mimicry.  
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5.5. Experimental Details 
5.5.1. Spectroscopy 
5.5.1.1. Fluorescence Spectra and Quantum Yield Determination 
2 µM solutions of M1, M2, BOD1, BOD2 were prepared in CH2Cl2. Emission 
spectra were recorded with excitation at 524 nm and with both excitation and 
emission slit widths set to 3 nm. To these solutions, different stock solutions of TFA 
(2 M, 10 M or 13 M TFA) were added in 2 − 4 µl aliquots until there were no further 
spectroscopic changes. For M1 and BOD1, 30 mM of TFA is enough for more than 
90% quenching of initial fluorescence. For M2, 500 mM TFA was required to achive 
the same outcome. For anion titrations different stock solutions of TBACl (0.6 mM, 
10 mM, 0.5 M, 2 M), TBABr (10 mM, 2 M), TBAI (10 mM, 2 M), TBAF (1 M), 
TBAOAc (1 M), TBAHSO4 (0.5 M) were used. 
For quantum yield measurements, absorbance values of all the compounds (BOD 1, 
BOD 2, M1, M1•H+, M1•H+•Cl−, M2) were between 0.05 − 0.15 to avoid self 
quenching (quartz cells with 1 cm path length were used). As a reference compound, 
10-(4-iodophenyl)-2,8-diethyl-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-
c:1',2'-f][1,3,2] diazaborinin-4-ium-5-uide, was used with a known quantum yield 
(0.78) in CHCl3 (Scheme 24).164  
 
Scheme 24. Structure of the BODIPY compound used as the reference for the quantum yield 
calculations 
The following equation was used for quantum yield calculation,  
 
                     Q = QR (I/IR)(AR/A) x (n2/nR2)      Equation 5 
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where QR is the quantum yield of the reference BODIPY compound (0.78), I and IR 
are the integrated areas of the emission spectra for sample and reference, 
respectively; A and AR represent absorbance values at the excitation wavelength (524 
nm) for sample and standard assuming a path length of 1 cm; and n and nR refer to 
refractive indices of the solvents in which the sample and standard compounds were 
dissolved, respectively.  All samples were dissolved in CH2Cl2 with a refractive 
index of 1.42 whereas the reference compound was dissolved in CHCl3 (nR = 1.49). 
The integrated areas were determined using Origin between 534 − 700 nm. 
 
5.5.1.2. Binding Constant Determination  
All binding constants were determined in CH2Cl2. The ∆G values were determined 
using Sivvu by global fitting of the data. Binding constants in the presence and 
absence of TFA were calculated using the formula: 
    ∆G = −RTlnK          Equation 6 
 
For the purposes of data fitting, the ∆G value for ion pairing of TBACl was taken to 
be −27.7 kJ / mol191 and dilution was taken into consideration in the software. The 
error was estimated by randomly omitting approximately 20% of the data points 
multiple times and recalculating the ∆G value. Sivvu output from the fitting is given 
in the following plots for each sample together with the associated error analyses. In 
each of the figures, the extinction coefficient (molar absorptivity) spectra of each 
absorbing species, the raw absorbance spectra for the titration within the wavelength 
range used in the calculation, speciation curves relative to the composition of each 
solution examined (solution number) and an error contour plot are presented. Red 
colors in the contour plot identify areas of greatest deviation.  
The ∆G for the dissociation of TFA into its acid, H+, and conjugate base was 
determined to be −17.79 kJ/mol in CH2Cl2 by monitoring UV-Vis absorptions during 
dilution of TFA in CH2Cl2. The data were analyzed using Sivvu software. For any 
titrations that involve TFA, the −17.79 kJ/mol value was used as the ∆G and its 
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ionization was included in the fitting analysis. The binding affinity of the 
trifluoroacetate anion (TFA−) with M1 was estimated from titration of the 
tetrabutylammonium (TBA+) salt of this anion with M1, the dissociation constant 
obtained by this method is –30.72 kJ/mol. The ion pairing between TFA− and TBA+ 
was also estimated from the titration spectra obtained upon the addition of TBACl to 
TFA and TBACl, and is found to be −30.94 kJ/mol. 
 
5.5.1.3. Reversibility-Stability Experiment 
 In order to understand if the compound is still intact after TFA addition, a 
deprotonation experiment was performed with a base and UV-Vis spectral change 
was analyzed. To a  solution of M1 (10 µM) was added excess amounts of TFA (44 
mM) to prepare M1•H+. Restoration of the initial spectrum was attained upon 
addition of a base, Et3N.  The base solution was prepared by diluting 1 ml of Et3N 
with 9 ml of CH2Cl2 (1.4 M). The original spectrum was obtained after addition of an 
excess amount of (excess with respect to TFA) the Et3N solution. 
 
5.5.2. Synthesis 
 
Synthesis of Compound 56:192 Citrazinic acid (5 g, 32.3 mmol) and 
tetraethylammonium chloride (5.34 g, 32.3 mmol) were suspended in 
phosphorous(V) oxychloride (10 ml). The reaction mixture was stirred at 140 oC for 
18 h. Upon cooling to RT, the mixture was poured over ice (75 g ) and stirred for an 
additional 2 h. A brown solid product was obtained by filtering (5.03 g, 81%).  
1H NMR (DMSO-d6, 400 MHz, δ ppm) 7.82 (s, 2H; ArH).  
13C NMR (DMSO-d6, 400 MHz, δ ppm) 164.1, 150.6, 145.1, 123.3. 
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Synthesis of Compound 57: 2,6-Dichloroisonicotinic acid (1.2 g, 6.3 mmol) was 
suspended in thionyl chloride (SOCl2, 10 ml) and the mixture was refluxed for 2 h. 
After cooling to RT, SOCl2 was evaporated under vacuum to produce a brown solid 
(1.31 g, quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.83 (s, 2H; ArH).  
13C NMR (CDCl3, 400 MHz, δ ppm) 165.4, 152.2, 144.6, 123.0. 
 
Synthesis of Compound 58: 2,6-Dichloroisonicotinoyl chloride (750 mg, 3.56 
mmol) was dissolved in dichloromethane (CH2Cl2, 100 ml) and the solution was 
sparged with argon for 20 min. 2,4-Dimethyl-3-ethyl pyrrole (2.2 eq., 966 mg, 1.06 
ml) was added and the solution was refluxed for 3.5 h. After cooling to RT, 
triethylamine (4 ml) was added to the reaction mixture. Subsequently, BF3•OEt2 (4 
ml) was added and the reaction mixture was stirred for 1 h at RT. After washing with 
H2O, the organic layer was collected and dried over Na2SO4. The crude product was 
purified by flash silica column chromatography using CH2Cl2/hexanes (50/50; v/v) 
as the mobile phase affording a red solid (530 mg, 33%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.29 (s, 2H; ArH), 2.51 (s, 6H; ArCH3), 2.30 (q, 
4H, J = 7.4 Hz; ArCH2), 1.41 (s, 6H; ArCH3), 0.98 (t, 6H, J = 7.4 Hz; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 155.8, 151.5, 149.8, 137.3, 134.0, 132.8, 129.3, 
123.1, 17.1, 14.5, 12.7, 12.4.  
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MS (HiResESI) Cald for C22H24BCl2F2N3 (M-H)– 448.1334; Found 448.1346 (M-H)–
.
 
Synthesis of Compound 59: Compound 58 (350 mg, 0.78 mmol) was dissolved in 
tetrahydrofuran (30 ml) and diisopropylamine (10 ml). Argon was sparged through 
the solution for 20 min prior to the addition of CuI (15 mg, 0.078 mmol) and 
Pd(PPh3)2Cl2 (33 mg, 0.047 mmol). The flask was sealed and trimethylsilylacetylene 
(1.1 ml, 7.8 mmol) was added using a syringe. The reaction was stirred for 12 h at 
RT. The crude product was extracted with ethyl acetate then water and the organic 
layer was collected and dried over Na2SO4. The product was purified by column 
chromatography (SiO2) using CH2Cl2/hexanes (2/1; v/v) as the mobile phase 
resulting in an orange solid (375 mg, 84%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.37 (s, 2H; ArH), 2.51 (s, 6H; ArCH3), 2.29 (q, 
4H, J = 7.4 Hz; CH2), 1.39 (s, 6H; ArCH3), 0.97 (t, 6H, J = 7.4 Hz; CH3), 0.24 (s, 
18H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 155.5, 145.5, 144.6, 138.1, 134.9, 133.9, 130.0, 
126.7, 102.8, 97.5, 17.5, 15.0, 13.0, 12.9, 0.4.  
MS (HiResESI) Cald for C32H42BF2N3Si2 (M-H)– 572.2906; Found 572.2902 (M-H)– 
 
Synthesis of Compound 60: Compound 59 (200 mg, 0.35 mmol) was dissolved in a 
mixture of THF (15 ml) and MeOH (15 ml). K2CO3 (145 mg, 1.05 mmol) was added, 
and the reaction was stirred at RT. After 15 min, TLC showed that all the starting 
compound was consumed. The reaction was quenched with saturated NH4Cl (aq) and 
extracted with CH2Cl2. The organic layer was collected, dried over Na2SO4 and 
evaporated in vacuo. The product was purified by column chromatography using 
EtOAc/hexanes (1/1; v/v) as the mobile phase to afford an orange solid (150 mg, 
quantitative). 
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1H NMR (CDCl3, 500 MHz, δ ppm) 7.44 (s, 2H; ArH), 3.22 (s, 2H; CH), 2.51 (s, 6H; 
ArCH3), 2.28 (4H, J = 7.4 Hz; CH2), 1.36 (s, 6H; ArCH3), 0.97 (t, 6H, J = 7.4 Hz; 
CH3). 
13C NMR (CDCl3, 500 MHz, δ ppm) 155.3, 145.5, 143.6, 137.5, 133.9, 133.7, 129.5, 
126.9, 81.5, 79.1, 30.3, 17.0, 14.5, 12.6, 12.4.  
MS (HiResESI) Cald for C26H26BF2N3 (M-H)– 428.2114; Found 428.2131 (M-H)–. 
 
 
Synthesis of Compound 61: 3-Bromo-5-iodobenzoic acid (1 g, 3.06 mmol) was 
suspended in SOCl2 (10 ml) and refluxed for 2 h. The reaction mixture was cooled to 
RT and the SOCl2 was evaporated to dryness to yield the product (1.05 g, 
quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.33 (s, 1H; ArH), 8.18 (s, 1H; ArH), 8.14 (s, 
1H; ArH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 165.8, 146.0, 138.4, 136.0, 133.2, 123.5, 94.3. 
 
Synthesis of Compound 62: 3-Bromo-5-iodobenzoyl chloride, 61 (1.04 g, 3.01 
mmol) was dissolved in CH2Cl2 (100 ml) and degassed with argon for 20 min. 2,4-
Dimethyl-3-ethyl pyrrole (2.1 eq., 0.85 ml) was added and the solution was refluxed 
for 3.5 h. After cooling to RT, Et3N (4 ml) was added followed by BF3•OEt2 (4 ml) 
and the reaction mixture was stirred for 1 h at RT. The reaction mixture was washed 
with H2O and the organic layer was collected and dried over Na2SO4. The product 
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was purified by flash column chromatography (SiO2) using CH2Cl2:hexanes (50/50; 
v/v) as the mobile phase to produce a red solid (735 mg, 42%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.98 (t, 1H, J = 1.5 Hz; ArH), 7.61 (t, 1H, J = 
1.5 Hz; ArH), 7.44 (t, 1H, J = 1.5 Hz; ArH), 2.50 (s, 6H; ArCH3), 2.29 (q, 4H, J = 
7.8 Hz; ArCH2), 1.36 (s, 6H, ArCH3), 0.98 (t, 6H, J = 7.6 Hz; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 154.8, 140.1, 139.4, 137.9, 136.0, 135.8, 133.4, 
131.0, 130.3, 123.4, 94.5, 17.1, 14.6, 12.6, 12.3.  
MS (HiResESI) Cald for C23H25BBrF2IN2 (M-H)– 583.0233; Found 583.0203 (M-
H)–. 
 
Synthesis of Compound 63: Compound 62 (280 mg, 0.48 mmol) was dissolved in 
THF (30 ml) and diisopropylamine (10 ml) and then purged with argon (20 min). To 
the solution was added CuI (18 mg, 0.096 mmol) and Pd(PPh3)2Cl2 (40 mg, 0.058 
mmol). The flask was sealed and 10 equivalents of trimethylsilylacetylene (0.68 ml, 
4.8 mmol) was added using a syringe. The reaction was stirred for 12 h at RT. The 
reaction mixture was extracted with EtOAc and the organic layer was collected and 
dried over Na2SO4. The product was purified by column chromatography using 
EtOAc/hexanes (1/4; v/v) as the mobile phase (orange solid, 270 mg, 98%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.66 (t, 1H, J = 1.4 Hz; ArH), 7.32 (d, 2H, J = 
1.4 Hz; ArH), 2.50 (s, 6H; ArCH3), 2.28 (q, 4H, J = 7.3 Hz; ArCH2), 1.35 (s, 6H; 
ArCH3), 0.97 (t, 6H, J = 7.3 Hz; CH3), 0.22 (s, 18H; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 154.3, 138.1, 136.2, 135.6, 133.0, 131.4, 130.5, 
124.5, 103.1, 96.4, 86.0, 17.1, 14.6, 12.6, 12.3, 0.8.  
MS (HiResESI) Cald for C33H43BF2N2Si2 (M-H)– 571.2954; Found 571.2964 (M-H)– 
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Synthesis of Compound 64: Compound 63 (275 mg, 0.48 mmol) was dissolved in 
THF (15 ml) and MeOH (15 ml). K2CO3 (199 mg, 1.44 mmol) were added and the 
reaction was stirred at RT. After 15 min all the starting compound was consumed. 
The reaction was quenched with saturated NH4Cl (aq) and extracted with CH2Cl2. 
The organic layer was collected, dried over Na2SO4 and evaporated in vacuo. The 
product was purified by column chromatography using acetone/hexanes (1/3; v/v) as 
the mobile phase resulting in a pure orange solid (190 mg, 92%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.70 (s, 1H; ArH), 7.40 (s, 2H; ArH), 3.14 (s, 
2H; CH), 2.51 (s, 6H; ArCH3), 2.28 (q, 4H, J = 7.3 Hz; ArCH2), 1.33 (s, 6H; 
ArCH3), 0.97 (t, 6H, J = 7.3 Hz; CH3).  
13C NMR (CDCl3, 500 MHz, δ ppm) 154.5, 138.0, 137.2, 136.5, 135.8, 133.2, 132.2, 
130.5, 123.6, 110.0, 81.7, 79.2, 17.1, 14.6, 12.6, 12.2.  
MS (HiResESI) Cald for C27H27BF2N2 (M-H)– 427.2162; Found 427.2139 (M-H)–. 
 
 
Synthesis of Compound 65: 3-Bromo-5-iodobenzoic acid (2 g, 6.12 mmol), 4-
dimethylamino pyridine (374 mg, 3.06 mmol) and triethylene glycol monomethyl 
ether (1.23 ml, 7.65 mmol) were dissolved in THF (25 ml). N-N'-
dicyclohexylcarbodiimide (1.4 g, 6.73 mmol) was added and the reaction mixture 
was stirred at RT for 12 h. The white solids were removed by vacuum filtration and 
the solvent was evaporated from the filtrate. The crude product was purified by 
column chromotography using EtOAc/hexanes (1/1; v/v) as the mobile phase 
affording a colorless liquid (2.69 g, 93%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.27 (d, 1H, J = 1.8 Hz; ArH), 8.11 (d, 1H, J = 
1.6 Hz; ArH), 8.00 (d, 1H, J = 1.8 Hz; ArH), 4.45 (m, 2H; OCH2), 3.79 (m, 2H; 
OCH2), 3.68-3.61 (m, 6H; OCH2), 3.51 (m, 2H; OCH2), 3.34 (s, 3H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.8, 143.8, 137.2, 133.3, 132.0, 122.9, 93.9, 
71.9, 77.0, 76.7, 71.9, 70.6, 69.0, 64.8, 59.0. 
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Synthesis of Compound 66: Compound 65 (1.5 g, 3.2 mmol) was dissolved in THF 
(30 ml) and diisopropylamine (10 ml). Argon was purged through the solution for 20 
min after which CuI (61 mg, 0.32 mmol) and Pd(PPh3)2Cl2 (135 mg, 0.192 mmol) 
were added. The flask was sealed and trimethylsilylacetylene (2.8 ml, 18.2 mmol) 
was added by a syringe. The reaction was stirred for 12 h at RT, extracted with 
CH2Cl2 and the organic layer was collected and dried over Na2SO4. The product was 
cpurified by column chromatography using EtOAc:hexanes (1/2; v/v) as the mobile 
phase to produce a light brown liquid (1.42 g, 97%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.0 (d, 2H, J = 1.6 Hz; ArH), 7.70 (t, 1H, J = 1.6 
Hz; ArH), 4.45 (m, 2H; OCH2), 3.80 (m, 2H; OCH2), 3.68-3.61 (m, 6H; OCH2), 3.52 
(m, 2H; OCH2), 3.34 (s, 3H; OCH3), 0.22 (s, 18H; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 165.1, 139.1, 132.7, 130.5, 123.8, 102.9, 96.1, 
71.9, 70.6, 69.1, 64.4, 59.0, 0.2. 
 
Synthesis of Compound 67:193 Compound 66 (1.5 g, 3.26 mmol) was dissolved in 
THF (50 ml) and the mixture was cooled to 0 oC using an ice bath. 
Tetrabuthylammonium fluoride (8.17 ml, 1M in THF) was added slowly. The 
reaction was stirred at 0 oC for 10 min until all the starting compound was consumed. 
The reaction mixture was filtered through a silica pad and the product was purified 
by column chromatography (SiO2) using EtOAc/hexanes (1/1; v/v) as the mobile 
phase affording a yellow oily liquid (949 mg, 92%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.09 (s, 2H; ArH), 7.79 (s, 1H; ArH), 4.45 (m, 
2H; OCH2), 3.80 (m, 2H; OCH2), 3.67-3.61 (m, 6H; OCH2), 3.49 (m, 2H; OCH2), 
3.34 (s, 3H; OCH3), 3.12 (s, 2H; CH).  
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13C NMR (CDCl3, 400 MHz, δ ppm) 164.9, 139.3, 133.3, 130.8, 123.0, 81.9, 78.9, 
71.9, 70.6, 69.0, 64.5, 59.0. 
 
 
Synthesis of Compound 68194: 4-Tert-butylaniline (3 g, 3.2 ml, 20.1 mmol) was 
dissolved in ethanol (80 ml). I2 (10 g, 41 mol) and Ag2SO4 (12.5 g, 41 mol) were 
added and the mixture was stirred for 1 h at RT. After completion, the solid 
precipitate was removed by filtration, the ethanol was evaporated and the crude 
product was extracted with CH2Cl2 and washed with 5% NaOH solution. The organic 
layer was washed with water and then dried over Na2SO4. The product was purified 
by column chromatography using CH2Cl2/hexanes (1/3; v/v) as mobile phase to 
generate a brown oily liquid (5.75 g, 71%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.60 (s, 2H; ArH), 4.45 (b, 2H; NH2), 1.23 (s, 
9H; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 144.6, 143.8, 136.5, 81.7, 33.7, 31.3. 
 
Synthesis of Compound 69195: Compound 68  (5.75 g, 14.3 mmol) was dissolved in 
ethanol (50 ml), the reaction mixture was cooled to 0oC using an ice bath after which 
1 ml of concentrated H2SO4 was added. Subsequently, NaNO2 (3.5 g) was added 
quickly and the mixture was refluxed for 24 h. The reaction was neutralized with 
NaOH solution and extracted with CHCl3. The organic layer was collected, dried 
over Na2SO4 and evaporated in vacuo. The product was purified by column 
chromatography using hexanes as mobile phase to afford a white solid (2.8 g, 51%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.89 (t, 1H, J = 1.5 Hz; ArH), 7.68 (d, 2H, J = 
1.5 Hz; ArH), 1.30 (s, 9H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 155.6, 142.2, 134.1, 94.9, 34.9, 31.0. 
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Synthesis of Compound 70196: Compound 69 (2.32 g, 6 mmol), NaN3 (1.17 g, 18 
mmol), sodium ascorbate (134 mg, 0.6 mmol), CuI (228 mg, 1.2 mmol) and N1,N2-
dimethylethane-1,2-diamine (193 µl, 1.8 mmol) were added to a previously degassed 
33 ml solvent mixture (ethanol:water:toluene; 7:3:1; v/v). The reaction was refluxed 
for 2 h under argon and monitored by TLC. After all the starting compound was 
consumed in 2 h, the reaction was cooled to RT. The crude product was purified by 
column chromatography using hexanes as the mobile phase producing a yellow oily 
liquid (980 mg, 76%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.83 (d, 2H, J = 1.5 Hz; ArH), 6.54 (t, 1H, J = 
1.5 Hz; ArH), 1.33 (s, 9H; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 155.1, 141.3, 113.0, 106.9, 35.1, 31.1. 
 
Synthesis of Compound 71: Compound 67 (160 mg, 0.53 mmol) and compound 70 
(1.02 g, 5.3 mmol) were dissolved in toluene (15 ml). The solution was degassed 
with argon for 20 min and charged with three equivalents of 1,8-diazabicycloundec-
7-ene (DBU, 250 µl, 1.6 mmol) and CuI (50 mg, 0.26 mmol). The mixture was 
stirred at 70oC for 2 h under argon. After cooling to RT the crude product was 
purified by column chromatography using hexanes/acetone (2/1; v/v) to afford a 
yellow oily liquid (110 mg, 45%).  
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1H NMR (CD2Cl2, 400 MHz, δ ppm) 8.70 (t, 1H, J = 1.6 Hz; ArH), 8.54 (s, 2H; 
ArH), 8.47 (d, 2H, J = 1.6 Hz; ArH), 7.63 (t, 2H, J = 1.6 Hz; ArH), 7.37 (t, 2H, J = 
2.0 Hz; ArH), 7.14 (t, 2H, J = 1.8 Hz; ArH), 4.52 (m, 2H; OCH2), 3.87 (m, 2H; 
OCH2), 3.71 (m, 2H; OCH2), 3.66 (m, 2H; OCH2), 3.59 (m, 2H; OCH2), 3.47 (m, 
2H; OCH2), 3.25 (s, 3H; OCH3), 1.40 (s, 9H; CH3).  
13C NMR (CD2Cl2, 500 MHz, δ ppm) 165.7, 155.4, 146.9, 141.49, 137.9, 131.4, 
128.9, 128.1, 126.2, 118.8, 116.5, 114.1, 108.4, 71.8, 70.7, 70.5, 69.1, 64.6, 58.5, 
35.3, 30.8.  
MS (HiResESI) Cald for C38H44N12O5 (M+I)– 875.2603; Found 875.2574 (M+I)–. 
 
Synthesis of Compound M1: Compound 60 (42 mg, 0.1 mmol) and compound 71 
(75 mg, 0.1 mmol) were dissolved in toluene (75 ml) and degassed with argon for 30 
minutes. This solution was then added dropwise (over one hour) to a degassed 
toluene solution (200 ml) containing DBU (150 µl) and CuI (catalytic amount). The 
reaction mixture was heated to 70oC during this addition. After addition was 
completed, the reaction was stirred for an additional hour at 70o C and then cooled to 
RT. The crude product was purified by column chromatography (SiO2) using CH2Cl2 
as the initial mobile phase which was changed to hexanes/acetone (1/1; v/v) after the 
fast-migrating byproducts were collected. Fractions containing the macrocycle 
product were subjected to additional column chromatography using CH2Cl2:acetone 
(9:1; v/v) as mobile phase to afford a red waxy solid (40 mg, 34%).  
1H NMR (CD2Cl2, 500 MHz, δ ppm) 10.34 (s, 1H; ArH), 10.14 (s, 1H; ArH), 9.69 (s, 
2H; ArH), 8.40-7.90 (m, 11H; ArH), 4.42-3.30 (m, 15H; OCH2), 2.60-2.14 (m, 10H; 
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ArCH3 + ArCH2), 1.61-1.20 (m, 22H; ArCH3 + CH3), 0.89 (s, 6H; ArCH3); To 
increase the peak resolution tetrabutylammonium salt of chloride was added to the 
NMR solution.   
1H NMR (For M1+Cl–, CD2Cl2, 500 MHz, δ ppm) 10.85 (s, 2H; ArH), 10.58 (s, 2H; 
ArH), 9.40 (s, 1H; ArH), 8.94 (s, 2H; ArH), 8.78 (s, 1H; ArH), 8.49 (s, 2H; ArH), 
8.44 (s, 2H; ArH), 8.26 (s, 2H; ArH), 4.60 (m, 2H; OCH2), 3.95 (m, 2H; OCH2), 3.78 
(m, 2H; OCH2), 3.71 (m, 2H; OCH2), 3.66 (m, 2H; OCH2), 3.55 (m, 2H; OCH2), 
3.36 (s, 3H; OCH3), 3.31 (TBACl), 2.57 (s, 6H; ArCH3), 2.37 (q, 4H; ArCH2), 1.68 
(TBACl), 1.60 (s, 6H; ArCH3), 1.54 (s, 18H; CH3), 1.45 (TBACl), 1.03 
(TBACl+6H).  
13C NMR (M+Cl; CD2Cl2, 500 MHz, δ ppm) 167.4, 156.5, 155.4, 151.9, 150.6, 
148.0, 146.6, 145.6, 139.1, 136.7, 135.6, 133.5, 130.7, 129.8, 129.1, 126.0, 124.5, 
122.4, 120.9, 118.5, 115.7, 114.5, 106.4, 71.8, 70.5, 69.6, 63.8, 59.2, 35.6, 29.7, 29.1, 
16.9, 14.3, 12.3, 11.6.  
MS (HiResESI) Cald for C64H70BF2N15O5 (M+I) – 1304.4796; Found 1305.4746 
(M+I) –. 
 
Synthesis of Compound M2: Compound 64 (43 mg, 0.1 mmol) and compound 71 
(75 mg, 0.1 mmol) were dissolved in toluene (75 ml) and degassed with argon for 30 
minutes. This solution was then added dropwise (over one hour) to a degassed 
toluene solution (200 ml) containing Et3N (50 µl) and CuI (30 mg). The reaction 
mixture was heated to 70oC during this addition. After addition was completed, the 
reaction was stirred for an additional two hours at 70o C and then cooled to RT. 
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Additional amounts of Et3N (55 µl) and CuI (30 mg) were added and the mixture 
was stirred for a further 48 h.  The crude product was subjected to an initial round 
column chromatography (SiO2) using CH2Cl2 as the mobile phase followed by 
hexanes/acetone (1/1; v/v) after the fast-migrating byproducts were collected. The 
compound collected was washed with THF and subjected to a second round of 
column chromatography (SiO2) using CH2Cl2 as the mobile phase to remove BHT 
(2,6-dimethyl-4-tert-butylphenol) originating from the THF used in the previous 
purification procedure to afford a red oily liquid (19 mmol, 22 mg, 19%).  
1H NMR (For M2+Cl–, CD2Cl2, 500 MHz, δ ppm) 10.41 (s, 2H; ArH), 10.37 (s, 2H; 
ArH), 9.17 (s, 1H; ArH), 9.03 (s, 1H; ArH), 8.73 (s, 2H; ArH), 8.65 (s, 2H; ArH), 
8.34 (s, 2H; ArH), 8.12 (s, 2H; ArH), 4.57 (m, 2H; OCH2), 3.92 (m, 2H; OCH2), 3.73 
(m, 2H; OCH2), 3.67 (m, 2H; OCH2), 3.65 (m, 2H; OCH2), 3.59 (m, 2H; OCH2), 
3.33 (s, 3H; OCH3), 3.31 (TBACl), 2.52 (s, 6H; ArCH3), 2.32 (q, 4H; ArCH2), 1.68 
(TBACl), 1.53 (s, 6H; ArCH3), 1.49 (s, 18H; CH3), 1.45 (TBACl), 1.03 
(TBACl+6H).  
MS (HiResESI) Cald for C65H71BF2N14O5 (M+I)–  1303.4849; Found 1303.4788 
(M+I)–. 
 
 
Synthesis of Compound BOD-Q-1: Methyl-quaternized pyridine BODIPY197 (30 
mg, 57.4 µmol) was dissolved in CH2Cl2 (3 ml). Ammonium hexafluorophosphate 
(150 mg, 915 µmol) was added and the reaction mixture was stirred at RT for 12 h 
after which the reaction mixture was washed with H2O and the organic layer was 
collected and dried over Na2SO4 to obtain a non-emissive red solid (31 mg, 
quantitative).  
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1H NMR (CDCl3, 400 MHz, δ ppm) 8.89 (d, 2H, J = 6.44 Hz; ArH), 7.95 (d, 2H, J = 
6.18 Hz; ArH), 4.50 (s, 3H; CH3), 2.46 (s, 6H; ArCH2), 2.43 (q, 4H, J = 8.63 Hz; 
CH2), 1.26 (s, 6H; ArCH3), 0.89 (t, 6H, J = 7.52 Hz; CH3). 
MS (HiResESI) Cald for C23H29BF2N3+  396.2417; Found 396.2311, ∆ = 26.8 ppm. 
 
Synthesis of Compound 72: Quinoline-5-carboxaldehyde, compound 34 (472 mg, 3 
mmol) was dissolved in CH2Cl2 (100 ml) and degassed with argon for 20 min. 2,4-
Dimethyl-3-ethyl pyrrole (2.2 eq., 0.89 ml) and a catalytic amount of trifluoroacetic 
acid (TFA) was added and the solution was stirred for at RT. After 12 h, p-chloranil 
(0.74 g, 3 mmol) was added and the reaction was stirred for 1 h followed by addition 
of Et3N (4 ml) then by BF3•OEt2 (4 ml) and the reaction mixture was stirred for an 
additional 1 h at RT. The reaction mixture was washed with H2O and the organic 
layer was collected and dried over Na2SO4. The product was purified by flash 
column using CH2Cl2 as the mobile phase to produce a red solid (323 mg, 25%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.04 (d, 1H, J = 4.32 Hz; ArH), 8.40 (d, 1H, J = 
8.4 Hz; ArH), 7.85 (m, 1H; ArH), 7.77 (m, 1H; ArH), 7.52 (m, 1H; ArH), 7.41 (d, 
1H, J = 4.32 Hz; ArH), 2.55 (s, 6H; ArCH3), 2.24 (q, 4H, J = 7.52 Hz; CH2), 1.00 (s, 
6H; ArCH3), 0.95 (t, 6H, J = 7.52 Hz; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 190.2, 154.8, 150.3, 148.3, 142.7, 137.8, 134.7, 
133.3, 130.4, 129.8, 127.9, 127.2, 125.1, 121.2, 17.0, 14.5, 12.6, 11.3. 
MS (HiResESI) Cald for C26H29BF2N3+  432.2417; Found 432.2463, ∆ = 10.60 ppm. 
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Synthesis of Compound BOD-Q-2: Compound 72 (90 mg, 0.21 mmol) was 
dissolved in EtOAc and CH2Cl2 (5:5 ml) and an excess amount of iodomethane (1 
ml) was added. The reaction was stirred at RT for 12 h. The resulting precipitate was 
filtered to obtain the red iodide salt of quinolinium BODIPY (30 mg, 25%). This 
compound (7 mg) was dissolved in a minimum volume of CH2Cl2. Ammonium 
hexafluorophosphate (20 mg, 122 µmol) was added and the solution was stirred at 
RT for 12 h, washed with H2O and the organic layer was collected and dried over 
Na2SO4 to a obtain non-emissive red solid (7.2 mg, quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.38 (d, 1H, J = 5.82 Hz; ArH), 8.40 (d, 1H, J = 
8.76 Hz; ArH), 8.22 (m, 2H; ArH), 7.90 (m, 2H; ArH), 4.76 (s, 3H; CH3), 2.50 (s, 
6H; ArCH3), 2.17 (q, 4H, J = 7.44 Hz; CH2), 0.95 (s, 6H; ArCH3), 0.90 (t, 6H, J = 
7.48 Hz; CH3). 
MS (HiResESI) Cald for C27H31BF2N3+ 446.25736; Found 436.26234, ∆ = 11.2 ppm. 
 
Preparation of tetrabutylammonium trifluoroacetate. Trifluoroacetic acid (154 
ml, 2 mmol) was added to a 1 M tetrabutylammonium hydroxide (2 ml) solution in 
methanol. The mixture was stirred at RT for 3 h. Water formed during the reaction 
was removed by evaporating to dryness (quantitative, white solid).  
1H NMR (CDCl3, 400 MHz, δ ppm) 3.21 (t, 8H, J = 8.13 Hz; NCH2), 1.60 (m, 8H; 
CH2), 1.38 (m, 8H; CH2), 0.94 (t, 12H, J = 7.28 Hz; CH3). 
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CHAPTER 6 
Integrated Logic Gate for Some Function: Self Reporting 
Activatable Photosensitizer 
 
Sundus Erbas-Cakmak, Yusuf Cakmak, Engin U. Akkaya 
 
6.1 Objective 
Compared to silicon-based logic operations chemical logic gates are still in their 
formative years. They can perform quiet complex tasks such as 
multiplexer/demultiplexer, flip-flop logics, subtracter/adder or key-pad-lock systems. 
Even, some smart oligonucleotide-base constructs playing simple games such as Tic-
Tac-Toe have been reported, integration of one functional operation to another for 
furher purpose is still to be improved. In the research presented in this section of the 
thesis, integration of two chemical logic gates is proposed to concetinate an acid 
activatable photosensitizer to the activity reporting moiety through singlet oxygen 
mediated information relay.  
 
6.2 Introduction 
Complexity of biochemical reaction networks usually result from the cascade of 
reactions that control or are controlled by other reactions in the network. This 
enables signal relay among functional biological modules and provides intricate 
emerging processes. Same analogy does apply to silicon-based logic operations. 
Complex digital computational processes are indeed show similar level of 
dependency of series of simple logic operations from which sophisticated algorithms 
can be effectively produced.  
In chemical logic gates, physical integration of simple logic gates has been reported.  
Nevertheless, the functional relations between each independent modules or 
concetenated logic gates as a whole have not been done so far. To enable such 
 
 
155 
 
purposeful relation, photodynamic action and chemical sensor approach is used in 
this work.  Since the output of a PDT action is 1O2, a reaction based sensing of this 
output to report the activity of the first action is aimed.  
1O2 is known to react readily through addition reactions. Reaction of 1O2 with diene 
produces endoperoxide and when the olefins are reactants then the product is a 
hydroperoxide. Electron rich olefins are also susceptible to 1O2 attack through 2+2 
cycloaddition reaction producing dioxetanes.198 This product is usually decomposes 
spontenously. 1O2-olefin reaction is used in literature to create various cleavable 
systems in which PDT agents are used as 1O2 generators. Among them, the reaction 
with (Z)-1,2-bis(alkyllthio)ethene is chosen to build a 1O2 related logic gate in this 
research since this is reported to have quite higher reaction rate and the relatively 
easy synthesis.199 The reaction of this linker with 1O2 is shown in Scheme 26. 
Following the initial addition of 1O2 to the double bond, unstable dioxethane is 
formed. Spontaneous decomposition of this group produces S-alkyl methanethioate. 
In aqueous solution with the aid of amines this group is hydrolyzed to thiols.  
 
 
Scheme 25. Mechanism of reaction of 1O2 with electron rich olefins. 
This cleavage is used to separate the energy transfer modules (donor and acceptor 
dyes) in the project to report the presence of 1O2. The pH-activatable photosensitizer 
is chosen based on the work presented in chapter 4. The photosensitizer has a highly 
applicable pKa value (6.92). In its deprotonated form, the singlet oxygen generation 
efficiency of the photosensitizer dereases substantially due to diminished excitability 
at the wavelength of light source and due to some other deactivation pathways 
involved in deprotonated case.  
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6.3 Design of the Functionally Integrated Logic Gates 
The functional relations between two different logic gates are designed as follows. 
The first logic operation is an AND logic gate that builds a pH-activatable 
photosensitizer. ICT character of the photosensitizer enables a hypsochromic shift of 
the absorption of the PS upon protonation and the spectral change enables an 
enhanced excitation at the wavelength of LED light source. The requirement of light 
(660 nm) and acid for the singlet oxygen generation create the first AND logic 
operation (Scheme 27).  
 
Scheme 26. Representative illustration of pH-activatable photosensitizer (AND logic gate 1) 
and release of FRET donor upon reaction with 1O2 (AND logic gate 2). A represents FRET 
acceptor, D represents FRET donor and PS represents photosensitizer. The output of the first 
logic gate (1O2) is an input for the next which concatenates two gates functionally.  
In the second AND logic gate construct, a Förster-type energy transfer system is 
designed with the BODIPY dye (compound 74) being the energy donor and a 
distyryl-BODIPY dye (compound 75) as energy acceptor. Energy transfer from the 
former dye decreases its emission intensity at 537 nm. The two dyes are attached to 
one another with a special linker, a (Z)-1,2-bis(alkyllthio)ethene group that is 
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reported in literature to be cleaved by singlet oxygen efficiently. Presence of the 1O2 
input liberates the FRET donor and upon excitation with the light (520 nm), an 
enhanced emission from the donor BODIPY dye is expected to be observed. Since 
the 1O2 is the output of the initial AND logic gate, the two gates are concatenated. 
Physical proximity between two logic gates is obtained by embedding both 
molecules within same micellar construct. The semi-chemical structures of the 
molecules and the individual energy transfer modules are shown in Scheme 27. 
Modules are used to analyze the energy transfer process in compound 80. As an 
alternative second logic, glutathione is used as an input due to its 1O2 scavenging 
property to construct an INHIBIT logic gate.  
By the mechanism explained above, an activatable photosensitizer generates 1O2 in 
slightly acidic media upon irradiation with 660 nm light and reports its activity in the 
form of 1O2 reaction to separate FRET modules of compound 80. The end product is 
an emission at 537 nm from the FRET donor.   
 
Scheme 27. Chemical structures of photosensitizer (compound 38), singlet oxygen reporter 
(compound 80) and individual FRET modules (compound 74, the FRET donor and 
compound 75, the FRET acceptor). The 1O2 reactive group is highlighted with red. Complete 
chemical structures are given in the experimental part. 
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6.4  Results and Discussion 
6.4.1 Construction of First AND Gate 
The photophysics, pH characteristics and photodynamic activity of the 
photosensitizer (compound 38) are extensively studied in chapter 4 of this thesis. 
Aqeous solution of this compound within Cremephor EL micelle has a pKa value of 
6.92 and displays a large hypsochromic spectral shift in absorption upon protonation 
from 720 nm to 649 nm. These properties make the compound an excellent candidate 
for pH-activatable photosensitizer for use in tumor therapy. By choosing an 
excitation wavelength which selectively excites protonated form of the PS, the PDT 
activity can be controlled with this input.  
Figure 47 displays the photodynamic activity of the micelle encapsulated compound 
38 in various conditions in aqueous solution. Singlet oxygen generation is followed 
by the decrease in the absorption of trap molecule (see chapter 4, experimental part) 
which bleaches as a result of the reaction with 1O2. As it is obviously seen from the 
decrease in the absorption at 378 nm, 1O2 generation is more pronounced in slightly 
acidic solution (pH ~ 6.0) owing to the spectral match with the light of excitation. 
There is almost no decrease in absorption in slightly basic (pH ~ 7.5) solutions 
containing photosensitizer. There may be other reasons for the poor 1O2 generation 
efficiency of the PS in basic solutions since the emission of the compound upon 
excitation at the maximum absorption wavelength decreases as well. There may be 
other deactivation pathways beside spectral mismatch that acts on the phenolate form 
to quench the fluorescence and decrease the 1O2 generation efficiency. Such systems 
usually have strong charge transfer character and the non-radiative transitions may 
dominate as also observed by the quenching of the fluorescence. 
The requirement of light for 1O2 generation is also observed since under any 
conditions trap absorption does not significantly change unless the light is irradiated. 
To check the stability of the 1O2 trap under experimental conditions, two experiments 
are performed. Trap under acidic and basic aqueous solutions do not decompose as 
followed by the electronic absorption spectra.  
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Figure 47. Relative 1O2 generation efficiency of micellar compound 38 (7.5 µM) in aqeous 
solution in the presence (black, triangle) and absence (red, tiangle) of the acid as followed by 
the absorption change of the trap at 378 nm. The change in the trap absorption in slightly 
basic (blue, square) and acidic (green, circle) solutions (pH ~ 7.5 and 6.0 respectively). In the 
first 15 min, the samples were kept under dark and for the following 50 min; the samples 
were irradiated with 660 nm light using LED array.   
With the use of the results obtained from PDT experiments an AND logic is 
constructed. Inputs are acid and light of 660 nm wavelength and output is 1O2 
generation efficiency. Output values are determined from the percent decrease of the 
trap absorption. Values are taken from data after samples are kept for 15 min under 
dark or after irradiated for 15 min with light of 660 nm. 1% decrease in absorption of 
the trap is determined as threshold for the logic gate (Figure 48). Electronic 
absorption spectra and the photophysical properties of the compound 38 (both 
protonated and deprotonated forms) are given in Figure 50 and Table 8 respectively. 
The compound is essentially non-emissive in its phenolate form. 
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6.4.2 Construction of Second AND Gate and Concetination 
 
Figure 48. AND logic construct out of compound 38 where output is 1O2 as measured by % 
decrease in trap absorbance within 15 min (under dark or with 660 nm irradiation).  Inputs 
are 660 nm light and acid and threshold is determined to be 1. 
Once the 1O2 generation efficiency of the photosensitizer is controlled with an AND 
logic, the second part of the integrated-logic construct is developed. The inputs of 
this part are light of 520 nm and 1O2. The latter input is provided by the PDT action 
in the first logic operation. To analyze the integration, two molecules (compound 38 
and 80) are incorporated together within the micelle with a mole ratio of 
approximately 1:1. The concentrations are estimated by comparison of the absorption 
values with the THF absorptivities.  
Comparison of the emission spectra of the compound 80 with the modules shows that 
the emission of the FRET donor part (compound 74) at 537 nm is quenched 
considerably in compound 80 as also verified with the decrease in the quantum yield 
of this part from 0.96 to 0.14 (Figure 49, Table 8).  On the other hand, FRET 
acceptor module can not be excited at 520 nm to produce emission at 670 nm while 
compound 80 shows intense emission at this wavelength upon excitation at 520 nm. 
Both of these spectroscopic results indicate an efficient FRET process between the 
modules with a calculated FRET efficiency of 0.85%. The lack of unit efficiency in 
this process is probably due to poor spectral overlap between donor-acceptor 
moieties. Excitation spectra also confirms that the acceptor emission is a product of 
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excitation of both donor and acceptor moieties (Figure 50b). In contrast, excitation 
spectra of compound 75 does not display any peaks around 524 nm when emission at 
670 nm is followed.  
 
Figure 49. Comparison of emission spectra of equally absorbing compounds 80 (black, solid) 
and 74 (red, dashed) (a) excited at 520 nm and compounds 80 (black, solid) and 75 (red, dashed) 
(b) excited at the same wavelength in THF. 
Figure 50. Electronic absorption spectra of compounds 80 (black, solid), 75 (red, dashed), 74 (blue, 
dot), 38 (green, dashed-dot), 38 in the presence of piperidine (purple, dashed, dotdot) in THF (a), 
comparison of excitation spectra of equally absorbing compounds 75 (red, dashed) and 80 (black, 
solid) for emission at 670 nm  in THF (b). 
(a) (b) 
(c) (d) 
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Since the PS produces singlet oxygen only in the presence of acid, acidic conditions 
are interpreted as the presence of 1O2 in the second logic gate. Liberation of the 
FRET donor upon reaction of compound 80 with 1O2 is expected. The samples kept 
under dark do not display any change in the emission of the FRET donor module of 
the compound 80 at 537 nm (Figure 51).  Likewise, under slightly basic conditions, 
no significant change in the emission is observed since 1O2 is not generated 
Figure 51. Change in the emission spectra of compound 80 (0.75 µM) in the presence of 
compound 38 (0.75 µM) in slightly acidic (a) and basic (b) aqueous solutions upon irradiation 
with 660 nm light for 50 min. The spectrum is recorded by excitation at 520 nm.   
Figure 52. Change in the emission spectra of compound 80 (0.75 µM) in the presence of 
compound 38 (0.75 µM) in slightly acidic (a) and basic (b) aqueous solutions under dark. The 
spectrum is recorded by excitation at 520 nm.   
 
(b) (a) 
(a) (b) 
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efficiently under these conditions (Figure 52b). However, whence there is acid to 
activate the PS, the emission intensity of the donor at 537 nm increases more than 2-
folds indicating the liberation from the energy acceptor module (Figure 52a). 
Quantum yield of the donor emission within the micellar construct increases from 
0.14 to 0.29 and the rate of increase in the emission seems to be almost saturated 
(Figure 54). Yet the final quantum yields are far from the quantum yield of the free 
compound 74 and the excitation spectra shows that the emission at 670 nm can still 
be collected by excitation at donor absorption (Figure 53). This shows that the FRET 
process is still effective to some extent due to remaining uncleaved compound 80. 
This result may be due decrease in dissolved oxygen within the solution after certain 
time which decreases the reaction rate. In real biological media, the oxygen flow 
within the blood and tissue are usually under homeostasis and essentially constant.  
Comparing the quantum yields of the free compound 74 and the compound 80 after 
50 min light irradiation, 18% cleavage of the FRET module can be estimated. This is 
still enough to obtain an intense fluorescence output.  
 
Figure 53. Excitation spectra of micellar construct of compound 80 and 38 in aqeous media 
before and after irradiation with 660 nm light. The light is irradiated for 50 min and 
excitation spectra is recorded for emission at 670 nm.  
Overall results for the fluorescence enhancement in the presence acid or light of 660 
nm are given in Figure54. As it is obviously depicted, the singlet oxygen mediated 
fluorescence enhancement at 537 nm is apparently more pronounced in the presence 
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of 1O2 which is efficienctly produced in the presence of 660 nm light in acidic 
aqueous media.  
 
Table 8. Photophysical characterization of compounds 38, 74, 75 and 80. 
Compound λabsa λemb ε ΦFc 
38 645a 
720b 
667a 
-b 
40000a 
30000b 
0.13 
- 
74 525 535 70000 0.96 
75 654 670 76000 0.50 
80 525 
654 
537 
670 
85000 
93000 
0.14 
0.56 
 
a values in THF; b values in piperidine-added THF; c for emission at 537 nm Rhodamine 6G 
(water, φF = 0.95, n = 1.333) and for emission at 670 nm Cresyl Violet (MeOH, φF = 0.66, n = 
1.329) are used as reference compounds for quantum yield calculations. 
 
 
Figure 54. Fluorescence change at 537 nm of the micellar compounds 38 and 80 in D2O in 
the presence of different combinations of acid-base and dark-light conditions. Light is 
supplied by a 660 nm LED source. All four samples are excited at 520 nm.  
In order to make sure that the resultant increase is not a product of light solely, in 
other words to test the stability of the compound 80 under light illumination and 
same experimental conditions, a micelle containing only this compound is tested in 
aqueous solution. The results show that the increase in the emission of the donor in 
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the absence of the photosensitizer is significantly less efficient (Figure 55) indicating 
that the main contributer of the enhancement at 537 nm is 1O2.  
 
Figure 55. Comparison of fluorescence enhancement of micellar compound 80 (0.75 µM) in 
the presence (black, square) and absence (red, dot) of photosensitizer (compound 38) in D2O.  
Considering all the results above, the second AND logic is constructed. Since the 
excitation with 520 nm is required for the second logic gate, the absence of this light 
is accepted as 0 outputs (no excitation). The results are depicted with a given 
threshold of 0.3 in Figure 56.  
 
Figure 56. Construction of second AND logic gate with the inputs light (520 nm) and acid 
and the output is fold increase in emission at 537 nm. The threshold is determined as 0.3.  
Although light is accepted as an input of a logic gate in a number of different 
researches in literature, this input may seem trivial since the excitation is required 
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anyway for any fluorescence process. For that reason, an alternative input is adopted 
for the second gate, glutathione. Although increased level of GSH in tumor tissue is 
used for the activation of PS in the research presented in chapter 4, the high level of 
this molecule resist PDT action because of its singlet oxygen scavenging property. 
Since in the former project the PS is expected to be activated in the extracellular 
medium, the increase in the concentration of this molecule is not that high to 
interfere with PDT action. To suppress the PDT deactivating property of GSH at 
high concentration, scientists use chemicals to decrease the biological production of 
this molecule.200 In this project, GSH is used as input because of its role as singlet 
oxygen scavenging. For improved action of produced 1O2, GSH level should be low. 
The results of the fluorescence enhancement at 537 nm under different conditions are 
given in Figure 57.  
 
Figure 57. Comparison of fold increase in micellar compound 80 and 38 (0.75 µM) in the 
presence of different combinations of GSH, singlet oxygen (acid) or 660 nm light in aqueous 
solution. The fluorescence spectra are recorded by excitation at 520 nm.   
Results in Figure 57 and 58 shows that presence of GSH interferes with fluorescence 
enhancement. This data is read as follows, GSH act as a 1O2 scavanger and decrease 
the level of this molecule and thus rate of fluorescence enhancement is diminished. 
The lack of quantitative decrease in the fluorescence enhancement may be due to 
limited diffusion of GSH molecule to the interior of the micelle within the 
experimental time period (50 min). Yet, appropriate choice of threshold still allows 
the construction of an INHIBIT logic gate out of these results.  
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Figure 58. INHIBIT logic gate with the inputs 1O2 and GSH and the output is emission at 
537 nm.  
Considering all, two different integrated logic gates with a meaningful function are 
presented in this research. An activatable photosensitizer with valuable pH-
dependent activity constructs the first AND logic gate and the output of this logic 
(1O2) is used in the second logic gate as an input to release the FRET donor and 
restore its emission. Together with the 1O2 input use of light (520 nm) makes an 
AND logic gate while use of GSH enables the development of an INHIBIT logic 
gate. The representations of both integrated logics are given in Figure 59. With these 
results, for the first time, logic gates are integrated for some functional intention. An 
activatable and self-reporting photosensitizer is introduced with the concept of logic 
gate concetination.  
 
Figure 59. Representation of two different integrated logic gate constructs 
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6.5 Experimental Details 
Details of quantum yield calculations, lifetime measurements, micelle preparations 
are given in previous chapters, chapter 3, 4 and 5.  
 
6.5.1 PDT and Fluorescence Measurements 
1O2 dependent degradation of water soluble trap, 2,2'-(anthracene-9,10-
diylbis(methylene)dimalonic acid was used to measure photodynamic activity since 
the absorption of this compound at 378 nm decreases indicating the generation of 
1O2. Corresponsing reaction is given in the experimental section of Chapter 4. 
Measurements were performed using 660 nm LED and samples were irradiated with 
the light source from a 2 cm distance. All samples were aerated for 5 min prior to 
experiments. D2O was used for the solutions since the lifetime of 1O2 in this solution 
is higher. Relative 1O2 generation efficiencies in different conditions were 
determined by taking the percent decrease of the trap absorption in a given time. 
Micellar constructs were prepared as described in experimental part of Chapter 4 and 
1:1 ratio of compound 80 and compound 38 were used during micelle formation. pH 
of the solutions were adjusted by using NaOH and HCl solutions to slightly acidic 
(around 6) and slightly basic (around 7.5) values. The concentrations in micelle were 
determined by comparing the absorptivities of these compounds in THF solution.   
 
6.5.2 Synthesis 
 
Synthesis of Compound 73: 4-hydroxybenzaldehyde (1.23 g, 10 mmol) and 
compound 46 (4.8 g, 15 mmol) were dissolved in 50 ml acetonitrile. K2CO3 (3.2 g, 
22.4 mmol) and a few crystals of benzo-18-crown-6 were added. The reaction was 
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refluxed until all 4-hydroxybenzaldehyde was consumed. The solvent was 
evaporated in vacuo, extracted with water and CH2Cl2. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica 
gel column chromatography using CH2Cl2/Hexane (75:25, v/v). Fraction containing 
compound 73 was collected then the solvent was removed under reduced pressure 
(2.1 g, 7.8 mmol, 78%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.80 (s, 1H), 7.75 (d, J=7.42 Hz, 2H, ArH), 6.94 
(d, J=7.81 Hz, 2H, ArH), 4.13 (m, 2H; OCH2), 3.80 (m, 2H; OCH2), 3.70-3.40 (m, 
8H; OCH2), 3.27 (s, 3H, OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.8, 163.9, 131.9, 130.1, 114.9, 71.9, 70.9, 
70.7, 70.6, 69.5, 67.8, 59.0.  
 
Synthesis of Compound 74: CH2Cl2 (300 ml) was purged with Ar for 30 min. 4-
(prop-2-ynyloxy) benzaldehyde 6 (1 g, 6.24 mmol) and 2,4-dimethyl-3-ethyl pyrrole 
(1.54 g, 1.7 ml, 12.6 mmol) were added. 3 drops of trifluoroacetic acid was added. 
The reaction mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-
benzoquinone (1.54 g, 6.24 mmol) was added and the reaction mixture was stirred at 
room temperature for 45 min. Then triethyl amine (8 ml) and boron trifluoride 
diethyl etherate (8 ml) were added sequencially. After stirring at room temperature 
for 30 min, it was extracted with water. Organic layer was dried with Na2SO4 and 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using CHCl3/Hexane (75:25, v/v) as mobile phase. Fraction 
containing compound 74 was collected then the solvent was removed under reduced 
pressure (400 mg, 0.92 mmol, 15%). 
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1H NMR (CDCl3, 400 MHz, δ ppm) 7.21 (d, J = 8.72 Hz, 2H; ArH),  7.10 (d, J = 
8.72 Hz, 2H; ArH), 4.78 (d, J = 2. 40 Hz, 2H; OCH2), 2.57 (t, J = 2.44 Hz, 1H; CH), 
2.55 (s, 6H; ArCH3),  2.32 (q, J = 7.56 Hz, 4H; ArCH2), 1.33 (s, 6H; ArCH3), 1.0 (t, J 
= 7.60 Hz, 6H; CH3).  
13C NMR (CDCl3, 400 MHz, δ ppm) 158.0, 153.6, 140.0, 138.4, 132.8, 131.1, 129.8, 
128.9, 115.6, 78.1, 75.8, 56.0, 17.1, 14.6, 12.5, 11.8.  
 
Synthesis of Compound 75: Compound 73 (112 mg, 0.42 mmol) and compound 74 
(70 mg, 0.17 mmol) were dissolved in benzene (40 ml). Piperidine (0.4 ml) and 
acetic acid (0.4 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all BODIPY was consumed. After the reaction was completed, it was 
extracted with CH2Cl2 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc/MeOH (98:2, v/v). Fraction containing 
compound 75 was collected then the solvent was removed under reduced pressure 
(90 mg, 0.1 mmol, 59%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.68 (d, 2H, J = 16.77 Hz; ArH), 7.59 (d, 4H, J 
= 8.72 Hz; ArCH3), 7.25-7.18 (d + d, 2H + 2H; ArH), 7.13 (d, 2H, J = 8.64 Hz; 
ArH), 6.97 (d, 4H, J =8.72 Hz; ArH), 4.80 (d, 2H, J = 2.32 Hz; OCH2), 4.20 (t, 4H, J 
=4.68 Hz; OCH2), 3.80-3.60 (m, 8H; OCH2), 3.60 (m, 4H; OCH2), 3.40 (s, 6H; 
OCH3), 2.61 (q, 4H, J = 7.36 Hz; ArCH2), 1.40 (s, 6H; ArCH3), 1.15 (t, 6H, J = 7.40 
Hz; CH3). 
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13C NMR (CDCl3, 400 MHz, δ ppm) 159.4, 158.0, 150.4, 138.7, 137.7, 135.3, 133.6, 
133.3, 129.9, 129.2, 128.7, 118.2, 115.6, 114.9, 78.1, 75.9, 72.0, 70.9, 70.7, 70.6, 
69.7, 67.6, 59.0, 56.1, 18.4, 14.1, 11.7.   
HRMS (TOF-ESI): m/z calcd for C54H65BF2N2NaO9+ 957.46434 [M+Na]+; found: 
957.47300 [M+Na]+, Δ = 9.0 ppm. 
 
Synthesis of Compound 76: Argon was purged in EtOH (10 ml) for 15 min. NaOH 
(0.88 g, 22 mmol) and 3-mercaptopropanol (2 g, 1.86 ml, 22 mmol) were added and 
the reaction was stirred at 0oC ice bath for 30 min while the flask was sealed. Then, 
cis-1,2-dichloroethylene (1.04 g, 0.8 ml, 11 mmol) in degassed EtOH (1 ml) was 
added and the reaction mixture was refluxed for 18 h. After cooling to RT, it was 
extracted with petroleum ether and brine. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc/Hexanes (50:50, v/v) as mpbile phase. 
Fraction containing compound 76 was collected then the solvent was removed under 
reduced pressure (2 g, 9.6 mmol, 87%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.12 (s, 2H), 3.73 (t, J = 6.08 Hz, 4H; OCH2), 
2.84 (t, j = 7.04 Hz, 4H; SCH2), 2.57 (b, 2H; OH), 1.88 (m, 4H; CH2).  
13C NMR (CDCl3, 400 MHz, δ ppm) 123.9, 60.9, 32.7, 30.8.  
HRMS (TOF-ESI): m/z calcd for C8H16NaO2S2+: 231.04839 [M+Na]+; found: 
231.05234 [M+Na]+, Δ = 17.0 ppm. 
 
 
Synthesis of Compound 77: (Z)-3,3'-(ethene-1,2-diylbis(sulfanediyl))dipropan-1-ol, 
compound 76 (1.7 g, 8.16 mmol) was dissolved in 30 ml CH2Cl2 and 3.4 ml Et3N. In 
a dropper, p-toluene sulfonyl chloride (3.11 g, 16.32 mmol) was dissolved in CH2Cl2 
10 ml and was added to the previous solution dropwise while the reaction mixture 
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was being cooled with ice bath. It was stirred for 12h. After the extraction with 
water, organic layer was collected and dried with Na2SO4, evaporated under reduced 
pressure. The product was purified by silica gel column chromatography using 
CHCl3 as mobile phase. Fraction containing compound 77 was collected, then the 
solvent was removed under reduced pressure (white solid, 5.7 mmol, 2.95 g, 70%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.80 (d, 4H, J = 8.48 Hz; ArH), 7.37 (d, 4H, J = 
8.48 Hz; ArH), 5.98 (s, 2H; ArH), 4.14 (t, 4H, J = 5.93 Hz; OCH2), 2.73 (t, 4H, J = 
7.00 Hz; SCH2), 2.48 (s, 6H, ArCH3), 1.95 (m, 4H; CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 144.9, 132.9, 129.9, 127.9, 123.9, 68.3, 29.9, 
29.6, 21.7.  
HRMS (TOF-ESI): m/z calcd for C22H28NaO6S4+ 539.06609 [M+Na]+, found: 
539.07170 [M+Na]+, Δ = 10.0 ppm. 
 
Synthesis of Compound 78: Compound 77 (200 mg, 0.38 mmol) was dissolved in 10 
ml DMSO and sodium azide (247 mg, 3.8 mmol) was added to the reaction mixture. 
It was stirred 2h at 60 oC. After cooling to RT, it was extracted with EtOAc and 
brine. Organic layer was collected and dried with Na2SO4, evaporated under reduced 
pressure. (yellow oil, 3.8 mmol, 98 mg quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.10 (s, 2H), 3.45 (t, J = 6.57 Hz, 4H; NCH2), 
2.81 (t, j = 6.96 Hz, 4H; SCH2), 1.89 (m, 4H; CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 49.9, 37.6.   
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Synthesis of Compound 79: Compound 74 (80 mg, 184 µmol) and compound 78 
(476 mg, 1.84 mmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Flask was 
covered with aluminium folio to avoid light and Ar was purged for 15 min. Saturated 
solutions of CuSO4.5H2O (100 µl) and sodium ascorbate (100 µl) were added. 
Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
room temperature. After the reaction was completed, it was extracted with CH2Cl2 
and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography 
using EtOAc/Hexanes (50/50; v/v) as mobile phase. Fraction containing compound 
79 was collected, then the solvent was removed under reduced pressure (94 µmol, 65 
mg, 51%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.71 (s, 1H; ArH), 7.20 (d, J = 8.72 Hz, 2H; 
ArH), 7.12 (d, J = 8.56 Hz, 2H; ArH), 6.15 (d, J = 8.32 Hz, 1H; CH), 6.06 (d, J = 
8.37 Hz, 1H; CH), 5.26 (s, 2H, OCH2), 4.55 (t, J = 6.76 Hz, 2H; NCH2), 3.46 (t, J = 
6.53 Hz, 2H; NCH2),  2.84 (t, J = 6.97 Hz, 2H; SCH2), 2.75 (t, J = 6.76 Hz, 2H; 
SCH2), 2.53 (s, 6H; ArCH3), 2.30 (m, 2H + 4H; CH2 + ArCH2), 1.82 (m, 2H; CH2), 
1.33 (s, 6H; ArCH3), 1.0 (t, J = 7.49 Hz, 6H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 158.7, 153.6, 143.7, 140.0, 138.4, 132.7, 131.1, 
129.6, 128.5, 127.0, 125.4, 123.2, 122.7, 115.3, 62.1, 49.6, 48.4, 31.1, 30.7, 30.2, 
29.4, 17.1, 14.6, 12.5, 11.8.  
HRMS (TOF-ESI): m/z calcd for C34H43BF2N8NaOS2+ 715.29546 [M+Na]+, found: 
715.30182 [M+Na]+, Δ = 8.89 ppm. 
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Synthesis of Compound 80: Compound 79 (30 mg, 43 µmol) and compound 75 (35 
mg, 37 µmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Flask was covered 
with aluminium folio to avoid light and Ar was purged for 15 min. Saturated 
solutions of CuSO4.5H2O (100 µl) and sodium ascorbate (100 µl) were added. 
Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
room temperature. After the reaction was completed, it was extracted with CH2Cl2 
and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography 
using EtOAc/MeOH (90/10; v/v) as mobile phase. Fraction containing compound 80 
was collected, then the solvent was removed under reduced pressure (25 µmol, 40 
mg, 68%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.75-7.65 (s+ s+ d, 1H + 1H + 2H; ArH), 7.58 
(d, J = 8.80 Hz, 4H; ArH), 7.25-7.15 (d + d + d, 2H + 2H + 2H; ArH), 7.15-7.08 (d + 
d, 2H + 2H; ArH), 6.96 (d, J = 8.76 Hz, 2H; ArH), 6.11 (s, 2H; CH), 5.29 (s, 2H; 
OCH2), 5.27 (s, 2H; OCH2), 4.55 (m, 2H + 2H; NCH2), 4.20 (t, J = 5.0 Hz, 4H, 
OCH2), 3.90 (m, 4H; OCH2), 3.78 (m, 4H; OCH2), 3.72-3.60 (m, 8H; OCH2), 3.59 
(m, 4H; OCH2), 3.40 (s, 6H; OCH3), 2.77 (m, 4H, SCH2), 2.61 (m, 4H; CH2), 2.53 (s, 
6H; ArCH3), 2.30 (m, 4H + 4H; ArCH2), 1.38 (s, 6H; ArCH3), 1.34 (s, 6H; ArCH3), 
1.17 (t, J = 7.36 Hz, 6H; CH3), 1.00 (t, J = 7.60 Hz, 6H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 159.4, 158.7, 153.6, 150.4, 143.8, 140.0, 138.7, 
138.4, 137.7, 135.4, 133.6, 133.2, 132.7, 130.5, 130.0, 129.6, 128.9, 128.7, 128.6, 
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124.1, 124.0, 123.2, 118.1, 115.4, 115.3, 114.9, 71.9, 70.9, 70.7, 70.6, 69.7, 67.6, 
62.0, 59.0, 48.4, 30.7, 30.3, 18.4, 17.1, 14.6, 14.1, 12.5, 11.9, 11.7.  
HRMS (TOF-ESI): m/z calcd for C88H108B2F4N10NaO10S2+ 1649.77058 [M+Na]+, 
found: 1649.78090 [M+Na]+, Δ = 6.26 ppm. 
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CHAPTER 7 
CONCLUSION 
This thesis involves four different projects related to functional manufacture of logic 
gates to obtain controlled photodynamic action (Chapters 3, 4, 6) and in another 
context, a fluorescent chemosensor designed for selective detection of chloride anion 
(Chapter 5).  
Considering the time arrow of science, things are getting smaller and smarter as the 
knowledge grows immensely. More is known about molecular and genetic basis of 
diseases and therapies are more personalized accordingly. In parallel, technology 
products and organic devices are further becoming intelligent. Chemical logic gates 
increase the flexibility in functionality of the Boolean logic operations, and allow the 
creation of demanding complex works for different purposes. The missing link 
between the design of any kind of complex logic operation and assignment of real 
function is addressed to be reached in the projects of this thesis.  
The first of these projects (Chapter 3) is a proof of principle demonstration of use of 
a demultiplexer (DEMUX) logic operation within an operational framework. The 
logic gate enables the selection of one from a set of outputs by means of an address 
input. In the project, acid is chosen as an address input, in order to mimick the tumor 
microenvironment, and the outputs are assigned to be emission and photodynamic 
action. Acid controlled change of the roles of FRET donor and acceptor modules 
either activates or quenches one of the modules thus an output of the form of 
emission or singlet oxygen is selected accordingly. This enables the construction of a 
theranostic device with a promising logic gate construct which, once optimized 
accordingly, can find a real biological application.  
The project presented in Chapter 4 aims to carry the logic operation to a biologically 
meaningfull arena. Photosensitizer is optimized rationally to have response to acid of 
biological concentrations and glutathione. The latter input glutathione is reported to 
be elevated in cancer cells. Acid induced change in the absorption of the 
photosensitizer allows an increase of extinction at the wavelength of excitation and 
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activates it. However, an energy acceptor conjugated to PS via a reducible disulfide 
bond still deactivates it. Presence of the GSH enables the reduction of the bond and 
the photosensitizer becomes free. Activity of the PS is shown to be increased in the 
presence of both inputs in aqueous solution, hence, an AND logic gate is created for 
the development of a highly selective photodynamic therapy action.  
The third project (Chapter 5) is related to detection of chloride anion concetratin in 
acidic and neutral media. As a start, the response of fluorescent BODIPY-
triazolophane construct is shown to have response in organic solvent. An intriguing 
result is obtained considering the dynamic range of detection which ranges from 
micromolar to milimolar concentrations. The possible reasons of this large detection 
range and roles of other binding behaviour are investigated with a number of 
different control compounds lacking chloride binding pocket.  
The final project of this thesis (Chapter 6) is also related to applicability of molecular 
logic gates. The aim of the project is to integrate two simple logic gates such that the 
nature of each gate and the relay of the information from one to other have a 
practical meaning. An AND logic gate is used to control activity of a photosensitizer 
with acid and light. The output of this logic, which is singlet oxygen, is used by 
another logic gate to enhance the emission either in the form of another AND gate or 
an INHIBIT gate depending on the choice of inputs. By means of this concatenation, 
two gates are communicating with one another such that an activity of an activatable 
photosensitizer is monitored by the increase in the emission of a fluorescent reporter 
nearby within the micellar structure.  
Taking everything into consideration, this thesis successfully assigns functions to 
simple (AND) or more complex logic gates (DEMUX, integrated logic gates) and 
gives birth to new utilization for this nano-devices. In addition, a selective 
fluorescent sensor with a quite large dynamic response is introduced which can be 
optimized to work in aqueous solutions and find real applications.  
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